diethylcarbamazine has been researched along with Bancroftian Elephantiasis in 415 studies
Diethylcarbamazine: An anthelmintic used primarily as the citrate in the treatment of filariasis, particularly infestations with Wucheria bancrofti or Loa loa.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The efficacy of two strategies for control of Bancroftian filariasis using selective rather than community-wide diethylcarbamazine (DEC) chemotherapy was evaluated and compared in two endemic communities of north-eastern Tanzania, with pretreatment microfilariae (mf) prevalences of 22% and 38%, and geometric mean intensities (GMIs) of 668 mf/ml and 735 mf/ml of blood." | 9.08 | Selective diethylcarbamazine chemotherapy for control of Bancroftian filariasis in two communities of Tanzania: compared efficacy of a standard dose treatment and two semi-annual single dose treatments. ( Magnussen, P; Makunde, WH; Meyrowitsch, DW; Simonsen, PE, 1995) |
| " To compare the efficacy and side effects of ivermectin with those of diethylcarbamazine, the standard antifilarial treatment, we conducted a randomized, double-blind trial in 40 South Indian men with lymphatic filariasis caused by Wuchereria bancrofti." | 9.06 | A controlled trial of ivermectin and diethylcarbamazine in lymphatic filariasis. ( Frederick, S; Kumaraswami, V; Ottesen, EA; Perumal Pillai, SV; Prabhakar, R; Sadanandam, A; Tripathy, SP; Vijayasekaran, V, 1990) |
| "A pilot study for control of bancroftian filariasis through detection and treatment of microfilaria (mf) carriers and filaria disease cases with Diethylcarbamazine (DEC) undertaken in the rural areas of Srikakulam and Vizianagaram of Andhra Pradesh showed that this chemotherapeutic method of control of filaria in rural areas is feasible and acceptable to society." | 7.67 | Filariasis control in rural areas through detection and treatment with diethylcarbamazine. ( Biswas, H; Das, M; Narasimham, MV; Rao, VG; Sharma, SP; Yadava, RL, 1989) |
| "Two patients, one with Bancroftian filariasis and the other with onchocerciasis, and two healthy controls were treated with diethylcarbamazine (DEC)." | 7.67 | Increase in natural killer cell activity during diethylcarbamazine treatment of patients with filariasis. ( Bygbjerg, IC; Pedersen, BK; Svenson, M, 1987) |
| "This study was designed to reexamine the efficacy of diethylcarbamazine for bancroftian filariasis with special reference to changes in serum parasite antigen levels and antifilarial antibody titers after treatment." | 7.67 | Persistence of parasite antigenemia following diethylcarbamazine therapy of bancroftian filariasis. ( Ghosh, TK; Jain, DC; Santhanam, S; Sethumadhavan, KV; Weil, GJ, 1988) |
| "No other short-course oral treatment for onchocerciasis has been demonstrated to have macrofilaricidal activity." | 7.30 | A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis. ( Doe, F; Dubben, B; Fetcho, N; Fischer, K; Fischer, PU; Gordor, S; Goss, CW; Gyasi, ME; Hoerauf, A; Hong, AR; Kanza, E; King, CL; Laryea, R; Lew, D; Opoku, NO; Seidu, MA; Weil, GJ, 2023) |
| " In this double-blind, placebo-controlled study, the efficacy of local treatment of the affected limb combined with repeated doses of ivermectin or DEC, in preventing the occurrence of ADL in Brugia malayi lymphatic filariasis, was examined." | 6.69 | Prevention of acute adenolymphangitis in brugian filariasis: comparison of the efficacy of ivermectin and diethylcarbamazine, each combined with local treatment of the affected limb. ( Kumaraswami, V; Rajan, K; Shenoy, RK; Suma, TK, 1998) |
| " malayi, possibly due to reduced bioavailability in the lymphatic system." | 5.72 | Diethylcarbamazine mediated potentiation of emodepside induced paralysis requires TRP-2 in adult Brugia malayi. ( Kashyap, SS; Martin, RJ; McHugh, MA; Robertson, AP, 2022) |
| "punctulatus vector." | 5.35 | The impact of repeated rounds of mass drug administration with diethylcarbamazine plus albendazole on bancroftian filariasis in Papua New Guinea. ( Bockarie, MJ; Kastens, W; Kazura, JW; King, CL; Laney, SJ; Susapu, M; Weil, GJ; Williams, SA, 2008) |
| "Since bancroftian filariasis constituted a major public health problem on Little Kinmen (Liehyu District), Kinmen (Quemoy) Islands, a control programme was conducted on this island from 1970 to 1982." | 5.28 | Eradication of bancroftian filariasis by diethylcarbamazine-medicated common salt on Little Kinmen (Liehyu district), Kinmen (Quemoy) Islands, Republic of China. ( Fan, PC, 1990) |
| "The efficacy of two strategies for control of Bancroftian filariasis using selective rather than community-wide diethylcarbamazine (DEC) chemotherapy was evaluated and compared in two endemic communities of north-eastern Tanzania, with pretreatment microfilariae (mf) prevalences of 22% and 38%, and geometric mean intensities (GMIs) of 668 mf/ml and 735 mf/ml of blood." | 5.08 | Selective diethylcarbamazine chemotherapy for control of Bancroftian filariasis in two communities of Tanzania: compared efficacy of a standard dose treatment and two semi-annual single dose treatments. ( Magnussen, P; Makunde, WH; Meyrowitsch, DW; Simonsen, PE, 1995) |
| " To compare the efficacy and side effects of ivermectin with those of diethylcarbamazine, the standard antifilarial treatment, we conducted a randomized, double-blind trial in 40 South Indian men with lymphatic filariasis caused by Wuchereria bancrofti." | 5.06 | A controlled trial of ivermectin and diethylcarbamazine in lymphatic filariasis. ( Frederick, S; Kumaraswami, V; Ottesen, EA; Perumal Pillai, SV; Prabhakar, R; Sadanandam, A; Tripathy, SP; Vijayasekaran, V, 1990) |
| "Since diethylcarbamazine at the dosages used to treat filarial infections has little direct toxicity, most of the post-treatment reactions (termed Mazzotti reactions in onchocerciasis) result from the immunological inflammatory mechanisms activated in the process of clearing and killing the skin-swelling or blood-borne microfilariae." | 4.77 | Description, mechanisms and control of reactions to treatment in the human filariases. ( Ottesen, EA, 1987) |
| "Diethylcarbamazine citrate (DEC) is widely used to treat lymphatic filariasis and Tropical Pulmonary Eosinophilia." | 3.80 | Diethylcarbamazine inhibits NF-κB activation in acute lung injury induced by carrageenan in mice. ( Barbosa, KP; Donato, MA; Fragoso, IT; França, ME; Gomes, FO; Peixoto, CA; Ribeiro, EL; Rocha, SW; Rodrigues, GB; Santos, LA; Silva, AK; Silva, BS; Silva, TG, 2014) |
| " Croix to implement MDA for treatment of lymphatic filariasis and soil-transmitted helminthiasis by using once a year treatment with albendazole and diethylcarbamazine in a population of approximately 8 million persons." | 3.77 | Costs of integrated mass drug administration for neglected tropical diseases in Haiti. ( Baker, M; Brady, MA; Desir, L; Direny, A; Goldman, AS; Linehan, M; Oscard, R; Vely, JF, 2011) |
| "Diethylcarbamazine (DEC)-medicated salt was used to control bancroftian filariasis in 20 endemic counties and cities of Fujian Province in China." | 3.68 | Mass treatment of filariasis using DEC-medicated salt. ( Chen, Z; Huang, X; Liu, J; Tu, Z, 1992) |
| "A pilot study for control of bancroftian filariasis through detection and treatment of microfilaria (mf) carriers and filaria disease cases with Diethylcarbamazine (DEC) undertaken in the rural areas of Srikakulam and Vizianagaram of Andhra Pradesh showed that this chemotherapeutic method of control of filaria in rural areas is feasible and acceptable to society." | 3.67 | Filariasis control in rural areas through detection and treatment with diethylcarbamazine. ( Biswas, H; Das, M; Narasimham, MV; Rao, VG; Sharma, SP; Yadava, RL, 1989) |
| "A study was undertaken to explore the feasibility of treatment of clinical cases of filariasis by the Village Health Guides (VHG) and to assess the impact of different dose schedules by Diethylcarbamazine (DEC) on the frequency of acute attacks." | 3.67 | Feasibility of controlling lymphatic filarial diseases through primary health care system. ( Ghosh, TK; Kaur, R; Narasimham, MV; Narayana, MV; Patnaik, SK; Rao, CK, 1989) |
| "Two patients, one with Bancroftian filariasis and the other with onchocerciasis, and two healthy controls were treated with diethylcarbamazine (DEC)." | 3.67 | Increase in natural killer cell activity during diethylcarbamazine treatment of patients with filariasis. ( Bygbjerg, IC; Pedersen, BK; Svenson, M, 1987) |
| "This study was designed to reexamine the efficacy of diethylcarbamazine for bancroftian filariasis with special reference to changes in serum parasite antigen levels and antifilarial antibody titers after treatment." | 3.67 | Persistence of parasite antigenemia following diethylcarbamazine therapy of bancroftian filariasis. ( Ghosh, TK; Jain, DC; Santhanam, S; Sethumadhavan, KV; Weil, GJ, 1988) |
| "No other short-course oral treatment for onchocerciasis has been demonstrated to have macrofilaricidal activity." | 3.30 | A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis. ( Doe, F; Dubben, B; Fetcho, N; Fischer, K; Fischer, PU; Gordor, S; Goss, CW; Gyasi, ME; Hoerauf, A; Hong, AR; Kanza, E; King, CL; Laryea, R; Lew, D; Opoku, NO; Seidu, MA; Weil, GJ, 2023) |
| "One hundred sixty-four individuals were treated, and monitored for treatment emergent adverse events (TEAE)." | 3.30 | Safety and tolerability of moxidectin and ivermectin combination treatments for lymphatic filariasis in Côte d'Ivoire: A randomized controlled superiority study. ( Bjerum, CM; Budge, PJ; Fischer, PU; Gabo, PT; Goss, CW; King, CL; Koudou, BG; Lew, D; Ouattara, AF; Weil, GJ, 2023) |
| " Adverse events (AE) were assessed by active follow-up for 2 days and passive follow-up for an additional 5 days." | 3.11 | Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole + diethylcarbamazine + ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trial. ( Amuga, M; Bieb, S; Bjerum, C; Goss, CW; Howard, C; John, LN; Karl, S; Kerry, Z; King, CL; Kotty, B; Kualawi, M; Kumai, S; Laman, M; Lorry, L; Makita, L; O'Brian, K; Pomat, W; Robinson, LJ; Samuel, A; Tavul, L; Tisch, DJ; Wangi, J; Weil, GJ, 2022) |
| " Adverse events (AEs) were monitored actively for two days and passively for five more days." | 3.01 | An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India. ( Dwivedi, GP; Jambulingam, P; Krishnamoorthy, K; Kuttiatt, VS; Rahi, M; Raju, HKK; Somani, RK; Srividya, A; Subramanian, S; Suryaprakash, MK; Weil, GJ, 2021) |
| "Improved treatments for lymphatic filariasis (LF) could accelerate the global elimination program for this disease." | 3.01 | An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia. ( Alfian, R; Bogus, J; Christian, M; Destani, Y; Djuardi, Y; Fischer, PU; Iskandar, E; Lew, D; Lomiga, A; Maylasari, R; Minggu, D; Supali, T; Weil, GJ, 2021) |
| " Both treatments were well tolerated, and there were no serious adverse events." | 2.94 | Efficacy and Safety of a Single Dose of Ivermectin, Diethylcarbamazine, and Albendazole for Treatment of Lymphatic Filariasis in Côte d'Ivoire: An Open-label Randomized Controlled Trial. ( Aboulaye, M; Andersen, BJ; Bjerum, CM; King, CL; Kouadio, O; Koudou, BG; Marius, VK; Ouattara, AF; Weil, GJ, 2020) |
| "Lymphatic filariasis has remained endemic in Fiji despite repeated mass drug administration using the well-established and safe combination of diethylcarbamazine and albendazole (DA) since 2002." | 2.94 | The safety of combined triple drug therapy with ivermectin, diethylcarbamazine and albendazole in the neglected tropical diseases co-endemic setting of Fiji: A cluster randomised trial. ( Grobler, AC; Hardy, M; Kaldor, JM; Kama, M; King, CL; Robinson, LJ; Romani, L; Samuela, J; Steer, AC; Tuicakau, M; Weil, GJ; Whitfeld, MJ, 2020) |
| " Participants were monitored for adverse events (AE), parasite antigenemia, and microfilaremia." | 2.94 | Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster-randomized, community study. ( Beau de Rochars, VM; Bogus, J; Direny, AN; Dubray, CL; Ernest, JR; Fayette, CR; Goss, CW; Hast, M; Lemoine, JF; O'Brian, K; Pavilus, GE; Sabin, DF; Sircar, AD; Weil, GJ; Wiegand, RE, 2020) |
| " Adverse events (AEs) are common after LF treatment." | 2.90 | Systems analysis-based assessment of post-treatment adverse events in lymphatic filariasis. ( Andersen, BJ; Curtis, K; Fischer, PU; Hertz, MI; King, CL; Kupritz, J; Meite, A; Mitreva, M; Rosa, BA; Serge, T; Weil, GJ, 2019) |
| "In this open-label cohort study, treatment-naïve microfilaremic (>50 mf/mL, n = 32) and uninfected (circulating filarial antigen negative, n = 24) adults residing in Agboville district, Côte d'Ivoire, were treated with a single dose of IVM plus DEC plus ALB, and evaluated for adverse events (AEs) until 7 days post treatment." | 2.90 | Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'Ivoire. ( Bjerum, CM; Chhonker, YS; Edi, C; King, CL; Koudou, BG; Méité, A; Murry, DJ; Ouattara, AF; Penali, LK; Weil, GJ, 2019) |
| "The World Health Organization (WHO) currently recommends height or age-based dosing as alternatives to weight-based dosing for mass drug administration lymphatic filariasis (LF) elimination programs." | 2.90 | Dosing pole recommendations for lymphatic filariasis elimination: A height-weight quantile regression modeling approach. ( Dubray, C; Fischer, PU; Goss, CW; Hardy, M; Jambulingam, P; King, CL; Laman, M; Lemoine, JF; O'Brian, K; Robinson, LJ; Samuela, J; Schechtman, KB; Subramanian, S; Supali, T; Weil, GJ, 2019) |
| " This was independent of age (p = 0·27), symptomatic status (p = 0·57) and semi-annual/bi-annual dosing (p = 0·46)." | 2.84 | Lymphatic pathology in asymptomatic and symptomatic children with Wuchereria bancrofti infection in children from Odisha, India and its reversal with DEC and albendazole treatment. ( Agrawala, BK; Das, BK; Dwibedi, B; Horton, J; Kar, SK; Ramachandran, CP, 2017) |
| " The triple therapy had a similar adverse effect compared with the dual therapy group." | 2.82 | Efficacy and safety of triple therapy versus dual therapy for lymphatic filariasis: A systematic review and meta-analysis. ( Abd-Elsalam, S; Abdelazeem, B; Abuelazm, MT; Ashraf, M; Badr, H; Gamal, M, 2022) |
| " Adults were randomized into 2 treatment arms, DEC 6 mg/kg + ALB 400 mg (N = 12) or DEC 6 mg/kg + ALB 400 mg + IVM 200 μg/kg (N = 12), and monitored for microfilaria, parasite antigenemia, adverse events (AEs), and serum drug levels." | 2.82 | Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis. ( Baea, M; Fleckenstein, LL; Kazura, JW; King, CL; Lombore, B; Maki, E; Sanuku, N; Satofan, S; Schmidt, MS; Siba, PM; Thomsen, EK; Weil, GJ, 2016) |
| " In the absence of alternative drugs, the use of higher or more frequent dosing with the existing drugs needs to be explored." | 2.80 | A randomized controlled trial of increased dose and frequency of albendazole with standard dose DEC for treatment of Wuchereria bancrofti microfilaremics in Odisha, India. ( Dwibedi, B; Horton, J; Kar, SK; Kerketa, AS; Maharana, A; Mohanty, PC; Panda, SS; Ramachandran, CP, 2015) |
| " We assessed whether a single dose of doxycycline combined with the standard DEC regimen would reduce the incidence and severity of adverse reactions and increase the efficacy of standard treatment." | 2.75 | A single dose of doxycycline in combination with diethylcarbamazine for treatment of bancroftian filariasis. ( Nuchprayoon, S; Sanprasert, V; Sujariyakul, A, 2010) |
| "Global efforts to control lymphatic filariasis by annual mass treatment with DEC may have a beneficial effect on the HIV/AIDS epidemic in areas where HIV and lymphatic filariasis co-exist." | 2.73 | Effect of diethylcarbamazine on HIV load, CD4%, and CD4/CD8 ratio in HIV-infected adult Tanzanians with or without lymphatic filariasis: randomized double-blind and placebo-controlled cross-over trial. ( Dalgaard, P; Friis, H; Krarup, H; Magesa, S; Magnussen, P; Nielsen, NO; Simonsen, PE, 2007) |
| " The treatment arms administered with DEC alone and DEC+ALB demonstrated long-term benefits in reducing microfilaraemia significantly (P<0." | 2.72 | Impact of single dose of diethylcarbamazine and other antifilarial drug combinations on bancroftian filarial infection variables: assessment after 2 years. ( Dash, AP; Mani, TR; Munirathinam, A; Rajendran, R; Reuben, R; Sunish, IP, 2006) |
| "The Global Program for Elimination of Lymphatic Filariasis calls for mass drug administration for endemic populations outside of sub-Saharan Africa with a single dose of diethylcarbamazine (DEC) and albendazole (Alb) annually for 4-6 years." | 2.71 | A randomized clinical trial comparing single- and multi-dose combination therapy with diethylcarbamazine and albendazole for treatment of bancroftian filariasis. ( Ahmed, ES; El Setouhy, M; Farid, HA; Helmy, H; Hussain, O; Kandil, AM; Ramzy, RM; Weil, GJ, 2004) |
| " Safety was assessed by monitoring if adverse events (AEs) over 5 days affected daily acivities." | 2.71 | Safety, tolerability, efficacy and plasma concentrations of diethylcarbamazine and albendazole co-administration in a field study in an area endemic for lymphatic filariasis in India. ( Deshmukh, PR; Fleckenstein, L; Garg, BS; Gogtay, NJ; Ingole, NS; Kadam, VS; Karbwang, J; Kirodian, BG; Kshirsagar, NA; Lazdins-Helds, JK; Mehendale, AM; Rajgor, DD, 2004) |
| "A six-age class dosage schedule of Diethylcarbamazine (DEC) of 50mg (1-2 years), 100mg (3-4 years), 150mg (5-8 years), 200mg (9-11 years), 250mg (12-14 years) and 300mg for above 14 years is being adopted for annual single dose MDA for LF elimination treat Wuchereria bancrofti microfilaria carriers." | 2.71 | Tolerability and efficacy of a three-age class dosage schedule of Diethylcarbamazine citrate (DEC) in the treatment of microfilaria carriers of Wuchereria bancrofti and its implications in mass drug administration (MDA) strategy for elimination of lymphat ( Das, LK; Pani, SP; Vanamail, P, 2005) |
| " Both the DEC and albendazole were well tolerated when given alone or in combination, no adverse events being observed." | 2.70 | The pharmacokinetics, safety and tolerability of the co-administration of diethylcarbamazine and albendazole. ( Arun, SR; Fleckenstein, LL; John, A; Kumaraswami, V; Na-Bangchang, K; Shenoy, RK; Suma, TK, 2002) |
| "The global initiative to eradicate bancroftian filariasis currently relies on mass treatment with four to six annual doses of antifilarial drugs." | 2.70 | Mass treatment to eliminate filariasis in Papua New Guinea. ( Alexander, ND; Alpers, MP; Bockarie, F; Bockarie, MJ; Dimber, Z; Ibam, E; Kastens, W; Kazura, JW; Tisch, DJ, 2002) |
| "WHO has targeted lymphatic filariasis for elimination." | 2.69 | Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes. ( Alexander, ND; Alpers, MP; Bockarie, F; Bockarie, MJ; Dimber, Z; Hyun, P; Ibam, E; Kazura, JW, 1998) |
| " In this double-blind, placebo-controlled study, the efficacy of local treatment of the affected limb combined with repeated doses of ivermectin or DEC, in preventing the occurrence of ADL in Brugia malayi lymphatic filariasis, was examined." | 2.69 | Prevention of acute adenolymphangitis in brugian filariasis: comparison of the efficacy of ivermectin and diethylcarbamazine, each combined with local treatment of the affected limb. ( Kumaraswami, V; Rajan, K; Shenoy, RK; Suma, TK, 1998) |
| " As compared to results from other studies with diethylcarbamazine and IVER at different dosages and periodicities, the dosage of IVER 400 seems the most effective; but a yearly intake might not be sufficient." | 2.67 | Long-term efficacy of single-dose treatment with 400 micrograms.kg-1 of ivermectin in bancroftian filariasis: results at one year. ( Cartel, JL; Chanteau, S; Glaziou, P; Martin, PM; Moulia-Pelat, JP; Nguyen, LN, 1993) |
| "Diethylcarbamazine (DEC) was studied with and without 56 BaP." | 2.67 | Reduction of filaritic lymphoedema and elephantiasis by 5,6 benzo-alpha-pyrone (coumarin), and the effects of diethylcarbamazine (DEC). ( Casley-Smith, J; Casley-Smith, JR; Jamal, S, 1993) |
| "The use of ivermectin in lymphatic filariasis (both bancroftian and brugian) has been recently explored in several studies." | 2.67 | A comparative study of the efficacy and tolerability of single and split doses of ivermectin and diethylcarbamazine in periodic brugian filariasis. ( Kumaraswami, V; Rajan, K; Shenoy, RK; Thankom, S, 1993) |
| " Carriers were examined and questioned regarding their experience of adverse reactions, which were graded 0 to 3 according to severity, at 6, 12 and 24 hours and at 4 days after treatment." | 2.67 | Safety trial of single-dose treatments with a combination of ivermectin and diethylcarbamazine in bancroftian filariasis. ( Cartel, JL; Chanteau, S; Gay, VM; Glaziou, P; Martin, PM; Moulia-Pelat, JP; Nguyen, LN, 1993) |
| " The results observed during the 12-month period which followed this last treatment have confirmed that (i) in terms of immediate clearance or complete negativation of microfilaremia, the efficacy of ivermectin is higher than that of DEC (at dosage of 3 or 6 mg/kg), (ii) DEC is more effective than ivermectin in sustaining the reduction of microfilaremia over a longer period of time and (iii) the efficacy of repeated single doses of either DEC 3 mg/kg or ivermectin 100 mcg/kg is much higher when given semi-annually than annually." | 2.67 | Compared efficacy of repeated annual and semi-annual doses of ivermectin and diethylcarbamazine for prevention of Wuchereria bancrofti filariasis in French Polynesia. Final evaluation. ( Cardines, R; Cartel, JL; Martin, PM; Moulia-Pelat, JP; Nguyen Ngnoc, L; Plichart, R; Roux, JF; Spiegel, A, 1992) |
| "Centperazine treated patients showed significantly less side effects (8." | 2.67 | Double blind clinical trial on centperazine & DEC in bancroftian filariasis. ( Ali, ML; Das, BK; Das, PK; Mishra, AC; Mohapatra, BN; Rath, RN, 1990) |
| "We included randomized controlled trials (RCTs) and cluster-RCTs that compared albendazole to placebo or no placebo, or compared albendazole combined with a microfilaricidal drug to a microfilaricidal drug alone, given to people known to have lymphatic filariasis or communities where lymphatic filariasis was known to be endemic." | 2.61 | Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis. ( Budhathoki, SS; Garner, P; Johnson, S; Macfarlane, CL; Richardson, M, 2019) |
| "Flubendazole (FBZ) was approved in 1980 for the treatment of gastrointestinal nematode infections in both veterinary and human medicine." | 2.61 | Flubendazole as a macrofilaricide: History and background. ( Geary, TG; Mackenzie, CD; Silber, SA, 2019) |
| "The Global Programme to Eliminate Lymphatic Filariasis (GPELF) was launched in response to the call proposed at the 50th World Health Assembly." | 2.61 | Lessons from lymphatic filariasis elimination and the challenges of post-elimination surveillance in China. ( Fang, Y; Zhang, Y, 2019) |
| "To provide context for the results of a large-scale, international safety trial of MDA using triple drug therapy, we searched Ovid Medline for studies published from 1985-2017 that reported adverse events (AEs) following treatment of LF with IVM, DEC, ALB, or any combination of these medications." | 2.58 | Adverse events following single dose treatment of lymphatic filariasis: Observations from a review of the literature. ( Andersen, BJ; Budge, PJ; Herbert, C; Weil, GJ, 2018) |
| "The recurrences are common after such treatment." | 2.55 | New developments in chyluria after global programs to eliminate lymphatic filariasis. ( Abeygunasekera, AM; Balagobi, B; Sutharshan, K, 2017) |
| "Approximately 15 million people with lymphatic filariasis (LF) live in Southeast Asia." | 2.46 | Elimination of lymphatic filariasis in Southeast Asia. ( Bergquist, R; Chayabejara, S; Duong, S; Hernandez, L; Sudomo, M; Wu, WP, 2010) |
| "A successful experience of lymphatic filariasis control in the Republic of Korea is briefly reviewed." | 2.45 | Successful control of lymphatic filariasis in the Republic of Korea. ( Chai, JY; Cheun, HI; Cho, SH; Kim, TS; Kong, Y; Lee, JK; Lee, JS, 2009) |
| "Mass treatment with diethylcarbamazine (DEC)-medicated salt has been used in a number of places as a control measure for lymphatic filariasis." | 2.44 | Diethylcarbamazine (DEC)-medicated salt for community-based control of lymphatic filariasis. ( Adinarayanan, S; Critchley, J; Das, PK; Gelband, H, 2007) |
| "The Global Programme to Eliminate Lymphatic Filariasis recommends albendazole in combination with other antifilarial drugs." | 2.43 | Albendazole for the control and elimination of lymphatic filariasis: systematic review. ( Addiss, D; Critchley, J; Ejere, H; Gamble, C; Garner, P; Gelband, H, 2005) |
| "Mass treatment with albendazole co-administered with another antifilarial drug is part of a global programme to eliminate lymphatic filariasis." | 2.43 | Albendazole for lymphatic filariasis. ( Addiss, D; Critchley, J; Ejere, H; Gamble, C; Garner, P; Gelband, H, 2005) |
| "For diethylcarbamazine-albendazole treatment the average mf loss was approximately 83% (ranging from 54% to 100% in the different studies) and worm-productivity loss was 100% (in all studies)." | 2.43 | Model-based analysis of trial data: microfilaria and worm-productivity loss after diethylcarbamazine-albendazole or ivermectin-albendazole combination therapy against Wuchereria bancrofti. ( de Kraker, ME; Habbema, JD; Stolk, WA; van Oortmarssen, GJ, 2006) |
| "Mass treatment with albendazole, co-administered with another antifilarial drug, is being promoted as part of a global programme to eliminate lymphatic filariasis." | 2.42 | Albendazole for lymphatic filariasis. ( Addiss, D; Critchley, J; Ejere, H; Gamble, C; Garner, P; Gelband, H, 2004) |
| "The pathogenesis of lymphatic filariasis has been a matter of debate for many decades." | 2.41 | Pathogenesis of lymphatic disease in bancroftian filariasis: a clinical perspective. ( Dreyer, G; Figueredo-Silva, J; Norões, J; Piessens, WF, 2000) |
| " Both DEC and ivermectin show, as expected, an adverse event profile compatible with the destruction of microfilariae." | 2.41 | An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis. ( Addiss, DG; Awadzi, K; Beach, MJ; Belizario, VY; Dunyo, SK; Espinel, M; Gyapong, JO; Horton, J; Hossain, M; Ismail, MM; Jayakody, RL; Lammie, PJ; Lazdins, JK; Makunde, W; Ottesen, EA; Richard-Lenoble, D; Selve, B; Shenoy, RK; Simonsen, PE; Wamae, CN; Weerasooriya, MV; Witt, C, 2000) |
| "The global initiatives to eliminate lymphatic filariasis as a public health problem by the year 2020 have generated a great deal of debate in India, the largest endemic country." | 2.41 | Towards elimination of lymphatic filariasis in India. ( Augustin, DJ; Das, PK; Kumar, A; Ramaiah, KD, 2001) |
| "Thus, it is likely that patients with lymphatic filariasis present within the American health care system and may be overlooked." | 2.40 | Lymphatic filariasis in immigrants from developing countries. ( Cunningham, NM, 1997) |
| "Where lymphatic filariasis has diminished since about the 1950s, it has most frequently, though not always, been a direct result of chemotherapeutic intervention against the parasite." | 2.39 | Diethylcarbamazine salt in the control of lymphatic filariasis. ( Gelband, H, 1994) |
| "Lymphatic filariasis is the most widespread of human filarial infections, a group of vector-borne infestations." | 2.38 | Recent advances in the chemotherapy of lymphatic filariasis. ( Navaratnam, V, 1993) |
| "Tropical pulmonary eosinophilia is one of the many PIE syndromes [pulmonary infiltrates with eosinophilia (of the peripheral blood)]." | 2.38 | Tropical pulmonary eosinophilia. ( Nutman, TB; Ottesen, EA, 1992) |
| "As a result malayan and bancroftian filariasis were proclaimed to have reached the criterion of basic elimination in 1985 and 1987 respectively." | 2.38 | Filariasis and its control in Fujian, China. ( Chen, YN; Chen, Z; Huang, XH; Liu, JY; Liu, XJ; Tu, ZP; Weng, SP; Yang, FZ; Zhang, YZ; Zheng, GB, 1991) |
| "We conducted a community-based, observational, cohort event monitoring study to compare the types, frequency, severity, and predictors of adverse events following dual versus triple therapy in 20,421 eligible residents." | 1.91 | Comparative Safety Surveillance of Triple (IDA) Versus Dual Therapy (DA) in Mass Drug Administration for Elimination of Lymphatic Filariasis in Kenya: A Cohort Event Monitoring Study. ( Aklillu, E; Barry, A; Guantai, A; Khaemba, C; Kirui, E; Njenga, SM; Oluka, M; Omondi, WP; Parthasarathi, G, 2023) |
| " Pharmacokinetic parameters were determined using standard non-compartmental analysis methods." | 1.91 | Pharmacokinetics of Moxidectin combined with Albendazole or Albendazole plus Diethylcarbamazine for Bancroftian Filariasis. ( Alshehri, A; Bala, V; Bjerum, C; Budge, PJ; Chhonker, YS; Fischer, PU; Gabo, TP; King, CL; Koudou, BG; Meïté, A; Murry, DJ; Ouattara, AF; Weil, GJ, 2023) |
| "We used the introduction of the Japanese encephalitis (JE) vaccine in India as an example to understand more fully the process of introducing any new clinical product in India." | 1.72 | Lessons Learned from the Japanese Encephalitis Vaccine Introduction in India That Supported the Introduction of Ivermectin-Diethylcarbamazine-Albendazole for Lymphatic Filariasis Elimination. ( Ghosh, RS; Haldar, P; Jacobson, J, 2022) |
| " malayi, possibly due to reduced bioavailability in the lymphatic system." | 1.72 | Diethylcarbamazine mediated potentiation of emodepside induced paralysis requires TRP-2 in adult Brugia malayi. ( Kashyap, SS; Martin, RJ; McHugh, MA; Robertson, AP, 2022) |
| "These results demonstrate a clear dose-response relationship for the effect of ALB on clearance of CFA and microfilaremia." | 1.62 | Results From 2 Cohort Studies in Central Africa Show That Clearance of Wuchereria bancrofti Infection After Repeated Rounds of Mass Drug Administration With Albendazole Alone Is Closely Linked to Individual Adherence. ( Awaca-Uvon, NP; Boussinesq, M; Campillo, JT; Chesnais, CB; Kuyangisa-Simuna, G; Louya, F; Missamou, F; Pion, SDS; Tambwe, JP; Weil, GJ, 2021) |
| "Fear of adverse events (AEs) negatively affects compliance to mass drug administration (MDA) for lymphatic filariasis (LF) elimination program." | 1.56 | Frequency and Clinical Significance of Localized Adverse Events following Mass Drug Administration for Lymphatic Filariasis in an Endemic Area in South India. ( Krishnamoorthy, K; Kuttiatt, VS; Purushothaman, J; Somani, RK; Swaminathan, S; Weil, GJ, 2020) |
| "Achieving elimination of lymphatic filariasis (LF) as a public health problem requires a minimum of five effective rounds of mass drug administration (MDA) and demonstrating low prevalence in subsequent assessments." | 1.56 | Risk factors associated with failing pre-transmission assessment surveys (pre-TAS) in lymphatic filariasis elimination programs: Results of a multi-country analysis. ( Bah, Y; Baker, M; Batcho, W; Benjamin Didier, B; Bougma, R; Bougouma, C; Brady, M; Burgert-Brucker, CR; Coulibaly, YI; Doumbia, SS; Georges, N; Headland, M; Karim, MJ; Kraemer, J; Lemoine, JF; Marfo, B; Muheki, E; Mwingira, U; Ndayishimye, E; Nshala, A; Pangaribuan, HU; Rimal, P; Salissou, AB; Shoemaker, EA; Shott, J; Stelmach, R; Wijayanti, E; Yevstigneyeva, V; Zoerhoff, KL, 2020) |
| " This paper aims to describe Samoa's experience with program coverage and adverse events (AEs) in the first round of triple-drug MDA." | 1.56 | A community survey of coverage and adverse events following country-wide triple-drug mass drug administration for lymphatic filariasis elimination, Samoa 2018. ( Gass, K; Graves, PM; Kearns, T; Lau, CL; Mayfield, HJ; Naseri, T; Sheridan, S; Thomsen, R; Willis, GA, 2020) |
| "The Global Programme to Eliminate Lymphatic Filariasis (LF) is using mass drug administration (MDA) of antifilarial medications to treat filarial infections, prevent disease and interrupt transmission." | 1.56 | A triple-drug treatment regimen to accelerate elimination of lymphatic filariasis: From conception to delivery. ( Jacobson, JA; King, JD; Weil, GJ, 2020) |
| "Conventional oral therapy of lymphatic filariasis drugs is only effective to kill microfilariae in the bloodstream, but is often ineffective to kill adult filarial (macrofilariae) in the complex anatomy of the lymphatic system." | 1.51 | Solid lipid nanoparticle-based dissolving microneedles: A promising intradermal lymph targeting drug delivery system with potential for enhanced treatment of lymphatic filariasis. ( Anjani, QK; Donnelly, RF; McCarthy, HO; McCrudden, MTC; Permana, AD; Ramadon, D; Tekko, IA, 2019) |
| "Lymphatic filariasis is endemic in nine of the eleven Member States of the World Health Organization South East Asia Region." | 1.51 | How Thailand eliminated lymphatic filariasis as a public health problem. ( Boondej, P; Gopinath, D; Khuanyoung, N; Prempree, P; Ramaiah, KD; Rojanapanus, S; Santabutr, W; Thammapalo, S; Toothong, T, 2019) |
| " When distributing microfilaricides however, considerable care is needed to minimise the risk of severe adverse events (SAEs) in areas that are co-endemic for onchocerciasis or LF and loiasis." | 1.48 | Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns. ( Basáñez, MG; Cano, J; O'Hanlon, SJ; Pullan, RL; Rebollo, MP; Tekle, AH; Wanji, S; Zouré, HG, 2018) |
| "Endemicity of lymphatic filariasis (LF) in Cambodia was proven in 1956 when microfilariae were detected in mosquitos in the Kratié province." | 1.48 | How elimination of lymphatic filariasis as a public health problem in the Kingdom of Cambodia was achieved. ( Brady, MA; Char, MC; Huy, R; Khieu, V; Muth, S; Odermatt, P; Or, V; Ramaiah, KD; Sidwell, J; Tep, C; Tsuyuoka, R; Yajima, A, 2018) |
| "Chyluria, a chronic manifestation of lymphatic filariasis, is rare in children." | 1.48 | Chyluria in young child: a rare presentation. ( Garg, G; Goel, A; Goel, S; Singh, M, 2018) |
| "The Global Program to Eliminate Lymphatic Filariasis has achieved extraordinary success in reducing transmission and preventing morbidity through mass drug administration (MDA) to the population at-risk." | 1.48 | Effectiveness of annual single doses of diethylcarbamazine citrate among bancroftian filariasis infected individuals in an endemic area under mass drug administration in Brazil. ( Araújo, J; Braga, C; Brandão, E; da Silva, JSF; de Souza Melo, PFA; Duarte, FM; Feitosa Luna, C; Grilis, MR; Marcondes, M; Oliveira, P; Rocha, A, 2018) |
| "Lymphatic filariasis is widely endemic in Myanmar." | 1.48 | The prevalence of lymphatic filariasis infection and disease following six rounds of mass drug administration in Mandalay Region, Myanmar. ( Aye, NN; Bradbury, RS; Dickson, BFR; Douglass, J; Graves, PM; McBride, WJ; Nwe, TW; Shwe, M; Wai, T; Win, SS, 2018) |
| "The Tanzanian National Lymphatic Filariasis Elimination Programme reported annual treatment coverage for Rufiji District ranging from 54." | 1.46 | Lymphatic filariasis elimination efforts in Rufiji, southeastern Tanzania: decline in circulating filarial antigen prevalence in young school children after twelve rounds of mass drug administration and utilization of long-lasting insecticide-treated nets ( Derua, YA; Jones, C; Malecela, MN; Ngasalla, B; Tarimo, D, 2017) |
| "Lymphatic filariasis is one of the most debilitating and disfiguring scourges among all diseases." | 1.46 | Filarial breast lump. ( Mohapatra, DP; Mohapatra, MM; Panda, DK, 2017) |
| "The Global Programme to Eliminate Lymphatic Filariasis (LF) aims to eliminate the disease as a public health problem by 2020 by conducting mass drug administration (MDA) and controlling morbidity." | 1.46 | Detecting and confirming residual hotspots of lymphatic filariasis transmission in American Samoa 8 years after stopping mass drug administration. ( Andreosso, A; Fuimaono, S; Graves, PM; Lau, CL; Roineau, M; Ryan, S; Sheridan, S; Tufa, J, 2017) |
| "Lymphatic filariasis is a tropical parasitic disease and is endemic in India." | 1.46 | Filarial pleural effusion without peripheral blood or pleural fluid eosinophilia. ( Anantha, S; Chaudhary, A; Shukla, AD; Verma, AK, 2017) |
| "Lymphatic filariasis is targeted for elimination as a public health problem by 2020." | 1.46 | Effectiveness of a triple-drug regimen for global elimination of lymphatic filariasis: a modelling study. ( Hollingsworth, TD; Irvine, MA; Michael, E; Singh, BK; Smith, ME; Stolk, WA; Subramanian, S; Weil, GJ, 2017) |
| "Human lymphatic filariasis (LF) is a major cause of disability globally." | 1.43 | Circulating filarial antigen detection in brugian filariasis. ( Bhattacharya, SM; Mahajan, RC; Malla, N; Mewara, A; Sehgal, R; Shenoy, RK; Tripathi, PK, 2016) |
| "Lymphatic filariasis has been targeted for elimination by 2020, and a threshold of 65% coverage of mass drug administration (MDA) has been adopted by the Global Programme to Eliminate Lymphatic Filariasis (GPELF)." | 1.42 | Are we nearly there yet? Coverage and compliance of mass drug administration for lymphatic filariasis elimination. ( Alexander, ND, 2015) |
| " Albendazole (ALB) is being administered with diethyl carbamazine (DEC) in filariasis endemic areas to eliminate lymphatic filariasis (LF) and helminth infections." | 1.42 | Impact on prevalence of intestinal helminth infection in school children administered with seven annual rounds of diethyl carbamazine (DEC) with albendazole. ( Kalimuthu, M; Kumar, VA; Munirathinam, A; Nagaraj, J; Rajendran, R; Sunish, IP; Tyagi, BK, 2015) |
| "Under the Global Programme to Eliminate Lymphatic Filariasis (LF), mass drug administration (MDA) is being implemented in Tamil Nadu, south India, by the State health machinery." | 1.40 | Persistence of lymphatic filarial infection in the paediatric population of rural community, after six rounds of annual mass drug administrations. ( Ashok Kumar, V; Kalimuthu, M; Munirathinam, A; Sunish, IP; Tyagi, BK, 2014) |
| "Lymphatic filariasis is still endemic in many parts of India." | 1.40 | Measuring impact on filarial infection status in a community study: role of coverage of mass drug administration (MDA). ( Kumar, A; Sachan, P, 2014) |
| "The approaches are applied to a lymphatic filariasis study that motivated this study." | 1.39 | Semiparametric regression analysis of clustered interval-censored failure time data with informative cluster size. ( Sun, J; Zhang, X, 2013) |
| " Between August 1998 and July 1999, all individuals aged 8 months from Magoda and Mpapayu villages in north-eastern Tanzania, were administered with monthly low dose diethylcarbamazine (DEC) at a dosage of 50mg in children aged < 15 years and 100mg in adults aged ≥ 15 years." | 1.38 | Impact of insecticide treated mosquito nets and low dose monthly diethylcarbamazine on lymphatic filariasis infection between 1999 and 2004 in two endemic communities of north-eastern Tanzania. ( Bygbjerg, IC; Gesase, S; Lemnge, MM; Mmbando, BP; Segeja, MD, 2012) |
| "Adjusting MDA dosage schedules according to weight-for-age and sex may be may contribute to reduce the occurrence of adverse drug reactions in the population." | 1.38 | Adverse reactions following mass drug administration with diethylcarbamazine in lymphatic filariasis endemic areas in the Northeast of Brazil. ( Braga, C; Costa, GM; Lima, AW; Medeiros, Z; Santos, ZC, 2012) |
| "We present here a unique case of lymphatic filariasis." | 1.37 | A rare case of reversible acquired AA-type renal amyloidosis in a chronic filariasis patient receiving antifilarial therapy. ( Daga, MK; Garg, Sk; Kumar, R; Mohanty, PK; Nayak, HK; Pandey, BK; Sinha, Nk, 2011) |
| "Lymphatic filariasis is one of the major public health problems across the globe." | 1.37 | An uncommon infectious cause of pleural effusion. ( Aggarwal, A; Dev, M; Misra, K; Rajashekaraiah, LC; Sharma, V, 2011) |
| "Baseline lymphatic filariasis microfilarial age-prevalence data from three geographically distinct endemic regions, across which the major vector populations implicated in parasite transmission also differed, were used to fit and calibrate the relevant vector-specific filariasis transmission models." | 1.36 | Geographic and ecologic heterogeneity in elimination thresholds for the major vector-borne helminthic disease, lymphatic filariasis. ( Bockarie, M; Gambhir, M; Kazura, J; Michael, E; Remais, J; Spear, R; Tisch, D, 2010) |
| "Nearly 45% of people living at risk for lymphatic filariasis (LF) worldwide live in India." | 1.36 | Increasing compliance with mass drug administration programs for lymphatic filariasis in India through education and lymphedema management programs. ( Cantey, PT; Fox, LM; Rao, G; Rout, J; Williamson, J, 2010) |
| "Elephantiasis is a late manifestation of lymphatic filariasis, which apart from limbs may involve genitalia or breasts." | 1.35 | Clinical and pathological aspects of filarial lymphedema and its management. ( Shenoy, RK, 2008) |
| "punctulatus vector." | 1.35 | The impact of repeated rounds of mass drug administration with diethylcarbamazine plus albendazole on bancroftian filariasis in Papua New Guinea. ( Bockarie, MJ; Kastens, W; Kazura, JW; King, CL; Laney, SJ; Susapu, M; Weil, GJ; Williams, SA, 2008) |
| "The global program to eliminate lymphatic filariasis (LF) is currently based on mass drug administration (MDA) with annual single dose of antifilarials." | 1.35 | Clinicians' attitude on mass drug administration under the program to eliminate lymphatic filariasis: a qualitative study from Orissa, India. ( Babu, BV; Kerketta, AS, 2009) |
| "Lymphatic filariasis is increasingly viewed as the result of an infection that is often acquired in childhood." | 1.35 | Antifilarial drugs, in the doses employed in mass drug administrations by the Global Programme to Eliminate Lymphatic Filariasis, reverse lymphatic pathology in children with Brugia malayi infection. ( Dhananjayan, G; Kumaraswami, V; Padma, S; Rahmah, N; Shenoy, RK; Suma, TK, 2009) |
| "We report a case of huge filarial elephantiasis of the vulva, in a 40-year-old multipara with background history of secondary infertility." | 1.35 | Huge filarial elephantiasis vulvae in a Nigerian woman with subfertility. ( Adesiyun, AG; Samaila, MO, 2008) |
| "(1) Lymphatic filariasis is a set of parasitic diseases that are endemic in tropical and subtropical regions and can be disabling in the long term." | 1.35 | Lymphatic filariasis. ( , 2008) |
| "Lymphatic filariasis is targeted to be eliminated globally, at least as a public-health problem, by 2020." | 1.34 | Impact of the 2004 mass drug administration for the control of lymphatic filariasis, in urban and rural areas of the Western province of Sri Lanka. ( Bradley, MH; Gunawardena, GS; Ismail, MM; Karunaweera, ND, 2007) |
| " However, there is no uniform pattern either in the dosage of DEC or in the use of antibiotics." | 1.34 | Clinicians' practices related to management of filarial adenolymphangitis and lymphoedema in Orissa, India. ( Babu, BV; Kerketta, AS; Swain, BK, 2007) |
| "Because lymphatic filariasis (LF) elimination efforts are hampered by a dearth of economic information about the cost of mass drug administration (MDA) programs (using either albendazole with diethylcarbamazine [DEC] or albendazole with ivermectin), a multicenter study was undertaken to determine the costs of MDA programs to interrupt transmission of infection with LF." | 1.34 | National mass drug administration costs for lymphatic filariasis elimination. ( Aikins, M; Amarillo, ML; Belizario, VY; Brady, MA; Garshong, B; Goldman, AS; Guisinger, VH; Gyapong, J; Haddix, AC; Kabali, C; Kamal, HA; Kanjilal, S; Kyelem, D; Lizardo, J; Malecela, M; Mubyazi, G; Nitièma, PA; Ottesen, EA; Ramzy, RM; Rheingans, R; Streit, TG; Wallace, A, 2007) |
| "Current programmes to eliminate lymphatic filariasis (LF) are largely based on annual mass administrations of single doses of antifilarial drugs." | 1.33 | Pattern of community compliance with spaced, single-dose, mass administrations of diethylcarbamazine or ivermectin, for the elimination of lymphatic filariasis from rural areas of southern India. ( Das, PK; Pani, SP; Ramaiah, KD; Subramanian, S; Vanamail, P; Yuvaraj, J, 2005) |
| "Border bancroftian filariasis caused by Wuchereria bancrofti nocturnally subperiodic mainly exists in Karens residing alongside the Thailand-Myanmar border." | 1.33 | Border and imported bancroftian filariases: baseline seroprevalence in sentinel populations exposed to infections with Wuchereria bancrofti and concomitant HIV at the start of diethylcarbamazine mass treatment in Thailand. ( Bhumiratana, A; Gaewchaiyo, G; Koyadun, S; Limpairojn, N; Satitvipawee, P; Srisuphanunt, M, 2005) |
| "Wuchereria bancrofti-mediated lymphatic filariasis is widely prevalent." | 1.33 | Lymphatic filariasis: possible pathophysiological nexus with oxidative stress. ( Bhandari, Y; Ganesh, BB; Goswami, K; Kulkarni, S; Pal, BK; Reddy, MV, 2006) |
| "In India, the programme to eliminate lymphatic filariasis, which is largely based on mass administrations of diethylcarbamazine, has, in terms of coverage and compliance, been generally much less successful in urban areas than in rural communities." | 1.33 | Use of an inclusive-partnership strategy in urban areas of Orissa, India, to increase compliance in a mass drug administration for the control of lymphatic filariasis. ( Babu, BV; Behera, DK; Kar, SK; Kerketta, AS; Mishra, S; Rath, K; Swain, BK, 2006) |
| "The WHO Global Program to Eliminate Lymphatic Filariasis (WHO-FIL) needed a reliable supply of diethylcarbamazine citrate (DEC) of known acceptable quality at an affordable price, so in August 1999, it started the DEC Project." | 1.32 | Ensuring supplies of quality diethylcarbamazine citrate (DEC). ( Kitler, ME; Zagaria, N, 2003) |
| "Severe adverse reactions to lymphatic filariasis treatment using DEC with or without albendazole are uncommon." | 1.32 | Frequency, severity, and costs of adverse reactions following mass treatment for lymphatic filariasis using diethylcarbamazine and albendazole in Leogane, Haiti, 2000. ( Addiss, DG; Beach, MJ; Lafontant, J; Lammie, J; Lammie, PJ; McLaughlin, SI; Michel, MC; Radday, J; Rheingans, R, 2003) |
| "A two-arm community-based lymphatic filariasis elimination trial is being carried out in Tamil Nadu state, India to assess the effect of 2 annual single-dose mass drug administrations of diethylcarbamazine + albendazole (DEC + ALB) on microfilaraemia and antigenaemia in one arm, and diethylcarbamazine(DEC) alone in the other arm." | 1.32 | Impact of two annual single-dose mass drug administrations with diethylcarbamazine alone or in combination with albendazole on Wuchereria bancrofti microfilaraemia and antigenaemia in south India. ( Abdullah, SM; Arunachalam, N; Mani, TR; Munirathinam, A; Rajendran, R; Satyanarayana, K; Sunish, IP, 2004) |
| "In countries where bancroftian filariasis is endemic, lymphedema of the leg is a public health problem, particularly for women, who are disproportionately affected." | 1.32 | Histopathologic improvement with lymphedema management, Léogâne, Haiti. ( Addiss, DG; Guarner, J; Jones, TL; Louis-Charles, J; Valme, AL; Wilson, SF, 2004) |
| "Lymphatic filariasis is a widespread infectious disease of children in endemic areas, but little is known about the early lymphatic damage in children and its evolution, either with or without treatment." | 1.31 | Lymphatic filariasis in children: adenopathy and its evolution in two young girls. ( Amaral, F; Carvalho, K; Dreyer, G; Figueredo-Silva, J; Ottesen, EA, 2001) |
| " This indicates that an annual dosage scheme is applicable to high-endemicity areas." | 1.30 | Efficacy of five annual single doses of diethylcarbamazine for treatment of lymphatic filariasis in Fiji. ( Kimura, E; Koroivueta, J; Mataika, JU; Shimada, M, 1998) |
| "Diethylcarbamazine (DEC) treatment led to a significant increase in IgG and IgM levels in microfilaraemic individuals." | 1.30 | Antibody response to a filarial antigen fraction in individuals exposed to Wuchereria bancrofti infection in India. ( Bal, M; Das, MK, 1999) |
| "We initiated a longitudinal study of Bancroftian filariasis to improve understanding of dynamics and risk factors for infection in villages near Cairo, Egypt." | 1.30 | A longitudinal study of Bancroftian filariasis in the Nile Delta of Egypt: baseline data and one-year follow-up. ( Ahmed, ES; El Setouhy, M; Faris, R; Kandil, AM; Ramzy, RM; Weil, GJ, 1999) |
| "Adverse reactions following treatment of onchocerciasis and bancroftian filariasis are common and frequently severe." | 1.29 | Interleukin-6 and tumor necrosis factor in the pathogenesis of adverse reactions after treatment of lymphatic filariasis and onchocerciasis. ( Awadzi, K; Clark, IA; Francis, H; Ottesen, EA; Rockett, KA; Turner, PF, 1994) |
| "Treatment with diethylcarbamazine reversed both the physical and lymphoscintigraphic abnormalities." | 1.29 | Diethylcarbamazine-induced reversal of early lymphatic dysfunction in a patient with bancroftian filariasis: assessment with use of lymphoscintigraphy. ( Johnston, W; Kenney, RT; Moore, TA; Nutman, TB; Reynolds, JC, 1996) |
| "A control program for bancroftian filariasis was conducted on Kinmen Proper from 1970 to 1982." | 1.28 | Filariasis eradication on Kinmen Proper, Kinmen (Quemoy) Islands, Republic of China. ( Fan, PC, 1990) |
| " These results indicate that incomplete drug regimens, differences in serum drug levels, and inadequate drug dosage are not the primary causes of treatment failure and suggest there is a degree of parasite tolerance for DEC." | 1.28 | Evidence of nonsusceptibility to diethylcarbamazine in Wuchereria bancrofti. ( Dickinson, CM; Eberhard, ML; Lammie, PJ; Roberts, JM, 1991) |
| "One hundred thirty-two residents of a bancroftian filariasis-endemic area of Papua New Guinea (PNG) were treated with a 72 mg/kg dose of DEC." | 1.28 | Serological evaluation of the macrofilaricidal effects of diethylcarbamazine treatment in bancroftian filariasis. ( Alpers, MP; Day, KP; Garner, P; Kazura, JW; Mitchell, GF; Raiko, A; Spark, R; Weiss, N; Wenger, JD, 1991) |
| "Since bancroftian filariasis constituted a major public health problem on Little Kinmen (Liehyu District), Kinmen (Quemoy) Islands, a control programme was conducted on this island from 1970 to 1982." | 1.28 | Eradication of bancroftian filariasis by diethylcarbamazine-medicated common salt on Little Kinmen (Liehyu district), Kinmen (Quemoy) Islands, Republic of China. ( Fan, PC, 1990) |
| "In levamisole pretreated animals on the other hand, the 'take' was much lower (68." | 1.28 | Susceptibility of Mastomys natalensis to Brugia malayi following pretreatment with antifilarials. ( Murthy, PK; Sen, AB; Tyagi, K, 1990) |
| "The rate of bancroftian filariasis in the area was 39%." | 1.28 | Diethylcarbamazine in the control of bancroftian filariasis in the highly endemic Ok Tedi area of Papua New Guinea: phase 1. ( Bulungol, PK; Kereu, RK; Schuurkamp, GJ, 1990) |
| "Treatment with diethylcarbamazine (DEC) triggered a transient increase in serum levels of filarial antigens bearing the epitope recognized by the monoclonal antibody HC 11." | 1.28 | Parasite antigenemia in untreated and treated lymphatic filarial infections. ( Cheng, WF; Fang, RL; Piessens, WF; Tao, ZH; Xu, M; Zheng, HJ, 1990) |
| "Lymphangitis has not recurred." | 1.28 | Observations on the clinical manifestations and treatment of an experimental infection with Brugia malayi in man. ( Chen, YN; Fang, Z; Liu, JY; Tu, ZP; Wang, GQ, 1989) |
| "A combined weekly low dosage and short term standard dose treatment with diethylcarbamazine (DEC) to control Timorian filariasis is described." | 1.27 | Combined low dosage and short term standard dose treatment with diethylcarbamazine to control Timorian filariasis. ( Partono, F, 1985) |
| " A dosage of 6 mg diethylcarbamazine citrate (DEC-C)/kg body weight was administered either daily or weekly (total of 6 doses, 36 mg/kg body weight), and impact on B." | 1.27 | The effect of diethylcarbamazine citrate on incidence and recovery rates of Brugia malayi microfilaremia in Sabah, Malaysia. ( Chan, MK; Dennis, DT; Hiil, JL; Kan, SK; Lim, PK; Lim, TW; Mak, JW; Parmar, SS, 1988) |
| "Although acute tropical pulmonary eosinophilia (TPE) is well recognized as a manifestation of filarial infection, the processes that mediate the abnormalities of the lung in TPE are unknown." | 1.27 | Acute tropical pulmonary eosinophilia. Characterization of the lower respiratory tract inflammation and its response to therapy. ( Cornelius, MJ; Ferrans, VJ; Kumaraswami, V; Nutman, TB; O'Donnell, KM; Pinkston, P; Rom, WN; Takemura, T; Vijayan, VK; Yenokida, G, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 41 (9.88) | 18.7374 |
| 1990's | 94 (22.65) | 18.2507 |
| 2000's | 139 (33.49) | 29.6817 |
| 2010's | 99 (23.86) | 24.3611 |
| 2020's | 42 (10.12) | 2.80 |
| Authors | Studies |
|---|---|
| Sashidhara, KV | 1 |
| Singh, SP | 1 |
| Misra, S | 2 |
| Gupta, J | 1 |
| Misra-Bhattacharya, S | 2 |
| Niles, RA | 1 |
| Thickstun, CR | 1 |
| Cox, H | 1 |
| Dilliott, D | 2 |
| Burgert-Brucker, CR | 2 |
| Harding-Esch, EM | 1 |
| Clementson, N | 1 |
| Sampson, A | 1 |
| Alexandre, JS | 1 |
| Morice Trejos, AC | 1 |
| Scholte, RGC | 1 |
| Krentel, A | 5 |
| Abuelazm, MT | 1 |
| Abdelazeem, B | 1 |
| Badr, H | 1 |
| Gamal, M | 1 |
| Ashraf, M | 1 |
| Abd-Elsalam, S | 1 |
| Tavul, L | 3 |
| Laman, M | 5 |
| Howard, C | 2 |
| Kotty, B | 2 |
| Samuel, A | 2 |
| Bjerum, C | 2 |
| O'Brian, K | 3 |
| Kumai, S | 2 |
| Amuga, M | 1 |
| Lorry, L | 2 |
| Kerry, Z | 2 |
| Kualawi, M | 1 |
| Karl, S | 2 |
| Makita, L | 2 |
| John, LN | 1 |
| Bieb, S | 2 |
| Wangi, J | 2 |
| Weil, GJ | 44 |
| Goss, CW | 9 |
| Tisch, DJ | 4 |
| Pomat, W | 1 |
| King, CL | 20 |
| Robinson, LJ | 7 |
| Ghosh, RS | 1 |
| Haldar, P | 1 |
| Jacobson, J | 3 |
| King, JD | 3 |
| Rainima-Qaniuci, M | 1 |
| Lepaitai, HB | 1 |
| Bhagirov, R | 1 |
| Padmasiri, E | 1 |
| Naseri, T | 2 |
| Thomsen, R | 2 |
| Won, KY | 2 |
| Brant, TA | 1 |
| Dodd, E | 1 |
| Nua, MT | 1 |
| Utu, F | 1 |
| Tufa, A | 1 |
| Chutaro, E | 1 |
| Camacho, J | 1 |
| Suiaunoa-Scanlan, L | 1 |
| Thean, LJ | 1 |
| Mani, J | 1 |
| Hardy, M | 6 |
| Samuela, J | 6 |
| Romani, L | 3 |
| Kaldor, J | 1 |
| Steer, AC | 4 |
| Faktaufon, D | 1 |
| Bechu, V | 1 |
| Naqio, F | 1 |
| Sosene, V | 1 |
| Sekihara, M | 1 |
| Otaki, J | 1 |
| Buhagiar, TS | 1 |
| Yajima, A | 2 |
| Tripathi, B | 1 |
| Roy, N | 2 |
| Dhingra, N | 1 |
| Jambulingam, P | 8 |
| Subramanian, S | 14 |
| Krishnamoorthy, K | 11 |
| Supali, T | 8 |
| Fischer, P | 4 |
| Dubray, C | 3 |
| Fayette, C | 1 |
| Lemoine, JF | 6 |
| King, C | 1 |
| Fischer, PU | 10 |
| Timinao, L | 1 |
| Howard, SC | 1 |
| John, L | 1 |
| Albert, JM | 1 |
| Payne, M | 1 |
| Bjerum, CM | 5 |
| Kelly-Hope, L | 1 |
| Mandal, AK | 1 |
| Jana, JK | 1 |
| Gayen, S | 1 |
| Pal, AC | 1 |
| McLure, A | 1 |
| Graves, PM | 4 |
| Lau, C | 1 |
| Shaw, C | 1 |
| Glass, K | 1 |
| Sabesan, S | 5 |
| Hoti, SL | 4 |
| Srividya, A | 3 |
| Jain, T | 1 |
| Kumar, A | 4 |
| Rahi, M | 2 |
| Kashyap, SS | 2 |
| McHugh, MA | 1 |
| Robertson, AP | 2 |
| Martin, RJ | 2 |
| Opoku, NO | 1 |
| Doe, F | 1 |
| Dubben, B | 1 |
| Fetcho, N | 1 |
| Fischer, K | 1 |
| Gordor, S | 1 |
| Gyasi, ME | 1 |
| Hoerauf, A | 4 |
| Hong, AR | 1 |
| Kanza, E | 1 |
| Laryea, R | 1 |
| Lew, D | 4 |
| Seidu, MA | 1 |
| Greene, SE | 1 |
| Huang, Y | 1 |
| Curtis, KC | 1 |
| Khaemba, C | 1 |
| Barry, A | 1 |
| Omondi, WP | 2 |
| Kirui, E | 1 |
| Oluka, M | 1 |
| Parthasarathi, G | 1 |
| Njenga, SM | 3 |
| Guantai, A | 1 |
| Aklillu, E | 1 |
| Chhonker, YS | 2 |
| Bala, V | 1 |
| Ouattara, AF | 5 |
| Koudou, BG | 5 |
| Gabo, TP | 1 |
| Alshehri, A | 1 |
| Meïté, A | 3 |
| Budge, PJ | 3 |
| Murry, DJ | 2 |
| Gabo, PT | 1 |
| Williams, PDE | 1 |
| Andersen, BJ | 3 |
| Rosa, BA | 1 |
| Kupritz, J | 1 |
| Serge, T | 1 |
| Hertz, MI | 1 |
| Curtis, K | 1 |
| Mitreva, M | 1 |
| Aboulaye, M | 2 |
| Kouadio, O | 2 |
| Marius, VK | 2 |
| Permana, AD | 1 |
| Tekko, IA | 1 |
| McCrudden, MTC | 1 |
| Anjani, QK | 1 |
| Ramadon, D | 1 |
| McCarthy, HO | 1 |
| Donnelly, RF | 1 |
| Kuttiatt, VS | 2 |
| Somani, RK | 2 |
| Swaminathan, S | 2 |
| Purushothaman, J | 1 |
| Kama, M | 2 |
| Tuicakau, M | 2 |
| Whitfeld, MJ | 2 |
| Grobler, AC | 2 |
| Kaldor, JM | 2 |
| Shriram, AN | 1 |
| Premkumar, A | 1 |
| De, A | 1 |
| Paul, SK | 1 |
| Vijayachari, P | 1 |
| Kazura, JW | 10 |
| Zoerhoff, KL | 1 |
| Headland, M | 1 |
| Shoemaker, EA | 1 |
| Stelmach, R | 1 |
| Karim, MJ | 1 |
| Batcho, W | 1 |
| Bougouma, C | 1 |
| Bougma, R | 1 |
| Benjamin Didier, B | 1 |
| Georges, N | 1 |
| Marfo, B | 1 |
| Pangaribuan, HU | 1 |
| Wijayanti, E | 1 |
| Coulibaly, YI | 1 |
| Doumbia, SS | 1 |
| Rimal, P | 1 |
| Salissou, AB | 1 |
| Bah, Y | 1 |
| Mwingira, U | 1 |
| Nshala, A | 1 |
| Muheki, E | 1 |
| Shott, J | 1 |
| Yevstigneyeva, V | 1 |
| Ndayishimye, E | 1 |
| Baker, M | 3 |
| Kraemer, J | 1 |
| Brady, M | 1 |
| Dubray, CL | 1 |
| Sircar, AD | 1 |
| Beau de Rochars, VM | 2 |
| Bogus, J | 3 |
| Direny, AN | 7 |
| Ernest, JR | 1 |
| Fayette, CR | 2 |
| Hast, M | 1 |
| Pavilus, GE | 1 |
| Sabin, DF | 1 |
| Wiegand, RE | 1 |
| Campillo, JT | 1 |
| Awaca-Uvon, NP | 1 |
| Missamou, F | 1 |
| Tambwe, JP | 1 |
| Kuyangisa-Simuna, G | 1 |
| Louya, F | 1 |
| Boussinesq, M | 1 |
| Pion, SDS | 1 |
| Chesnais, CB | 2 |
| Sankari, T | 2 |
| Pani, SP | 12 |
| Das, PK | 25 |
| Willis, GA | 1 |
| Mayfield, HJ | 1 |
| Kearns, T | 1 |
| Gass, K | 1 |
| Sheridan, S | 2 |
| Lau, CL | 2 |
| Ottesen, EA | 15 |
| Horton, J | 5 |
| Jacobson, JA | 2 |
| Njomo, DW | 2 |
| Kimani, BW | 1 |
| Kibe, LW | 1 |
| Okoyo, C | 1 |
| Sultani, HM | 1 |
| Raju, HKK | 1 |
| Suryaprakash, MK | 1 |
| Dwivedi, GP | 1 |
| Basker, N | 1 |
| Beau de Rochars, M | 2 |
| Ga, AL | 1 |
| Mallya, S | 1 |
| Schechtman, KB | 2 |
| Andersen, B | 1 |
| Djuardi, Y | 2 |
| Christian, M | 1 |
| Iskandar, E | 1 |
| Alfian, R | 1 |
| Maylasari, R | 1 |
| Destani, Y | 1 |
| Lomiga, A | 1 |
| Minggu, D | 1 |
| Agrawal, S | 1 |
| Singh, M | 2 |
| Phulware, RH | 1 |
| Gonzales, M | 1 |
| Noland, GS | 2 |
| Mariano, EF | 1 |
| Blount, S | 2 |
| Modi, A | 1 |
| Gamit, S | 1 |
| Jesalpura, BS | 1 |
| Kurien, G | 1 |
| Kosambiya, JK | 1 |
| Jones, C | 1 |
| Ngasalla, B | 1 |
| Derua, YA | 1 |
| Tarimo, D | 1 |
| Malecela, MN | 1 |
| Abeygunasekera, AM | 1 |
| Sutharshan, K | 1 |
| Balagobi, B | 1 |
| Ojha, CR | 1 |
| Joshi, B | 1 |
| Kc, KP | 1 |
| Dumre, SP | 1 |
| Yogi, KK | 1 |
| Bhatta, B | 1 |
| Adhikari, T | 1 |
| Crowley, K | 2 |
| Marasini, BR | 1 |
| Smith, ME | 4 |
| Singh, BK | 2 |
| Michael, E | 7 |
| Kshirsagar, NA | 2 |
| Gogtay, NJ | 2 |
| Garg, BS | 2 |
| Deshmukh, PR | 2 |
| Rajgor, DD | 2 |
| Kadam, VS | 2 |
| Thakur, PA | 1 |
| Gupta, A | 2 |
| Ingole, NS | 2 |
| Lazdins-Helds, JK | 2 |
| Panda, DK | 1 |
| Mohapatra, DP | 1 |
| Mohapatra, MM | 1 |
| Ryan, S | 1 |
| Roineau, M | 1 |
| Andreosso, A | 1 |
| Fuimaono, S | 1 |
| Tufa, J | 1 |
| Shukla, AD | 1 |
| Chaudhary, A | 1 |
| Verma, AK | 1 |
| Anantha, S | 1 |
| Kar, SK | 6 |
| Dwibedi, B | 2 |
| Das, BK | 2 |
| Agrawala, BK | 1 |
| Ramachandran, CP | 2 |
| Lammie, PJ | 17 |
| Eberhard, ML | 10 |
| Addiss, DG | 10 |
| Milord, MD | 1 |
| Lafontant, JG | 3 |
| Streit, TG | 6 |
| Rao, RU | 4 |
| Samarasekera, SD | 4 |
| Nagodavithana, KC | 4 |
| Dassanayaka, TDM | 2 |
| Punchihewa, MW | 3 |
| Ranasinghe, USB | 3 |
| Cano, J | 1 |
| Basáñez, MG | 1 |
| O'Hanlon, SJ | 1 |
| Tekle, AH | 1 |
| Wanji, S | 1 |
| Zouré, HG | 1 |
| Rebollo, MP | 2 |
| Pullan, RL | 1 |
| Khieu, V | 1 |
| Or, V | 1 |
| Tep, C | 1 |
| Odermatt, P | 1 |
| Tsuyuoka, R | 1 |
| Char, MC | 1 |
| Brady, MA | 3 |
| Sidwell, J | 1 |
| Huy, R | 1 |
| Ramaiah, KD | 17 |
| Muth, S | 1 |
| Garg, G | 1 |
| Goel, A | 3 |
| Goel, S | 1 |
| Khan, AM | 2 |
| Herbert, C | 1 |
| Stolk, WA | 7 |
| Prada, JM | 2 |
| Kontoroupis, P | 1 |
| de Vos, AS | 1 |
| Touloupou, P | 1 |
| Irvine, MA | 2 |
| Brown, P | 1 |
| Kloek, M | 1 |
| Hollingsworth, TD | 2 |
| de Vlas, SJ | 3 |
| Mendis, D | 1 |
| da Silva, JSF | 1 |
| Braga, C | 3 |
| Duarte, FM | 1 |
| Oliveira, P | 1 |
| Feitosa Luna, C | 1 |
| Marcondes, M | 1 |
| Araújo, J | 1 |
| Grilis, MR | 1 |
| de Souza Melo, PFA | 1 |
| Brandão, E | 1 |
| Rocha, A | 3 |
| Garchitorena, A | 1 |
| Raza-Fanomezanjanahary, EM | 1 |
| Mioramalala, SA | 1 |
| Ratsimbasoa, CA | 1 |
| Ramarosata, H | 1 |
| Bonds, MH | 1 |
| Rabenantoandro, H | 1 |
| Diwakar, DK | 1 |
| Wadhwani, N | 1 |
| Prasad, N | 1 |
| Reaves, BJ | 1 |
| Wallis, C | 1 |
| McCoy, CJ | 1 |
| Lorenz, WW | 1 |
| Rada, B | 1 |
| Wolstenholme, AJ | 1 |
| Rajaiah Prabhu, P | 1 |
| Moorthy, SD | 1 |
| Madhumathi, J | 1 |
| Pradhan, SN | 1 |
| Perbandt, M | 1 |
| Betzel, C | 1 |
| Kaliraj, P | 1 |
| Suamani, J | 1 |
| Sanuku, N | 3 |
| Cheng, YC | 1 |
| Satofan, S | 2 |
| Mancuso, B | 1 |
| Siba, PM | 3 |
| Dickson, BFR | 1 |
| Aye, NN | 1 |
| Nwe, TW | 1 |
| Wai, T | 1 |
| Win, SS | 1 |
| Shwe, M | 1 |
| Douglass, J | 1 |
| Bradbury, RS | 1 |
| McBride, WJ | 1 |
| Minetti, C | 1 |
| Tettevi, EJ | 1 |
| Mechan, F | 1 |
| Idun, B | 1 |
| Biritwum, NK | 1 |
| Osei-Atweneboana, MY | 1 |
| Reimer, LJ | 1 |
| Macfarlane, CL | 1 |
| Budhathoki, SS | 1 |
| Johnson, S | 1 |
| Richardson, M | 1 |
| Garner, P | 5 |
| Geary, TG | 2 |
| Mackenzie, CD | 2 |
| Silber, SA | 1 |
| Onakpoya, IJ | 1 |
| Edi, C | 1 |
| Penali, LK | 1 |
| Rojanapanus, S | 1 |
| Toothong, T | 2 |
| Boondej, P | 1 |
| Thammapalo, S | 1 |
| Khuanyoung, N | 1 |
| Santabutr, W | 1 |
| Prempree, P | 1 |
| Gopinath, D | 1 |
| Sharma, S | 1 |
| Reimer, J | 1 |
| O'Brien, DB | 1 |
| Brissau, JM | 2 |
| Donahue, MC | 1 |
| Carter, CE | 1 |
| Fang, Y | 1 |
| Zhang, Y | 1 |
| Nandha, B | 3 |
| Das, LK | 3 |
| Govindaraj, V | 1 |
| Abd Elaziz, KM | 2 |
| El-Setouhy, M | 3 |
| Bradley, MH | 2 |
| Ramzy, RM | 9 |
| Bockarie, MJ | 5 |
| Roy, RN | 1 |
| Sarkar, AP | 1 |
| Misra, R | 1 |
| Chakroborty, A | 1 |
| Mondal, TK | 1 |
| Bag, K | 1 |
| Zhang, X | 1 |
| Sun, J | 1 |
| Eddy, BA | 1 |
| Blackstock, AJ | 1 |
| Williamson, JM | 1 |
| Fox, LM | 3 |
| Sunish, IP | 14 |
| Munirathinam, A | 12 |
| Kalimuthu, M | 5 |
| Ashok Kumar, V | 3 |
| Tyagi, BK | 8 |
| Babu, BV | 9 |
| Babu, GR | 1 |
| Schmidt, MS | 2 |
| Thomsen, EK | 2 |
| Fleckenstein, L | 2 |
| Adhikari, RK | 1 |
| Sherchand, JB | 1 |
| Mishra, SR | 1 |
| Ranabhat, K | 1 |
| Wagle, RR | 1 |
| Sachan, P | 1 |
| Santos, LA | 1 |
| Ribeiro, EL | 1 |
| Barbosa, KP | 1 |
| Fragoso, IT | 1 |
| Gomes, FO | 1 |
| Donato, MA | 1 |
| Silva, BS | 1 |
| Silva, AK | 1 |
| Rocha, SW | 1 |
| França, ME | 1 |
| Rodrigues, GB | 1 |
| Silva, TG | 1 |
| Peixoto, CA | 2 |
| Rajendran, R | 13 |
| Nagaraj, J | 4 |
| Wijegunawardana, AD | 1 |
| Premakumara, WD | 1 |
| Perera, SN | 1 |
| Settinayake, S | 1 |
| Miller, JP | 1 |
| Alexander, ND | 3 |
| Bulman, CA | 1 |
| Bidlow, CM | 1 |
| Lustigman, S | 1 |
| Cho-Ngwa, F | 1 |
| Williams, D | 1 |
| Rascón, AA | 1 |
| Tricoche, N | 1 |
| Samje, M | 1 |
| Bell, A | 1 |
| Suzuki, B | 1 |
| Lim, KC | 1 |
| Supakorndej, N | 1 |
| Supakorndej, P | 1 |
| Wolfe, AR | 1 |
| Knudsen, GM | 1 |
| Chen, S | 1 |
| Wilson, C | 1 |
| Ang, KH | 1 |
| Arkin, M | 1 |
| Gut, J | 1 |
| Franklin, C | 1 |
| Marcellino, C | 1 |
| McKerrow, JH | 1 |
| Debnath, A | 1 |
| Sakanari, JA | 1 |
| Kerketa, AS | 1 |
| Maharana, A | 1 |
| Panda, SS | 1 |
| Mohanty, PC | 1 |
| Kumar, VA | 3 |
| Arunachalam, N | 5 |
| White, GB | 2 |
| Tipayamongkholgul, M | 1 |
| Suwannapong, N | 1 |
| Suvannadabba, S | 1 |
| Baea, M | 1 |
| Maki, E | 1 |
| Lombore, B | 1 |
| Fleckenstein, LL | 2 |
| Gonzalez, M | 1 |
| Lemnge, MM | 1 |
| Mmbando, BP | 1 |
| Segeja, MD | 1 |
| Gesase, S | 1 |
| Bygbjerg, IC | 2 |
| Tripathi, PK | 1 |
| Mahajan, RC | 2 |
| Malla, N | 2 |
| Mewara, A | 1 |
| Bhattacharya, SM | 1 |
| Shenoy, RK | 10 |
| Sehgal, R | 1 |
| Kushwaha, V | 1 |
| Saxena, K | 1 |
| Verma, R | 1 |
| Verma, SK | 1 |
| Katoch, D | 1 |
| Kumar, N | 1 |
| Lal, B | 1 |
| Murthy, PK | 2 |
| Singh, B | 1 |
| Honorato, SB | 1 |
| da Silva, CC | 1 |
| de Oliveira, YS | 1 |
| Mendonça, JS | 1 |
| Boechat, N | 1 |
| Ellena, J | 1 |
| Ayala, AP | 1 |
| Vinubala, C | 1 |
| Desormeaux, AM | 1 |
| Monestime, F | 1 |
| Desir, L | 2 |
| Carciunoiu, S | 1 |
| Miller, L | 1 |
| Knipes, A | 1 |
| Lammie, P | 3 |
| Smith, P | 1 |
| Stockton, M | 1 |
| Trofimovich, L | 1 |
| Bhandari, K | 1 |
| Reithinger, R | 1 |
| Ottesen, E | 1 |
| Mupfasoni, D | 1 |
| Montresor, A | 1 |
| Mikhailov, A | 1 |
| King, J | 1 |
| Ndeffo-Mbah, ML | 1 |
| Galvani, AP | 1 |
| Gaur, MK | 1 |
| Gupta, S | 1 |
| Wamae, CN | 5 |
| Mwandawiro, CS | 1 |
| Molyneux, DH | 2 |
| Gunawardena, NK | 1 |
| Amarasekera, ND | 1 |
| Pathmeswaran, A | 2 |
| de Silva, NR | 2 |
| Gunawardena, S | 1 |
| Sri Ranganathan, S | 1 |
| Fernandopulle, R | 1 |
| Chanteau, S | 4 |
| Roux, JF | 9 |
| Nielsen, NO | 3 |
| Simonsen, PE | 5 |
| Kaestel, P | 1 |
| Krarup, H | 2 |
| Magnussen, P | 3 |
| Magesa, S | 2 |
| Friis, H | 2 |
| Kastens, W | 3 |
| Susapu, M | 1 |
| Laney, SJ | 1 |
| Williams, SA | 1 |
| Wijesinghe, RS | 1 |
| Wickremasinghe, AR | 1 |
| Ekanayake, S | 1 |
| Perera, MS | 1 |
| Kerketta, AS | 5 |
| Lahariya, C | 2 |
| Mishra, A | 1 |
| Suma, TK | 6 |
| Kumaraswami, V | 12 |
| Rahmah, N | 1 |
| Dhananjayan, G | 1 |
| Padma, S | 1 |
| Thiruvengadam, B | 1 |
| Vanamail, P | 13 |
| Gunasekaran, S | 1 |
| Nilamani, N | 1 |
| Petersen, HH | 1 |
| Monrad, J | 1 |
| Magesa, SM | 1 |
| Norões, J | 4 |
| Figueredo-Silva, J | 4 |
| Dreyer, G | 10 |
| Mand, S | 1 |
| Pfarr, K | 1 |
| Sahoo, PK | 1 |
| Satapathy, AK | 1 |
| Specht, S | 1 |
| Klarmann, U | 1 |
| Debrah, AY | 1 |
| Ravindran, B | 3 |
| Bhumiratana, A | 3 |
| Pechgit, P | 1 |
| Koyadun, S | 3 |
| Siriaut, C | 2 |
| Yongyuth, P | 1 |
| Dixit, V | 2 |
| Gupta, AK | 2 |
| Prasad, GB | 4 |
| Cheun, HI | 1 |
| Kong, Y | 1 |
| Cho, SH | 1 |
| Lee, JS | 2 |
| Chai, JY | 1 |
| Lee, JK | 1 |
| Kim, TS | 1 |
| Mukhopadhyay, AK | 3 |
| Ranganath, BG | 1 |
| Gambhir, M | 1 |
| Bockarie, M | 2 |
| Tisch, D | 1 |
| Kazura, J | 2 |
| Remais, J | 1 |
| Spear, R | 1 |
| Sudomo, M | 1 |
| Chayabejara, S | 1 |
| Duong, S | 1 |
| Hernandez, L | 2 |
| Wu, WP | 1 |
| Bergquist, R | 1 |
| Cantey, PT | 1 |
| Rout, J | 1 |
| Rao, G | 1 |
| Williamson, J | 1 |
| Taylor, MJ | 2 |
| Zielinski-Gutierrez, E | 1 |
| Pa'au, M | 1 |
| Ngugi, BM | 1 |
| Mbui, J | 1 |
| Njaanake, HK | 1 |
| Tan, LH | 1 |
| Fong, MY | 1 |
| Mahmud, R | 1 |
| Muslim, A | 1 |
| Lau, YL | 1 |
| Kamarulzaman, A | 1 |
| Sanprasert, V | 1 |
| Sujariyakul, A | 1 |
| Nuchprayoon, S | 1 |
| Tomar, SS | 1 |
| Nayak, HK | 1 |
| Daga, MK | 1 |
| Garg, Sk | 1 |
| Sinha, Nk | 1 |
| Kumar, R | 1 |
| Mohanty, PK | 1 |
| Pandey, BK | 1 |
| Ramasamy, D | 1 |
| Laxmanappa, HS | 1 |
| Sharma, R | 1 |
| Das, MK | 2 |
| Yuvaraj, J | 4 |
| Jeremiah, CJ | 1 |
| Aboltins, CA | 1 |
| Stanley, PA | 1 |
| Ray, D | 1 |
| Harikrishna, S | 1 |
| Immanuel, C | 1 |
| Victor, L | 1 |
| Subramanyam, S | 1 |
| Moss, DM | 1 |
| Priest, JW | 1 |
| Boyd, A | 1 |
| Weinkopff, T | 1 |
| Kucerova, Z | 1 |
| Beach, MJ | 6 |
| Aggarwal, A | 1 |
| Rajashekaraiah, LC | 1 |
| Misra, K | 1 |
| Dev, M | 1 |
| Sharma, V | 1 |
| Goldman, AS | 2 |
| Direny, A | 1 |
| Oscard, R | 1 |
| Vely, JF | 1 |
| Linehan, M | 1 |
| Lima, AW | 1 |
| Medeiros, Z | 5 |
| Santos, ZC | 1 |
| Costa, GM | 1 |
| Sharma, DC | 1 |
| Kasturiratne, KT | 1 |
| Premaratne, BA | 1 |
| de Silva, HJ | 1 |
| Mwandawiro, C | 1 |
| Wambayi, E | 1 |
| Njenga, S | 1 |
| Kiliku, F | 1 |
| Ismid, IS | 1 |
| Rückert, P | 2 |
| Helmy, H | 5 |
| Kandil, AM | 4 |
| Ahmed, ES | 5 |
| Farid, HA | 3 |
| Faris, R | 3 |
| John, A | 2 |
| Arun, SR | 1 |
| Na-Bangchang, K | 1 |
| Mani, TR | 7 |
| Satyanarayana, K | 5 |
| Dimber, Z | 3 |
| Bockarie, F | 2 |
| Ibam, E | 2 |
| Alpers, MP | 4 |
| Ma, XW | 1 |
| Zhang, XQ | 1 |
| Xu, YL | 1 |
| Shi, ZJ | 1 |
| Sun, DJ | 1 |
| Wang, ZJ | 1 |
| Tao, ZH | 7 |
| Pan, SX | 1 |
| Liu, XJ | 2 |
| Zhang, SQ | 1 |
| Ou, ZY | 1 |
| Zhu, SZ | 1 |
| Li, QJ | 1 |
| Chang, J | 1 |
| Wu, RZ | 1 |
| Deng, SS | 2 |
| Zheng, XQ | 1 |
| Burkot, TR | 1 |
| Taleo, G | 2 |
| Toeaso, V | 1 |
| Ichimori, K | 1 |
| Chang, MS | 2 |
| Reuben, R | 3 |
| Curtis, CF | 1 |
| Malecela-Lazaro, M | 1 |
| Maxwell, CA | 1 |
| Kitler, ME | 1 |
| Zagaria, N | 1 |
| McLaughlin, SI | 1 |
| Radday, J | 4 |
| Michel, MC | 1 |
| Lammie, J | 1 |
| Rheingans, R | 2 |
| Lafontant, J | 1 |
| Pacella, M | 1 |
| Corbu, C | 1 |
| Naselli, A | 1 |
| Quilici, P | 1 |
| Carmignani, G | 1 |
| Chaubal, NG | 1 |
| Pradhan, GM | 1 |
| Chaubal, JN | 1 |
| Ramani, SK | 1 |
| PRASAD, BN | 1 |
| van Oortmarssen, GJ | 3 |
| Habbema, JD | 4 |
| Dean, M | 1 |
| Addiss, D | 5 |
| Critchley, J | 4 |
| Ejere, H | 3 |
| Gelband, H | 5 |
| Gamble, C | 3 |
| El Setouhy, M | 4 |
| Hussain, O | 2 |
| Abdullah, SM | 1 |
| Kirodian, BG | 1 |
| Mehendale, AM | 1 |
| Karbwang, J | 1 |
| Ramirez, BL | 1 |
| Alberto, FF | 1 |
| Collins, M | 1 |
| Nfonsam, V | 1 |
| Punsalan, T | 1 |
| Kron, MA | 1 |
| Maizels, RM | 3 |
| Dash, AP | 5 |
| Melrose, WD | 2 |
| De Rochars, MB | 3 |
| Roberts, JM | 5 |
| Dardith, D | 1 |
| Hussein, O | 1 |
| Joseph, A | 1 |
| Mony, P | 1 |
| Prasad, M | 1 |
| John, S | 1 |
| Mathai, D | 1 |
| Wilson, SF | 2 |
| Guarner, J | 1 |
| Valme, AL | 1 |
| Louis-Charles, J | 2 |
| Jones, TL | 1 |
| Schellekens, SM | 1 |
| Ananthakrishnan, S | 1 |
| Ravi, R | 3 |
| Satitvipawee, P | 2 |
| Furness, BW | 1 |
| Haser, JK | 1 |
| Srisuphanunt, M | 1 |
| Limpairojn, N | 1 |
| Gaewchaiyo, G | 1 |
| Rath, K | 3 |
| Jangid, PK | 1 |
| Nayak, AN | 1 |
| McCarthy, J | 1 |
| Fraser, M | 1 |
| Taleo, F | 1 |
| Yaviong, J | 1 |
| Amos, M | 1 |
| Babu, M | 1 |
| Kalkoa, M | 1 |
| Kanjilal, S | 2 |
| Mathieu, E | 2 |
| Rheingans, RD | 1 |
| Haddix, AC | 2 |
| Swain, BK | 3 |
| Mishra, S | 3 |
| Ellethy, AS | 1 |
| Setouhy, ME | 1 |
| Reddy, GS | 2 |
| Venkatesvarlou, N | 1 |
| Vijayan, AP | 1 |
| Pal, BK | 1 |
| Kulkarni, S | 1 |
| Bhandari, Y | 1 |
| Ganesh, BB | 1 |
| Goswami, K | 1 |
| Reddy, MV | 1 |
| de Kraker, ME | 1 |
| Vijay Kumar, KN | 2 |
| Hosein, E | 1 |
| Krishnamoorthy, P | 1 |
| Augustin, DJ | 4 |
| Snehalatha, KS | 1 |
| Nanda, B | 1 |
| Malecela-Lazaro, MN | 2 |
| Behera, DK | 1 |
| Manoempil, P | 1 |
| Servais, G | 1 |
| Makunde, WH | 2 |
| Kamugisha, ML | 1 |
| Makunde, RA | 1 |
| Kitua, AY | 1 |
| Srivastava, K | 1 |
| Vedi, S | 1 |
| Srivastava, S | 1 |
| Adinarayanan, S | 1 |
| Bisen, PS | 1 |
| Harinath, BC | 3 |
| Gunawardena, GS | 1 |
| Ismail, MM | 3 |
| Karunaweera, ND | 1 |
| Rizzo, JA | 1 |
| Belo, C | 1 |
| Lins, R | 1 |
| Grady, CA | 1 |
| Orelus, JN | 1 |
| Wendt, J | 1 |
| Wynd, S | 1 |
| Durrheim, DN | 1 |
| Carron, J | 1 |
| Gyapong, M | 1 |
| Chandra, G | 1 |
| Chatterjee, SN | 1 |
| Das, S | 1 |
| Sarkar, N | 1 |
| Milner, T | 1 |
| Houston, R | 2 |
| Dalgaard, P | 1 |
| Regu, K | 2 |
| Showkath Ali, MK | 2 |
| Koya, SM | 1 |
| Ganesh, B | 1 |
| Dhariwal, AC | 2 |
| Lal, S | 3 |
| Guisinger, VH | 1 |
| Aikins, M | 1 |
| Amarillo, ML | 1 |
| Belizario, VY | 2 |
| Garshong, B | 1 |
| Gyapong, J | 1 |
| Kabali, C | 1 |
| Kamal, HA | 2 |
| Kyelem, D | 1 |
| Lizardo, J | 1 |
| Malecela, M | 1 |
| Mubyazi, G | 1 |
| Nitièma, PA | 1 |
| Wallace, A | 1 |
| Patnaik, SK | 3 |
| Shannon, WD | 1 |
| Elango, A | 1 |
| Kiniboro, B | 1 |
| Tarongka, N | 1 |
| Hazlett, FE | 1 |
| Mohanan, MK | 1 |
| Adesiyun, AG | 1 |
| Samaila, MO | 1 |
| Satya Babu, P | 1 |
| Rao, KN | 1 |
| Pfarr, KM | 1 |
| Wibowo, H | 1 |
| Houwing-Duistermaat, JJ | 1 |
| Yazdanbakhsh, M | 4 |
| Sartono, E | 3 |
| Meyrowitsch, DW | 2 |
| Moulia-Pelat, JP | 7 |
| Nguyen, NL | 2 |
| Cartel, JL | 12 |
| Freedman, DO | 1 |
| Bui, T | 1 |
| De Almeida Filho, PJ | 1 |
| Maia e Silva, MC | 1 |
| Maciel, A | 1 |
| Furtado, AF | 1 |
| Fan, PC | 5 |
| Kruize, YC | 1 |
| Kurniawan, A | 2 |
| van der Meide, PH | 1 |
| Partono, F | 5 |
| Prybylski, D | 1 |
| Alto, WA | 1 |
| Mengeap, S | 1 |
| Odaibaiyue, S | 1 |
| Schuurkamp, GJ | 2 |
| Kereu, RK | 2 |
| Bulungol, PK | 2 |
| Kawereng, A | 1 |
| Spicer, PE | 1 |
| Navaratnam, V | 1 |
| Raina, VK | 2 |
| Guimarães, K | 1 |
| Brandt, C | 1 |
| Nguyen, LN | 5 |
| Glaziou, P | 3 |
| Cardines, R | 3 |
| Martin, PM | 8 |
| Turner, PF | 1 |
| Rockett, KA | 1 |
| Francis, H | 1 |
| Awadzi, K | 2 |
| Clark, IA | 1 |
| Casley-Smith, JR | 3 |
| Jamal, S | 2 |
| Casley-Smith, J | 1 |
| Greenberg, J | 1 |
| Perry, R | 1 |
| Weil, G | 1 |
| Day, K | 1 |
| Alpers, M | 1 |
| Rajan, K | 3 |
| Thankom, S | 1 |
| Gay, VM | 1 |
| Zheng, HJ | 6 |
| Cheng, WF | 6 |
| Wang, SH | 4 |
| Cheng, SZ | 2 |
| Ye, YM | 4 |
| Luo, LF | 4 |
| Chen, XR | 4 |
| Gan, GB | 4 |
| Piessens, WF | 8 |
| McNeeley, MB | 2 |
| Lee, SH | 1 |
| McNeeley, DF | 2 |
| Spencer, HC | 2 |
| Limaye, AP | 1 |
| Abrams, JS | 1 |
| Regunathan, J | 1 |
| Vijayasekaran, V | 3 |
| Jayaraman, K | 1 |
| Nutman, TB | 5 |
| Peng, HW | 1 |
| Chen, CC | 1 |
| Sandhya, K | 1 |
| Hascoet, H | 1 |
| Nicolas, L | 2 |
| Moore, TA | 1 |
| Reynolds, JC | 1 |
| Kenney, RT | 1 |
| Johnston, W | 1 |
| Cunningham, NM | 1 |
| van Eggermond, MC | 1 |
| van den Elsen, PJ | 1 |
| Langhammer, J | 1 |
| Birk, HW | 1 |
| Zahner, H | 1 |
| Hyun, P | 1 |
| Duke, BO | 1 |
| Karam, M | 1 |
| Behbehani, K | 1 |
| Nguyen, DT | 1 |
| Hoang, TH | 1 |
| Nguyen, TD | 1 |
| Dutta, P | 1 |
| Khan, SA | 1 |
| Baruah, NK | 1 |
| Sarma, CK | 1 |
| Mahanta, J | 1 |
| Weerasooriya, MV | 2 |
| Kimura, E | 4 |
| Dayaratna, DA | 1 |
| Weerasooriya, TR | 1 |
| Samarawickrema, WA | 2 |
| Langy, S | 1 |
| Plichart, C | 2 |
| Deparis, X | 1 |
| Mataika, JU | 1 |
| Koroivueta, J | 1 |
| Shimada, M | 2 |
| Takeuchi, T | 1 |
| Bal, M | 1 |
| Santos, A | 1 |
| Gopinath, R | 1 |
| Hanna, LE | 1 |
| Perumal, V | 1 |
| Kavitha, V | 1 |
| Radhakuttyamma, G | 1 |
| Dalia, S | 1 |
| Singaravelu, G | 1 |
| Mahalingam, S | 1 |
| Sumathy, S | 1 |
| Bansal, R | 1 |
| Mehandru, S | 1 |
| Jain, M | 1 |
| Ramu, K | 2 |
| Appavoo, NC | 3 |
| Saxena, NB | 1 |
| Kumar, KN | 1 |
| Chandrakala, AV | 2 |
| Schlemper, BR | 1 |
| Steindel, M | 1 |
| Grisard, EC | 1 |
| Carvalho-Pinto, CJ | 1 |
| Bernardini, OJ | 1 |
| de Castilho, CV | 1 |
| Rosa, G | 1 |
| Kilian, S | 1 |
| Guarneri, AA | 1 |
| Ferreira Neto, JA | 1 |
| Esterre, P | 1 |
| Sechan, Y | 2 |
| Witt, C | 1 |
| Lazdins, JK | 1 |
| Dunyo, SK | 1 |
| Espinel, M | 1 |
| Gyapong, JO | 1 |
| Hossain, M | 1 |
| Jayakody, RL | 1 |
| Makunde, W | 1 |
| Richard-Lenoble, D | 1 |
| Selve, B | 1 |
| Carvalho, K | 1 |
| Amaral, F | 1 |
| Mathew, N | 1 |
| Kalyanasundaram, M | 1 |
| Mohanty, SK | 1 |
| Patnaik, S | 1 |
| Dey, P | 1 |
| Pradeep Kumar, N | 1 |
| Patra, KP | 1 |
| Godbole, RE | 1 |
| Godbole, HR | 1 |
| Balakrishnan, N | 1 |
| Spiegel, A | 8 |
| Dissanayake, S | 1 |
| Xu, M | 3 |
| Spears, GF | 1 |
| Singh, KI | 1 |
| Penaia, L | 1 |
| Sone, PF | 1 |
| Pelenatu, S | 1 |
| Faaiuaso, ST | 1 |
| Self, LS | 1 |
| Dazo, BC | 1 |
| Nguyen Ngnoc, L | 2 |
| Plichart, R | 3 |
| Taneja, V | 1 |
| Rathaur, S | 1 |
| Liu, J | 1 |
| Chen, Z | 2 |
| Huang, X | 1 |
| Tu, Z | 1 |
| Andrade, LD | 1 |
| Pires, ML | 1 |
| Mendes, J | 1 |
| Pimentel, R | 1 |
| Galdino, E | 1 |
| Andrade, L | 1 |
| Moura, I | 1 |
| Casimiro, I | 1 |
| Beliz, F | 1 |
| Coutinho, A | 1 |
| Duym, L | 1 |
| Aarden, L | 1 |
| Ho, BC | 1 |
| Chan, KL | 1 |
| Dickerson, JW | 1 |
| Hightower, AW | 2 |
| Vijayan, VK | 2 |
| Sankaran, K | 1 |
| Venkatesan, P | 1 |
| Prabhakar, R | 3 |
| Nguyen, L | 3 |
| Barbazan, P | 1 |
| Cheng, SH | 2 |
| Zhang, SM | 1 |
| Chen, X | 1 |
| Fang, RL | 2 |
| Fuhrmen, JA | 1 |
| Richards, FO | 2 |
| Krishnarao, P | 1 |
| Kaur, R | 2 |
| Ghosh, TK | 5 |
| Kidson, C | 1 |
| Liu, JY | 2 |
| Tu, ZP | 2 |
| Zheng, GB | 1 |
| Chen, YN | 2 |
| Zhang, YZ | 1 |
| Weng, SP | 1 |
| Huang, XH | 1 |
| Yang, FZ | 1 |
| Panicker, KN | 1 |
| Bryan, RT | 1 |
| Bernard, Y | 1 |
| Dickinson, CM | 1 |
| Genelle, B | 1 |
| Day, KP | 1 |
| Spark, R | 1 |
| Raiko, A | 1 |
| Wenger, JD | 1 |
| Weiss, N | 1 |
| Mitchell, GF | 1 |
| Zhong, CH | 1 |
| Zhen, TM | 1 |
| Celerier, P | 2 |
| Burucoa, C | 2 |
| Perumal Pillai, SV | 1 |
| Sadanandam, A | 1 |
| Frederick, S | 1 |
| Tripathy, SP | 2 |
| Weller, PF | 1 |
| Liu, LX | 1 |
| Ramaprasad, P | 2 |
| Rao, VS | 1 |
| Bharati, MS | 1 |
| Tyagi, K | 1 |
| Sen, AB | 1 |
| Rath, RN | 1 |
| Ali, ML | 1 |
| Mishra, AC | 1 |
| Mohapatra, BN | 1 |
| Rajagopalan, PK | 1 |
| Fujimaki, Y | 1 |
| Mitsui, Y | 1 |
| Aoki, Y | 1 |
| Mak, JW | 2 |
| Lam, PL | 1 |
| Choong, MF | 1 |
| Suresh, K | 1 |
| Wang, GQ | 1 |
| Fang, Z | 1 |
| de Andrade, L | 1 |
| Lal, RB | 1 |
| Lowrie, RC | 4 |
| Narasimham, MV | 3 |
| Sharma, SP | 5 |
| Sundaram, RM | 1 |
| Sambasivam, V | 1 |
| Das, M | 4 |
| Biswas, H | 3 |
| Rao, VG | 1 |
| Yadava, RL | 1 |
| Rao, CK | 4 |
| Narayana, MV | 1 |
| Pedersen, BK | 1 |
| Svenson, M | 1 |
| Sabry, M | 1 |
| Sarma, RV | 1 |
| Vallishayee, RS | 1 |
| Rao, RS | 1 |
| Leiva, LE | 1 |
| Katz, SP | 1 |
| Wijers, DJ | 1 |
| Kaleli, N | 1 |
| Ngindu, AH | 1 |
| Sethumadhavan, KV | 2 |
| Santhanam, S | 2 |
| Jain, DC | 4 |
| Hiil, JL | 1 |
| Kan, SK | 1 |
| Parmar, SS | 1 |
| Chan, MK | 1 |
| Lim, PK | 1 |
| Lim, TW | 1 |
| Dennis, DT | 1 |
| Geva, H | 1 |
| Palti, A | 1 |
| Efrat, M | 1 |
| Pinkston, P | 1 |
| Rom, WN | 1 |
| O'Donnell, KM | 1 |
| Cornelius, MJ | 1 |
| Ferrans, VJ | 1 |
| Takemura, T | 1 |
| Yenokida, G | 1 |
| Kosare, GJ | 1 |
| Trivedi, GK | 1 |
| Sharma, GK | 2 |
| Sunny, PJ | 1 |
| Sorrian, TP | 1 |
| Nathan, MB | 1 |
| Hamilton, PJ | 1 |
| Monteil, S | 1 |
| Tikasingh, ES | 1 |
| Galtier, J | 1 |
| Julvez, J | 1 |
| Michault, A | 1 |
| Isautier, H | 1 |
| Chakravertty, RK | 1 |
| Srivastav, VK | 1 |
| Srivastava, SP | 1 |
| Chand, P | 1 |
| Ravindranathan, TC | 1 |
| Pillai, KB | 1 |
| Pandey, DS | 1 |
| Pandey, RS | 1 |
| Maeda, R | 1 |
| Hayashi, Y | 1 |
| Shibuya, T | 1 |
| Shen, ZL | 1 |
| Yuan, XZ | 1 |
| Gu, XR | 1 |
| Zhou, JS | 1 |
| Xia, SR | 1 |
| Ding, ZG | 1 |
| Zong, XY | 1 |
| Hong, YX | 1 |
| Song, CC | 1 |
| Forsyth, K | 1 |
| Kim, JS | 1 |
| No, BU | 1 |
| Lee, WY | 1 |
| Kumar, H | 1 |
| Raccurt, CP | 1 |
| Helmcke, MS | 1 |
| Kernizan, MS | 1 |
| Desinor, G | 1 |
| Duverseau, YT | 1 |
| Vickery, AC | 1 |
| Nayar, JK | 1 |
| Tamplin, ML | 1 |
| Fanning, MM | 1 |
| Sutanto, I | 1 |
| Boreham, PF | 1 |
| Munawar, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Community Based Safety Study of 2-drug (Diethylcarbamazine and Albendazole) Versus 3-drug (Ivermectin, Diethylcarbamazine and Albendazole) Therapy for Lymphatic Filariasis[NCT02899936] | 23,789 participants (Actual) | Interventional | 2016-07-31 | Completed | |||
| Community Studies to Monitor the Impact of Triple Drug Therapy Relative to Double Drug Therapy on Lymphatic Filariasis Infection Indicators[NCT03352206] | 20,092 participants (Actual) | Observational | 2017-10-18 | Completed | |||
| Safety and Efficacy of Novel Combination Regimens for Treatment of Onchocerciasis[NCT06070116] | Phase 2 | 300 participants (Anticipated) | Interventional | 2024-01-15 | Not yet recruiting | ||
| Alternative Chemotherapies for Lymphatic Filariasis (LF) Treatment and Elimination in Africa [Cote d'Ivoire][NCT02974049] | 189 participants (Actual) | Interventional | 2015-01-31 | Completed | |||
| Community Based Safety Study of 2-drug (Diethylcarbamazine and Albendazole) Versus 3-drug (Ivermectin, Diethylcarbamazine and Albendazole) Therapy for Lymphatic Filariasis, Scabies and Soil Transmitted Helminths in Fiji[NCT03177993] | 4,773 participants (Actual) | Interventional | 2017-07-13 | Completed | |||
| A Clinical Trial to Assess the Safety and Efficacy of Moxidectin Combination Treatments vs. Ivermectin Combination Treatments for Bancroftian Filariasis[NCT04410406] | Phase 3 | 164 participants (Actual) | Interventional | 2020-08-20 | Active, not recruiting | ||
| Evaluate Triple-Drug Therapy With Diethylcarbamize (DEC), Albendazole (ALB) and Ivermectin (IVM) That Could Accelerate LF Elimination Outside of Africa[NCT01975441] | Phase 2 | 182 participants (Actual) | Interventional | 2014-05-31 | Completed | ||
| Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Single Dose Treatment With Diethylcarbamazine, Albendazole and Ivermectin in Humans With and Without Wuchereria Bancrofti Infection in Côte d'Ivoire[NCT02845713] | Phase 1 | 66 participants (Actual) | Interventional | 2016-04-17 | Completed | ||
| When is it Appropriate to Stop? Applied Field Research to Develop an M&E Strategy to[NCT04124250] | 10,500 participants (Anticipated) | Observational | 2019-09-17 | Recruiting | |||
| Safety and Efficacy of Combination Therapy With Ivermectin, Diethylcarbamazine, and Albendazole (IDA) for Individuals With Onchocerciasis[NCT04188301] | Phase 2 | 154 participants (Actual) | Interventional | 2019-12-06 | Completed | ||
| Microfilarial Clearance From the Eye and Ocular Changes Associated With Ivermectin Treatment in Individuals With Onchocerciasis[NCT03517462] | 231 participants (Actual) | Interventional | 2018-08-06 | Completed | |||
| A Multi-center, Double-blind, Randomized, 24-month Study, to Compare the Efficacy of Doxycycline Once Daily for 6 Weeks Versus Placebo in Improving Filarial Lymphedema Independent of Active Filarial Infection[NCT02929134] | Phase 3 | 219 participants (Actual) | Interventional | 2018-02-16 | Completed | ||
| A Multi-center, Double-blind, Randomized, 24-month Study, to Compare the Efficacy of Doxycycline Once Daily for 6 Weeks Versus Placebo in Improving Filarial Lymphedema Independent of Active Filarial Infection[NCT02927496] | Phase 3 | 220 participants (Actual) | Interventional | 2018-06-19 | Completed | ||
| A Multi-center, Double-blind, Randomized, 24-month Study, to Compare the Efficacy of Doxycycline Once Daily for 6 Weeks Versus Placebo in Improving Filarial Lymphedema Independent of Active Filarial Infection[NCT02929121] | Phase 3 | 235 participants (Actual) | Interventional | 2019-01-15 | Completed | ||
| Comparison of Ivermectin Alone With Albendazole (ALB) Plus Ivermectin (IVM) in Their Efficacy Against Onchocerciasis[NCT03238131] | Phase 3 | 272 participants (Actual) | Interventional | 2012-04-30 | Completed | ||
| Efficacy and Nutritional Assessment Following Albendazole and Combined Albendazole/Ivermectin Treatment for Intestinal Helminth Infections in Rural Guatemalan Schoolchildren[NCT00207753] | 550 participants | Interventional | 2005-02-28 | Completed | |||
| Effect of Albendazole and Ivermectin Dose on Wuchereria Bancrofti Microfilarial Clearance in Mali: A Randomized, Open Label Study[NCT00339417] | Phase 2 | 1,000 participants (Anticipated) | Interventional | 2006-02-22 | Completed | ||
| Treatment of Mansonella Perstans Infection in an Area Coendemic for Lymphatic Filariasis: A Pilot Study of the Effects of Doxycycline[NCT00340691] | Phase 2 | 1,500 participants | Interventional | 2004-12-06 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The effectiveness of three treatment regimens for killing adult female O. volvulus worms based on the percentage of all adult female worms in nodules that are alive 18 months after treatment. (NCT04188301)
Timeframe: 18 months following treatment
| Intervention | Female worms in nodule (Count of Units) |
|---|---|
| IVM + ALB | 127 |
| IDA x 1 Dose | 142 |
| IDA x 3 Doses | 159 |
The effect of three treatment regimens for killing adult female O. volvulus worms will be compared based on the percentage of all adult female worms in nodules that are alive with embryos in the uterus 18 months after treatment. (NCT04188301)
Timeframe: 18 months following treatment.
| Intervention | Female worms in nodules (Count of Units) |
|---|---|
| IVM + ALB | 127 |
| IDA x 1 Dose | 142 |
| IDA x 3 Doses | 159 |
The effect of three treatment regimens for sterilizing adult female O. volvulus worms will be compared based on the percentage of all adult female worms that are fertile in the nodules 18 months after treatment. (NCT04188301)
Timeframe: 18 months following treatment.
| Intervention | Female worms with intact uterus (Count of Units) |
|---|---|
| IVM + ALB | 41 |
| IDA x 1 Dose | 40 |
| IDA x 3 Doses | 34 |
Rates of ocular adverse events of any grade within 3 months will be compared by treatment group. (NCT04188301)
Timeframe: within 3 months of treatment with IDA
| Intervention | Participants (Count of Participants) |
|---|---|
| IVM + ALB | 4 |
| IDA x 1 Dose | 4 |
| IDA x 3 Doses | 3 |
Rates of adverse events grade 3 or higher that occur within 7 days of treatment in the subset of participants who have intraocular microfilariae just prior to treatment with IDA will be compared by treatment group. (NCT04188301)
Timeframe: within 7 days following end of treatment
| Intervention | Participants (Count of Participants) |
|---|---|
| IVM + ALB | 0 |
| IDA x 1 Dose | 0 |
| IDA x 3 Doses | 0 |
Rates of severe adverse events (grade 3 or higher) following 1-day or 3-day triple drug treatment will be compared against those of the comparator regimen of 1 day of IVM/ALB. (NCT04188301)
Timeframe: Within 7 days following end of treatment
| Intervention | Participants (Count of Participants) |
|---|---|
| IVM + ALB | 0 |
| IDA x 1 Dose | 0 |
| IDA x 3 Doses | 0 |
The effectiveness of three treatment regimens for preventing reappearance of microfilariae in the skin as determined by skin snips at 12 and 18 months after treatment will be compared by treatment arm. Measured by the presence of microfilariae in skin snips. (NCT04188301)
Timeframe: Baseline, 12 months, and 18 months following treatment
| Intervention | Count of microfilarae+ participants (Number) | ||
|---|---|---|---|
| Baseline | Month 12 | Month 18 | |
| IDA x 1 Dose | 6 | 21 | 15 |
| IDA x 3 Doses | 0 | 21 | 17 |
| IVM + ALB | 7 | 23 | 20 |
The effectiveness of three treatment regimens for complete clearance of microfilariae from the skin as determined by skin snips at 3, 12, and 18 months after treatment with IDA will be compared by treatment arm. (NCT04188301)
Timeframe: Baseline, 3 months, 12 months, & 18 months following treatment.
| Intervention | Count of Skin Microfilaria (Geometric Mean) | |||
|---|---|---|---|---|
| Baseline | Month 3 | Month 12 | Month 18 | |
| IDA x 1 Dose | 1.7 | 3 | 2.5 | 9.0 |
| IDA x 3 Doses | NA | 2.1 | 4.7 | 8.6 |
| IVM + ALB | 3.1 | 1.9 | 4.9 | 7.0 |
38 reviews available for diethylcarbamazine and Bancroftian Elephantiasis
| Article | Year |
|---|---|
Efficacy and safety of triple therapy versus dual therapy for lymphatic filariasis: A systematic review and meta-analysis.
Topics: Albendazole; Animals; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filari | 2022 |
Setting the stage for a Global Programme to Eliminate Lymphatic Filariasis: the first 125 years (1875-2000).
Topics: Albendazole; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin | 2020 |
New developments in chyluria after global programs to eliminate lymphatic filariasis.
Topics: Animals; Chyle; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Glucose; Humans; Povidone- | 2017 |
Adverse events following single dose treatment of lymphatic filariasis: Observations from a review of the literature.
Topics: Albendazole; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Hu | 2018 |
Primary retroperitoneal filariasis: a common disease of tropics with uncommon presentation and review of literature.
Topics: Animals; Cysts; Diethylcarbamazine; Elephantiasis, Filarial; Humans; India; Male; Middle Aged; Perit | 2018 |
Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis.
Topics: Albendazole; Antigens, Helminth; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filar | 2019 |
Flubendazole as a macrofilaricide: History and background.
Topics: Albendazole; Animals; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Gastrointestinal Dis | 2019 |
EBM verdict: should albendazole be used for treating lymphatic filariasis? No.
Topics: Albendazole; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans; Social Problems | 2019 |
Lessons from lymphatic filariasis elimination and the challenges of post-elimination surveillance in China.
Topics: China; Diethylcarbamazine; Disease Eradication; Elephantiasis, Filarial; Epidemiological Monitoring; | 2019 |
Toward the elimination of lymphatic filariasis by 2020: treatment update and impact assessment for the endgame.
Topics: Albendazole; Anthelmintics; Chemoprevention; Diethylcarbamazine; Disease Eradication; Elephantiasis, | 2013 |
Coverage of, and compliance with, mass drug administration under the programme to eliminate lymphatic filariasis in India: a systematic review.
Topics: Community Health Services; Community Health Workers; Diethylcarbamazine; Disease Eradication; Drug A | 2014 |
Successful control of lymphatic filariasis in the Republic of Korea.
Topics: Animals; Brugia malayi; Diethylcarbamazine; Elephantiasis, Filarial; Endemic Diseases; Filaricides; | 2009 |
Elimination of lymphatic filariasis in Southeast Asia.
Topics: Albendazole; Animals; Asia, Southeastern; Brugia; China; Diethylcarbamazine; Elephantiasis, Filarial | 2010 |
Lymphatic filariasis and onchocerciasis.
Topics: Africa South of the Sahara; Age Factors; Albendazole; Animals; Anti-Bacterial Agents; Antinematodal | 2010 |
How endemic countries can accelerate lymphatic filariasis elimination? An analytical review to identify strategic and programmatic interventions.
Topics: Communicable Disease Control; Diethylcarbamazine; Elephantiasis, Filarial; Endemic Diseases; Health | 2011 |
Albendazole for lymphatic filariasis.
Topics: Albendazole; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Randomize | 2004 |
Lymphatic filariasis and Brugia timori: prospects for elimination.
Topics: Albendazole; Animals; Brugia; Diethylcarbamazine; Elephantiasis, Filarial; Female; Filaricides; Huma | 2004 |
Chemotherapy for lymphatic filariasis: progress but not perfection.
Topics: Albendazole; Animals; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Humans | 2003 |
Albendazole for the control and elimination of lymphatic filariasis: systematic review.
Topics: Adult; Albendazole; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filarici | 2005 |
Does longevity of adult Wuchereria bancrofti increase with decreasing intensity of parasite transmission? Insights from clinical observations.
Topics: Adolescent; Adult; Animals; Brazil; Chronic Disease; Diethylcarbamazine; Drug Resistance; Elephantia | 2005 |
Albendazole for lymphatic filariasis.
Topics: Albendazole; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Hu | 2005 |
Model-based analysis of trial data: microfilaria and worm-productivity loss after diethylcarbamazine-albendazole or ivermectin-albendazole combination therapy against Wuchereria bancrofti.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Anthelmintics; Antiparasitic Agents; Child; Diethylca | 2006 |
Diethylcarbamazine (DEC)-medicated salt for community-based control of lymphatic filariasis.
Topics: Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans; Sodium Chloride | 2007 |
Understanding the community impact of lymphatic filariasis: a review of the sociocultural literature.
Topics: Albendazole; Community Health Services; Cultural Characteristics; Diethylcarbamazine; Drug Therapy, | 2007 |
Recent advances in the chemotherapy of lymphatic filariasis.
Topics: Benzimidazoles; Benzothiazoles; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans; Iv | 1993 |
Diethylcarbamazine salt in the control of lymphatic filariasis.
Topics: Animals; Brugia malayi; China; Diethylcarbamazine; Elephantiasis, Filarial; Humans; India; Taiwan; W | 1994 |
Lymphatic filariasis in immigrants from developing countries.
Topics: Developing Countries; Diagnosis, Differential; Diethylcarbamazine; Elephantiasis, Filarial; Emigrati | 1997 |
Strategies and tools for the control/elimination of lymphatic filariasis.
Topics: Adult; Africa; Albendazole; Animals; Anthelmintics; Asia; Child; Diethylcarbamazine; Drug Administra | 1997 |
Strategies and tools for the control/elimination of lymphatic filariasis.
Topics: Adult; Africa; Albendazole; Animals; Anthelmintics; Asia; Child; Diethylcarbamazine; Drug Administra | 1997 |
Strategies and tools for the control/elimination of lymphatic filariasis.
Topics: Adult; Africa; Albendazole; Animals; Anthelmintics; Asia; Child; Diethylcarbamazine; Drug Administra | 1997 |
Strategies and tools for the control/elimination of lymphatic filariasis.
Topics: Adult; Africa; Albendazole; Animals; Anthelmintics; Asia; Child; Diethylcarbamazine; Drug Administra | 1997 |
[Bancrofitian filariasis, Malayan filariasis].
Topics: Animals; Diagnosis, Differential; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans; | 1999 |
The role of albendazole in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Animals; Brugia malayi; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Human | 1999 |
Pathogenesis of lymphatic disease in bancroftian filariasis: a clinical perspective.
Topics: Albendazole; Animals; Anthelmintics; Diethylcarbamazine; Elephantiasis, Filarial; Female; Filaricide | 2000 |
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Clinical Trials as Topic; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination | 2000 |
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Clinical Trials as Topic; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination | 2000 |
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Clinical Trials as Topic; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination | 2000 |
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Clinical Trials as Topic; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination | 2000 |
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Clinical Trials as Topic; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination | 2000 |
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Clinical Trials as Topic; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination | 2000 |
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Clinical Trials as Topic; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination | 2000 |
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Clinical Trials as Topic; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination | 2000 |
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Clinical Trials as Topic; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination | 2000 |
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Clinical Trials as Topic; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination | 2000 |
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Clinical Trials as Topic; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination | 2000 |
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Clinical Trials as Topic; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination | 2000 |
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Clinical Trials as Topic; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination | 2000 |
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Clinical Trials as Topic; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination | 2000 |
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Clinical Trials as Topic; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination | 2000 |
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Clinical Trials as Topic; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination | 2000 |
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Clinical Trials as Topic; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination | 2000 |
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Clinical Trials as Topic; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination | 2000 |
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Clinical Trials as Topic; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination | 2000 |
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Clinical Trials as Topic; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination | 2000 |
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Clinical Trials as Topic; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination | 2000 |
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Clinical Trials as Topic; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination | 2000 |
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Clinical Trials as Topic; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination | 2000 |
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Clinical Trials as Topic; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination | 2000 |
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Clinical Trials as Topic; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination | 2000 |
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Clinical Trials as Topic; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination | 2000 |
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Clinical Trials as Topic; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination | 2000 |
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Clinical Trials as Topic; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination | 2000 |
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Clinical Trials as Topic; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination | 2000 |
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Clinical Trials as Topic; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination | 2000 |
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Clinical Trials as Topic; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination | 2000 |
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Clinical Trials as Topic; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination | 2000 |
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Clinical Trials as Topic; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination | 2000 |
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Clinical Trials as Topic; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination | 2000 |
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Clinical Trials as Topic; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination | 2000 |
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Clinical Trials as Topic; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination | 2000 |
Salt fortified with diethylcarbamazine (DEC) as an effective intervention for lymphatic filariasis, with lessons learned from salt iodization programmes.
Topics: Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans; Iodine; National Health Programs; | 2000 |
Towards elimination of lymphatic filariasis in India.
Topics: Animals; Diethylcarbamazine; Elephantiasis, Filarial; Endemic Diseases; Filaricides; Humans; India; | 2001 |
Tropical pulmonary eosinophilia.
Topics: Animals; Brugia; Diagnosis, Differential; Diethylcarbamazine; Elephantiasis, Filarial; Humans; Immun | 1992 |
[Advances in filariasis control and research in China during 1986-1990. National Technical Steering Group for Filariasis Control and Research, MOPH].
Topics: Animals; Antibodies, Helminth; Antigens, Helminth; Brugia; Diethylcarbamazine; Elephantiasis, Filari | 1991 |
Filariasis and its control in Fujian, China.
Topics: Animals; Brugia; China; Diethylcarbamazine; Disease Reservoirs; Elephantiasis, Filarial; Female; Fil | 1991 |
Description, mechanisms and control of reactions to treatment in the human filariases.
Topics: Animals; Anthelmintics; Diethylcarbamazine; Elephantiasis, Filarial; Filariasis; Filaricides; Humans | 1987 |
82 trials available for diethylcarbamazine and Bancroftian Elephantiasis
| Article | Year |
|---|---|
Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole + diethylcarbamazine + ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trial.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Child; Child, Preschool; Diethylcarbamazine; Drug The | 2022 |
Mass drug administration of ivermectin, diethylcarbamazine, plus albendazole compared with diethylcarbamazine plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: a cluster-randomised trial.
Topics: Albendazole; Cross-Sectional Studies; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, | 2022 |
Mass drug administration of ivermectin, diethylcarbamazine, plus albendazole compared with diethylcarbamazine plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: a cluster-randomised trial.
Topics: Albendazole; Cross-Sectional Studies; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, | 2022 |
Mass drug administration of ivermectin, diethylcarbamazine, plus albendazole compared with diethylcarbamazine plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: a cluster-randomised trial.
Topics: Albendazole; Cross-Sectional Studies; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, | 2022 |
Mass drug administration of ivermectin, diethylcarbamazine, plus albendazole compared with diethylcarbamazine plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: a cluster-randomised trial.
Topics: Albendazole; Cross-Sectional Studies; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, | 2022 |
A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis.
Topics: Albendazole; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaric | 2023 |
Safety and tolerability of moxidectin and ivermectin combination treatments for lymphatic filariasis in Côte d'Ivoire: A randomized controlled superiority study.
Topics: Adult; Albendazole; Animals; Cote d'Ivoire; Diethylcarbamazine; Drug Therapy, Combination; Elephanti | 2023 |
Systems analysis-based assessment of post-treatment adverse events in lymphatic filariasis.
Topics: Adolescent; Adult; Aged; Albendazole; Antigens, Helminth; Cytokines; Diethylcarbamazine; Elephantias | 2019 |
Efficacy and Safety of a Single Dose of Ivermectin, Diethylcarbamazine, and Albendazole for Treatment of Lymphatic Filariasis in Côte d'Ivoire: An Open-label Randomized Controlled Trial.
Topics: Albendazole; Animals; Cote d'Ivoire; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, F | 2020 |
The safety of combined triple drug therapy with ivermectin, diethylcarbamazine and albendazole in the neglected tropical diseases co-endemic setting of Fiji: A cluster randomised trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albendazole; Antiparasitic Agents; Child; Child, Prescho | 2020 |
Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster-randomized, community study.
Topics: Adolescent; Adult; Albendazole; Animals; Antiparasitic Agents; Child; Child, Preschool; Diethylcarba | 2020 |
Heterogeneous response of Wuchereria bancrofti-infected persons to diethylcarbamazine (DEC) and its implications for the Global Programme to Eliminate Lymphatic Filariasis (GPELF).
Topics: Albendazole; Animals; Diethylcarbamazine; Elephantiasis, Filarial; Female; Filaricides; Humans; Iver | 2021 |
An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India.
Topics: Adolescent; Adult; Albendazole; Animals; Child; Diethylcarbamazine; Drug-Related Side Effects and Ad | 2021 |
A multicenter, community-based, mixed methods assessment of the acceptability of a triple drug regimen for elimination of lymphatic filariasis.
Topics: Adolescent; Adult; Albendazole; Diethylcarbamazine; Elephantiasis, Filarial; Female; Filaricides; Fo | 2021 |
Semiannual Treatment of Albendazole Alone is Efficacious for Treatment of Lymphatic Filariasis: A Randomized Open-label Trial in Cote d'Ivoire.
Topics: Albendazole; Animals; Cote d'Ivoire; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Iverm | 2022 |
Individual Efficacy and Community Impact of Ivermectin, Diethylcarbamazine, and Albendazole Mass Drug Administration for Lymphatic Filariasis Control in Fiji: A Cluster Randomized Trial.
Topics: Albendazole; Animals; Australia; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filar | 2021 |
An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Antibodies, Protozoan; Asymptomatic Diseases; Brugia; | 2021 |
Efficacy and tolerability of treatment with single doses of diethylcarbamazine (DEC) and DEC plus albendazole (ABZ) for three consecutive years in lymphatic filariasis: a field study in India.
Topics: Adult; Albendazole; Animals; Antigens, Helminth; Diethylcarbamazine; Double-Blind Method; Drug Admin | 2017 |
Lymphatic pathology in asymptomatic and symptomatic children with Wuchereria bancrofti infection in children from Odisha, India and its reversal with DEC and albendazole treatment.
Topics: Administration, Oral; Adolescent; Albendazole; Animals; Asymptomatic Infections; Child; Child, Presc | 2017 |
A Trial of a Triple-Drug Treatment for Lymphatic Filariasis.
Topics: Adolescent; Adult; Albendazole; Animals; Diethylcarbamazine; Drug Administration Schedule; Drug Ther | 2018 |
A Trial of a Triple-Drug Treatment for Lymphatic Filariasis.
Topics: Adolescent; Adult; Albendazole; Animals; Diethylcarbamazine; Drug Administration Schedule; Drug Ther | 2018 |
A Trial of a Triple-Drug Treatment for Lymphatic Filariasis.
Topics: Adolescent; Adult; Albendazole; Animals; Diethylcarbamazine; Drug Administration Schedule; Drug Ther | 2018 |
A Trial of a Triple-Drug Treatment for Lymphatic Filariasis.
Topics: Adolescent; Adult; Albendazole; Animals; Diethylcarbamazine; Drug Administration Schedule; Drug Ther | 2018 |
Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'Ivoire.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Cohort Studies; Cote d'Ivoire; Diethylcarbamazine; Dr | 2019 |
Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'Ivoire.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Cohort Studies; Cote d'Ivoire; Diethylcarbamazine; Dr | 2019 |
Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'Ivoire.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Cohort Studies; Cote d'Ivoire; Diethylcarbamazine; Dr | 2019 |
Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'Ivoire.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Cohort Studies; Cote d'Ivoire; Diethylcarbamazine; Dr | 2019 |
Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'Ivoire.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Cohort Studies; Cote d'Ivoire; Diethylcarbamazine; Dr | 2019 |
Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'Ivoire.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Cohort Studies; Cote d'Ivoire; Diethylcarbamazine; Dr | 2019 |
Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'Ivoire.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Cohort Studies; Cote d'Ivoire; Diethylcarbamazine; Dr | 2019 |
Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'Ivoire.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Cohort Studies; Cote d'Ivoire; Diethylcarbamazine; Dr | 2019 |
Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'Ivoire.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Cohort Studies; Cote d'Ivoire; Diethylcarbamazine; Dr | 2019 |
Dosing pole recommendations for lymphatic filariasis elimination: A height-weight quantile regression modeling approach.
Topics: Adolescent; Adult; Body Height; Body Weight; Child; Cohort Studies; Diethylcarbamazine; Drug Dosage | 2019 |
A randomized controlled trial of increased dose and frequency of albendazole with standard dose DEC for treatment of Wuchereria bancrofti microfilaremics in Odisha, India.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Dose-Response Relationship, Drug; Drug Therapy, Com | 2015 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; El | 2016 |
Micronutrient status indicators in individuals single- or double-infected with HIV and Wuchereria bancrofti before and after DEC treatment.
Topics: Adolescent; Adult; Aged; alpha 1-Antichymotrypsin; alpha-Tocopherol; Animals; beta Carotene; Biomark | 2009 |
Macrofilaricidal activity and amelioration of lymphatic pathology in bancroftian filariasis after 3 weeks of doxycycline followed by single-dose diethylcarbamazine.
Topics: Adolescent; Adult; Animals; Anthelmintics; Anti-Bacterial Agents; Diethylcarbamazine; Double-Blind M | 2009 |
Evaluation of effectiveness of diethylcarbamazine/albendazole combination in reduction of Wuchereria bancrofti infection using multiple infection parameters.
Topics: Adolescent; Adult; Albendazole; Animals; Anthelmintics; Antibodies, Helminth; Antigens, Helminth; Ch | 2011 |
A single dose of doxycycline in combination with diethylcarbamazine for treatment of bancroftian filariasis.
Topics: Adolescent; Adult; Animals; Diethylcarbamazine; Double-Blind Method; Doxycycline; Drug Administratio | 2010 |
Multiplex bead assay for serum samples from children in Haiti enrolled in a drug study for the treatment of lymphatic filariasis.
Topics: Anthelmintics; Antibodies, Helminth; Antigens, Helminth; Child; Child, Preschool; Diethylcarbamazine | 2011 |
The effect of six rounds of single dose mass treatment with diethylcarbamazine or ivermectin on Wuchereria bancrofti infection and its implications for lymphatic filariasis elimination.
Topics: Animals; Community Health Services; Culex; Diethylcarbamazine; Double-Blind Method; Drug Administrat | 2002 |
Treatment of Brugia timori and Wuchereria bancrofti infections in Indonesia using DEC or a combination of DEC and albendazole: adverse reactions and short-term effects on microfilariae.
Topics: Adolescent; Adult; Albendazole; Animals; Brugia; Diethylcarbamazine; Drug Therapy, Combination; Elep | 2002 |
The impact of single-dose diethylcarbamazine treatment of bancroftian filariasis in a low-endemicity setting in Egypt.
Topics: Adolescent; Adult; Animals; Antigens, Helminth; Child; Child, Preschool; Diethylcarbamazine; Egypt; | 2002 |
The pharmacokinetics, safety and tolerability of the co-administration of diethylcarbamazine and albendazole.
Topics: Administration, Oral; Adolescent; Adult; Albendazole; Chromatography, Gas; Chromatography, High Pres | 2002 |
Mass treatment to eliminate filariasis in Papua New Guinea.
Topics: Adolescent; Adult; Animals; Child; Child, Preschool; Culicidae; Diethylcarbamazine; Disease Reservoi | 2002 |
The impact of six rounds of single-dose mass administration of diethylcarbamazine or ivermectin on the transmission of Wuchereria bancrofti by Culex quinquefasciatus and its implications for lymphatic filariasis elimination programmes.
Topics: Animals; Culex; Diethylcarbamazine; Double-Blind Method; Drug Administration Schedule; Elephantiasis | 2003 |
A randomized clinical trial comparing single- and multi-dose combination therapy with diethylcarbamazine and albendazole for treatment of bancroftian filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Dose-Response Relationship, Drug; Drug Administrati | 2004 |
Safety, tolerability, efficacy and plasma concentrations of diethylcarbamazine and albendazole co-administration in a field study in an area endemic for lymphatic filariasis in India.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albendazole; Child; Child, Preschool; Diethylcarbamazine | 2004 |
Duplex Doppler sonographic assessment of the effects of diethylcarbamazine and albendazole therapy on adult filarial worms and adjacent host tissues in Bancroftian filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; | 2004 |
The efficacies of affected-limb care with penicillin diethylcarbamazine, the combination of both drugs or antibiotic ointment, in the prevention of acute adenolymphangitis during bancroftian filariasis.
Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; Combined Modality Therapy; Diethylcarbamazi | 2004 |
A randomized clinical trial to compare the efficacy of three treatment regimens along with footcare in the morbidity management of filarial lymphoedema.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti- | 2005 |
Effects of ivermectin and diethylcarbamazine on microfilariae and overall microfilaria production in bancroftian filariasis.
Topics: Adult; Animals; Diethylcarbamazine; Double-Blind Method; Drug Therapy, Combination; Elephantiasis, F | 2005 |
Tolerability and efficacy of single dose diethylcarbamazine (DEC) alone or co-administration with Ivermectin in the clearance of Wuchereria bancrofti microfilaraemia in Pondicherry, South India.
Topics: Adolescent; Adult; Animals; Antiparasitic Agents; Diethylcarbamazine; Double-Blind Method; Drug Ther | 2004 |
Tolerability and efficacy of a three-age class dosage schedule of Diethylcarbamazine citrate (DEC) in the treatment of microfilaria carriers of Wuchereria bancrofti and its implications in mass drug administration (MDA) strategy for elimination of lymphat
Topics: Adolescent; Age Factors; Animals; Carrier State; Child; Child, Preschool; Diethylcarbamazine; Elepha | 2005 |
Impact of single dose of diethylcarbamazine and other antifilarial drug combinations on bancroftian filarial infection variables: assessment after 2 years.
Topics: Albendazole; Animals; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Female | 2006 |
Implication of diethylcarbamazine induced morbidity and the role of cellular responses associated with bancroftian filariasis pathologies.
Topics: Adolescent; Animals; Diethylcarbamazine; Elephantiasis, Filarial; Female; Filaricides; Humans; Inter | 2006 |
Impact of 10 years of diethylcarbamazine and ivermectin mass administration on infection and transmission of lymphatic filariasis.
Topics: Animals; Child; Child, Preschool; Diethylcarbamazine; Double-Blind Method; Drug Administration Sched | 2007 |
Children and adolescents infected with Wuchereria bancrofti in Greater Recife, Brazil: a randomized, year-long clinical trial of single treatments with diethylcarbamazine or diethylcarbamazine-albendazole.
Topics: Adolescent; Adult; Albendazole; Animals; Anthelmintics; Brazil; Child; Diethylcarbamazine; Drug Ther | 2007 |
Effect of diethylcarbamazine on HIV load, CD4%, and CD4/CD8 ratio in HIV-infected adult Tanzanians with or without lymphatic filariasis: randomized double-blind and placebo-controlled cross-over trial.
Topics: Adult; Anthelmintics; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cross-O | 2007 |
Mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea: changes in microfilaremia, filarial antigen, and Bm14 antibody after cessation.
Topics: Animals; Antibodies, Helminth; Antigens, Helminth; Antiparasitic Agents; Child; Child, Preschool; Di | 2008 |
Doxycycline treatment of Brugia malayi-infected persons reduces microfilaremia and adverse reactions after diethylcarbamazine and albendazole treatment.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Brugia malayi; Child; Diethylcarbamazine; Double-Blin | 2008 |
Selective diethylcarbamazine chemotherapy for control of Bancroftian filariasis in two communities of Tanzania: compared efficacy of a standard dose treatment and two semi-annual single dose treatments.
Topics: Adolescent; Adult; Animals; Child; Child, Preschool; Diethylcarbamazine; Elephantiasis, Filarial; Fi | 1995 |
Lymphoscintigraphic assessment of the effect of diethylcarbamazine treatment on lymphatic damage in human bancroftian filariasis.
Topics: Acute Disease; Adolescent; Adult; Aged; Animals; Chronic Disease; Diethylcarbamazine; Elephantiasis, | 1995 |
Diethylcarbamazine in the control of bancroftian filariasis in the Ok Tedi area of Papua New Guinea: phase 2--annual single-dose treatment.
Topics: Adolescent; Adult; Animals; Child; Child, Preschool; Diethylcarbamazine; Drug Administration Schedul | 1994 |
Ivermectin plus diethylcarbamazine: an additive effect on early microfilarial clearance.
Topics: Animals; Carrier State; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Huma | 1994 |
Long-term efficacy of single-dose treatment with 400 micrograms.kg-1 of ivermectin in bancroftian filariasis: results at one year.
Topics: Animals; Diethylcarbamazine; Elephantiasis, Filarial; Female; Follow-Up Studies; Humans; Ivermectin; | 1993 |
Reduction of filaritic lymphoedema and elephantiasis by 5,6 benzo-alpha-pyrone (coumarin), and the effects of diethylcarbamazine (DEC).
Topics: Adult; Aged; Coumarins; Diethylcarbamazine; Double-Blind Method; Drug Therapy, Combination; Elephant | 1993 |
Comparison of single-dose diethylcarbamazine and ivermectin for treatment of bancroftian filariasis in Papua New Guinea.
Topics: Adult; Animals; Antigens, Helminth; Diethylcarbamazine; Double-Blind Method; Elephantiasis, Filarial | 1993 |
A comparative study of the efficacy and tolerability of single and split doses of ivermectin and diethylcarbamazine in periodic brugian filariasis.
Topics: Adolescent; Adult; Animals; Brugia; Diethylcarbamazine; Dose-Response Relationship, Drug; Double-Bli | 1993 |
Safety trial of single-dose treatments with a combination of ivermectin and diethylcarbamazine in bancroftian filariasis.
Topics: Adult; Aged; Animals; Carrier State; Diethylcarbamazine; Dose-Response Relationship, Drug; Drug Comb | 1993 |
[Efficacy of ivermectin for control of microfilaremia recurring after treatment with diethylcarbamazine: immunological observation].
Topics: Animals; Antibodies, Helminth; Antigens, Helminth; Diethylcarbamazine; Double-Blind Method; Elephant | 1993 |
Comparative efficacy of clearing-dose and single high-dose ivermectin and diethylcarbamazine against Wuchereria bancrofti microfilaremia.
Topics: Adolescent; Adult; Aged; Animals; Circadian Rhythm; Diethylcarbamazine; Double-Blind Method; Drug Ad | 1993 |
A preliminary study of filariasis related acute adenolymphangitis with special reference to precipitating factors and treatment modalities.
Topics: Adolescent; Adult; Aged; Animals; Anti-Bacterial Agents; Brugia; Causality; Diethylcarbamazine; Elep | 1995 |
[Combinations of ivermectin and diethylcarbamazine for improved control of lymphatic filariasis].
Topics: Adult; Aged; Communicable Disease Control; Diethylcarbamazine; Double-Blind Method; Drug Therapy, Co | 1996 |
Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes.
Topics: Adolescent; Adult; Animals; Anopheles; Child; Child, Preschool; Diethylcarbamazine; Drug Administrat | 1998 |
Prevention of acute adenolymphangitis in brugian filariasis: comparison of the efficacy of ivermectin and diethylcarbamazine, each combined with local treatment of the affected limb.
Topics: Acute Disease; Adult; Animals; Antinematodal Agents; Brugia malayi; Diethylcarbamazine; Double-Blind | 1998 |
Efficacy of a single dose treatment of Wuchereria bancrofti microfilaria carriers with diethylcarbamazine in Matara, Sri Lanka.
Topics: Adolescent; Adult; Animals; Carrier State; Child; Diethylcarbamazine; Elephantiasis, Filarial; Femal | 1998 |
A double-blind, placebo-controlled study of the efficacy of oral penicillin, diethylcarbamazine or local treatment of the affected limb in preventing acute adenolymphangitis in lymphoedema caused by brugian filariasis.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Animals; Brugia; Diethylcarbamazine; D | 1999 |
A double-blind, placebo-controlled study of the efficacy of oral penicillin, diethylcarbamazine or local treatment of the affected limb in preventing acute adenolymphangitis in lymphoedema caused by brugian filariasis.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Animals; Brugia; Diethylcarbamazine; D | 1999 |
A double-blind, placebo-controlled study of the efficacy of oral penicillin, diethylcarbamazine or local treatment of the affected limb in preventing acute adenolymphangitis in lymphoedema caused by brugian filariasis.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Animals; Brugia; Diethylcarbamazine; D | 1999 |
A double-blind, placebo-controlled study of the efficacy of oral penicillin, diethylcarbamazine or local treatment of the affected limb in preventing acute adenolymphangitis in lymphoedema caused by brugian filariasis.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Animals; Brugia; Diethylcarbamazine; D | 1999 |
A double-blind, placebo-controlled study of the efficacy of oral penicillin, diethylcarbamazine or local treatment of the affected limb in preventing acute adenolymphangitis in lymphoedema caused by brugian filariasis.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Animals; Brugia; Diethylcarbamazine; D | 1999 |
A double-blind, placebo-controlled study of the efficacy of oral penicillin, diethylcarbamazine or local treatment of the affected limb in preventing acute adenolymphangitis in lymphoedema caused by brugian filariasis.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Animals; Brugia; Diethylcarbamazine; D | 1999 |
A double-blind, placebo-controlled study of the efficacy of oral penicillin, diethylcarbamazine or local treatment of the affected limb in preventing acute adenolymphangitis in lymphoedema caused by brugian filariasis.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Animals; Brugia; Diethylcarbamazine; D | 1999 |
A double-blind, placebo-controlled study of the efficacy of oral penicillin, diethylcarbamazine or local treatment of the affected limb in preventing acute adenolymphangitis in lymphoedema caused by brugian filariasis.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Animals; Brugia; Diethylcarbamazine; D | 1999 |
A double-blind, placebo-controlled study of the efficacy of oral penicillin, diethylcarbamazine or local treatment of the affected limb in preventing acute adenolymphangitis in lymphoedema caused by brugian filariasis.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Animals; Brugia; Diethylcarbamazine; D | 1999 |
Treatment of the microfilaraemia of asymptomatic brugian filariasis with single doses of ivermectin, diethylcarbamazine or albendazole, in various combinations.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Brugia malayi; Diethylcarbamazine; Drug Administratio | 1999 |
[Efficacy of ivermectin for control of microfilaremia recurring after treatment with diethylcarbamazine. I. Clinical and parasitological observations].
Topics: Adolescent; Adult; Aged; Animals; Diethylcarbamazine; Double-Blind Method; Elephantiasis, Filarial; | 1992 |
[Ivermectin or diethylcarbamazine in spaced dosages in Bancroft's filariasis: which protocol?].
Topics: Adolescent; Adult; Animals; Diethylcarbamazine; Double-Blind Method; Drug Administration Schedule; E | 1992 |
Diethylcarbamazine treatment of bancroftian and malayan filariasis with emphasis on side effects.
Topics: Animals; Brugia malayi; Diethylcarbamazine; Elephantiasis, Filarial; Filariasis; Humans; Microfilari | 1992 |
Compared efficacy of repeated annual and semi-annual doses of ivermectin and diethylcarbamazine for prevention of Wuchereria bancrofti filariasis in French Polynesia. Final evaluation.
Topics: Adult; Animals; Carrier State; Diethylcarbamazine; Double-Blind Method; Drug Evaluation; Elephantias | 1992 |
Kinetics of circulating human IgG4 after diethylcarbamazine and ivermectin treatment of bancroftian filariasis.
Topics: Animals; Diethylcarbamazine; Elephantiasis, Filarial; Follow-Up Studies; Humans; Immunoglobulin G; I | 1992 |
Single versus repeated doses of ivermectin and diethylcarbamazine for the treatment of Wuchereria bancrofti var. pacifica microfilaremia. Results at 12 months of a double-blind study.
Topics: Adult; Animals; Carrier State; Diethylcarbamazine; Double-Blind Method; Drug Administration Schedule | 1991 |
Cumulative mortality rates in Aedes polynesiensis after feeding on polynesian Wuchereria bancrofti carriers treated with single doses of ivermectin, diethylcarbamazine and placebo.
Topics: Aedes; Animals; Carrier State; Diethylcarbamazine; Double-Blind Method; Elephantiasis, Filarial; Hum | 1991 |
Efficacy of ivermectin for control of microfilaremia recurring after treatment with diethylcarbamazine. I. Clinical and parasitologic observations.
Topics: Adolescent; Adult; Animals; Diethylcarbamazine; Double-Blind Method; Elephantiasis, Filarial; Female | 1991 |
Long term effect of diethylcarbamazine medicated common salt on bancroftian filariasis.
Topics: Animals; Diethylcarbamazine; Elephantiasis, Filarial; Humans; Microfilariae; Rural Health; Sodium Ch | 1991 |
The treatment of microfilaremia due to Wuchereria bancrofti var. pacifica: ivermectin versus diethylcarbamazine.
Topics: Adolescent; Adult; Animals; Diethylcarbamazine; Elephantiasis, Filarial; Humans; Ivermectin; Male; M | 1991 |
Comparison of high dose ivermectin and diethylcarbamazine for activity against bancroftian filariasis in Haiti.
Topics: Adolescent; Adult; Animals; Diethylcarbamazine; Double-Blind Method; Drug Tolerance; Elephantiasis, | 1991 |
Double blind study on efficacy and safety of single doses of ivermectin and diethylcarbamazine for treatment of Polynesian Wuchereria bancrofti carriers. Results at six months.
Topics: Adult; Animals; Carrier State; Diethylcarbamazine; Dose-Response Relationship, Drug; Double-Blind Me | 1991 |
A controlled trial of ivermectin and diethylcarbamazine in lymphatic filariasis.
Topics: Adult; Animals; Diethylcarbamazine; Double-Blind Method; Drug Administration Schedule; Elephantiasis | 1990 |
Efficacy of two different DEC regimens in the treatment of human filarial infection.
Topics: Adolescent; Adult; Animals; Child; Diethylcarbamazine; Elephantiasis, Filarial; Female; Filariasis; | 1990 |
Double blind clinical trial on centperazine & DEC in bancroftian filariasis.
Topics: Adolescent; Adult; Animals; Diethylcarbamazine; Double-Blind Method; Elephantiasis, Filarial; Filari | 1990 |
Inappropriateness of the association of diphenhydramine with diethylcarbamazine for the treatment of lymphatic filariasis.
Topics: Adolescent; Adult; Animals; Child; Child, Preschool; Diethylcarbamazine; Diphenhydramine; Drug Combi | 1989 |
The effects of 5,6 benzo-[a]-pyrone (coumarin) and DEC on filaritic lymphoedema and elephantiasis in India. Preliminary results.
Topics: Analysis of Variance; Coumarins; Diethylcarbamazine; Double-Blind Method; Elephantiasis, Filarial; F | 1989 |
295 other studies available for diethylcarbamazine and Bancroftian Elephantiasis
| Article | Year |
|---|---|
Galactolipids from Bauhinia racemosa as a new class of antifilarial agents against human lymphatic filarial parasite, Brugia malayi.
Topics: Animals; Anthelmintics; Bauhinia; Brugia malayi; Diethylcarbamazine; Elephantiasis, Filarial; Filari | 2012 |
Assessing factors influencing communities' acceptability of mass drug administration for the elimination of lymphatic filariasis in Guyana.
Topics: Albendazole; Community Health Services; Cross-Sectional Studies; Data Collection; Diethylcarbamazine | 2021 |
Lessons Learned from the Japanese Encephalitis Vaccine Introduction in India That Supported the Introduction of Ivermectin-Diethylcarbamazine-Albendazole for Lymphatic Filariasis Elimination.
Topics: Albendazole; Diethylcarbamazine; Elephantiasis, Filarial; Encephalitis, Japanese; Filaricides; Human | 2022 |
Accelerating the Uptake of WHO Recommendations for Mass Drug Administration Using Ivermectin, Diethylcarbamazine, and Albendazole.
Topics: Albendazole; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Hu | 2022 |
The Importance of Partnership in the Rollout of Triple-Drug Therapy to Eliminate Lymphatic Filariasis in the Pacific.
Topics: Albendazole; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Hu | 2022 |
Introduction of Triple-Drug Therapy for Accelerating Lymphatic Filariasis Elimination in India: Lessons Learned.
Topics: Albendazole; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans; India; Ivermectin | 2022 |
Country Reports on Practical Aspects of Conducting Large-Scale Community Studies of the Tolerability of Mass Drug Administration with Ivermectin/Diethylcarbamazine/Albendazole for Lymphatic Filariasis.
Topics: Albendazole; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Hu | 2022 |
Lessons from Large-Scale Tolerability and Acceptability Studies of Triple Drug Mass Drug Administration Performed to Support Policy Change and Accelerate Elimination of Lymphatic Filariasis.
Topics: Albendazole; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Hu | 2022 |
Compressing the Timelines for Development and Delivery: Accelerating Access to Triple-Drug Therapy to Eliminate Lymphatic Filariasis.
Topics: Albendazole; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; He | 2022 |
Potential of triple-drug therapy to accelerate lymphatic filariasis elimination.
Topics: Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans | 2022 |
Filariasis presenting as pancytopenia in a child.
Topics: Albendazole; Animals; Child; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; | 2022 |
Modelling lymphatic filariasis elimination in American Samoa: GEOFIL predicts need for new targets and six rounds of mass drug administration.
Topics: Albendazole; American Samoa; Animals; Child; Diethylcarbamazine; Elephantiasis, Filarial; Filaricide | 2022 |
Diethylcarbamazine citrate-fortified salt for lymphatic filariasis elimination in India.
Topics: Albendazole; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans; India; Iodine; Sodium | 2022 |
Diethylcarbamazine mediated potentiation of emodepside induced paralysis requires TRP-2 in adult Brugia malayi.
Topics: Adult; Animals; Brugia; Brugia malayi; Diethylcarbamazine; Elephantiasis, Filarial; Female; Humans; | 2022 |
IgG4 antibodies to the recombinant filarial antigen Wb-Bhp-1 decrease dramatically following treatment of lymphatic filariasis.
Topics: Albendazole; Animals; Antibodies, Helminth; Antigens, Helminth; Diethylcarbamazine; Elephantiasis, F | 2023 |
Comparative Safety Surveillance of Triple (IDA) Versus Dual Therapy (DA) in Mass Drug Administration for Elimination of Lymphatic Filariasis in Kenya: A Cohort Event Monitoring Study.
Topics: Albendazole; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Humans; | 2023 |
Pharmacokinetics of Moxidectin combined with Albendazole or Albendazole plus Diethylcarbamazine for Bancroftian Filariasis.
Topics: Albendazole; Diethylcarbamazine; Elephantiasis, Filarial; Female; Humans; Ivermectin; Macrolides; Ma | 2023 |
Diethylcarbamazine elicits Ca
Topics: Adult; Animals; Anthelmintics; Brugia malayi; Diethylcarbamazine; Elephantiasis, Filarial; Female; H | 2023 |
Solid lipid nanoparticle-based dissolving microneedles: A promising intradermal lymph targeting drug delivery system with potential for enhanced treatment of lymphatic filariasis.
Topics: Albendazole; Animals; Delayed-Action Preparations; Diethylcarbamazine; Doxycycline; Drug Carriers; D | 2019 |
Frequency and Clinical Significance of Localized Adverse Events following Mass Drug Administration for Lymphatic Filariasis in an Endemic Area in South India.
Topics: Adolescent; Adult; Albendazole; Anthelmintics; Diethylcarbamazine; Drug Therapy, Combination; Elepha | 2020 |
Elimination of diurnally sub-periodic Wuchereria bancrofti in Andaman and Nicobar Islands, India, using mass DEC-fortified salt as a supplementary intervention to MDA.
Topics: Albendazole; Animals; Antigens, Helminth; Child; Child, Preschool; Dietary Supplements; Diethylcarba | 2020 |
Single-Dose Triple-Drug Therapy for
Topics: Albendazole; Animals; Antigens, Helminth; Diethylcarbamazine; Drug Therapy, Combination; Elephantias | 2020 |
Risk factors associated with failing pre-transmission assessment surveys (pre-TAS) in lymphatic filariasis elimination programs: Results of a multi-country analysis.
Topics: Albendazole; Diethylcarbamazine; Disease Transmission, Infectious; Elephantiasis, Filarial; Filarici | 2020 |
Results From 2 Cohort Studies in Central Africa Show That Clearance of Wuchereria bancrofti Infection After Repeated Rounds of Mass Drug Administration With Albendazole Alone Is Closely Linked to Individual Adherence.
Topics: Albendazole; Animals; Antigens, Helminth; Cohort Studies; Congo; Diethylcarbamazine; Elephantiasis, | 2021 |
A community survey of coverage and adverse events following country-wide triple-drug mass drug administration for lymphatic filariasis elimination, Samoa 2018.
Topics: Albendazole; Animals; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Female | 2020 |
A triple-drug treatment regimen to accelerate elimination of lymphatic filariasis: From conception to delivery.
Topics: Albendazole; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Hu | 2020 |
Implementation challenges and opportunities for improved mass treatment uptake for lymphatic filariasis elimination: Perceptions and experiences of community drug distributors of coastal Kenya.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Anthelmintics; Brugia malayi; Diethylcarbamazine; Ele | 2020 |
Fine needle aspiration cytology of lymphatic filariasis presenting as a swelling over the left elbow.
Topics: Adolescent; Animals; Biopsy, Fine-Needle; Cytodiagnosis; Diethylcarbamazine; Elbow; Elephantiasis, F | 2021 |
Lymphatic filariasis elimination in the Dominican Republic: History, progress, and remaining steps.
Topics: Albendazole; Diethylcarbamazine; Disease Eradication; Dominican Republic; Elephantiasis, Filarial; H | 2021 |
Reaching endpoints for lymphatic filariasis elimination- results from mass drug administration and nocturnal blood surveys, South Gujarat, India.
Topics: Albendazole; Animals; Diethylcarbamazine; Disease Eradication; Drug Therapy, Combination; Elephantia | 2017 |
Lymphatic filariasis elimination efforts in Rufiji, southeastern Tanzania: decline in circulating filarial antigen prevalence in young school children after twelve rounds of mass drug administration and utilization of long-lasting insecticide-treated nets
Topics: Albendazole; Animals; Child; Cross-Sectional Studies; Diethylcarbamazine; Disease Eradication; Eleph | 2017 |
Impact of mass drug administration for elimination of lymphatic filariasis in Nepal.
Topics: Albendazole; Child; Diethylcarbamazine; Disease Transmission, Infectious; Drug Therapy; Drug Utiliza | 2017 |
Assessing endgame strategies for the elimination of lymphatic filariasis: A model-based evaluation of the impact of DEC-medicated salt.
Topics: Animals; Bayes Theorem; Brugia malayi; Diethylcarbamazine; Disease Eradication; Elephantiasis, Filar | 2017 |
Filarial breast lump.
Topics: Adult; Breast Diseases; Diagnosis, Differential; Diethylcarbamazine; Elephantiasis, Filarial; Female | 2017 |
Detecting and confirming residual hotspots of lymphatic filariasis transmission in American Samoa 8 years after stopping mass drug administration.
Topics: Adolescent; Adult; Aedes; Albendazole; American Samoa; Animals; Antibodies, Helminth; Antigens, Helm | 2017 |
Filarial pleural effusion without peripheral blood or pleural fluid eosinophilia.
Topics: Animals; Chest Pain; Diethylcarbamazine; Dyspnea; Elephantiasis, Filarial; Exudates and Transudates; | 2017 |
Global programme to eliminate lymphatic filariasis: progress report, 2016.
Topics: Albendazole; Anthelmintics; Diethylcarbamazine; Disease Eradication; Drug Therapy, Combination; Elep | 2017 |
Translating Research into Reality: Elimination of Lymphatic Filariasis from Haiti.
Topics: Diethylcarbamazine; Disease Eradication; Elephantiasis, Filarial; Filaricides; Haiti; Humans; Lymphe | 2017 |
Reassessment of areas with persistent Lymphatic Filariasis nine years after cessation of mass drug administration in Sri Lanka.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Child; Diethylcarbamazine; Elephantiasis, Filarial; F | 2017 |
Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
Topics: Africa South of the Sahara; Albendazole; Animals; Diethylcarbamazine; Drug Synergism; Drug Therapy, | 2018 |
How elimination of lymphatic filariasis as a public health problem in the Kingdom of Cambodia was achieved.
Topics: Adult; Albendazole; Cambodia; Child; Diethylcarbamazine; Elephantiasis, Filarial; Health Personnel; | 2018 |
Chyluria in young child: a rare presentation.
Topics: Child; Chyle; Diet, Fat-Restricted; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans | 2018 |
Lymphatic filariasis elimination programme in Assam, India, needs change in mass drug administration strategy to target the focus of infection.
Topics: Albendazole; Animals; Diethylcarbamazine; Elephantiasis, Filarial; Female; Filaricides; Humans; Indi | 2018 |
Are Alternative Strategies Required to Accelerate the Global Elimination of Lymphatic Filariasis? Insights From Mathematical Models.
Topics: Albendazole; Animals; Computer Simulation; Diethylcarbamazine; Disease Eradication; Drug Therapy, Co | 2018 |
Comprehensive Assessment of a Hotspot with Persistent Bancroftian Filariasis in Coastal Sri Lanka.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Anthelmintics; Antibodies, Helminth; Child; Culex; Di | 2018 |
Effectiveness of annual single doses of diethylcarbamazine citrate among bancroftian filariasis infected individuals in an endemic area under mass drug administration in Brazil.
Topics: Adolescent; Adult; Aged; Animals; Antibodies, Helminth; Antigens, Helminth; Brazil; Child; Child, Pr | 2018 |
Towards elimination of lymphatic filariasis in southeastern Madagascar: Successes and challenges for interrupting transmission.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albendazole; Child; Child, Preschool; Diethylcarbamazine | 2018 |
Recognition and killing of Brugia malayi microfilariae by human immune cells is dependent on the parasite sample and is not altered by ivermectin treatment.
Topics: Animals; Brugia malayi; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; High-Throughput Nu | 2018 |
Wucherria bancrofti glutathione S-Transferase: Insights into the 2.3 Å resolution X-ray structure and function, a therapeutic target for human lymphatic filariasis.
Topics: Animals; Binding Sites; Crystallography, X-Ray; Diethylcarbamazine; Elephantiasis, Filarial; Glutath | 2018 |
The prevalence of lymphatic filariasis infection and disease following six rounds of mass drug administration in Mandalay Region, Myanmar.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albendazole; Animals; Child; Child, Preschool; Cross-Sec | 2018 |
Elimination within reach: A cross-sectional study highlighting the factors that contribute to persistent lymphatic filariasis in eight communities in rural Ghana.
Topics: Albendazole; Animals; Anopheles; Antigens, Helminth; Brugia malayi; Child; Child, Preschool; Cross-S | 2019 |
Systematic sampling of adults as a sensitive means of detecting persistence of lymphatic filariasis following mass drug administration in Sri Lanka.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albendazole; Animals; Diethylcarbamazine; Elephantiasis, | 2019 |
How Thailand eliminated lymphatic filariasis as a public health problem.
Topics: Adolescent; Adult; Albendazole; Animals; Anthelmintics; Antibodies, Helminth; Antigens, Helminth; Ca | 2019 |
Economic performance and cost-effectiveness of using a DEC-salt social enterprise for eliminating the major neglected tropical disease, lymphatic filariasis.
Topics: Administration, Oral; Cost-Benefit Analysis; Diethylcarbamazine; Disease Eradication; Elephantiasis, | 2019 |
Towards elimination of lymphatic filariasis: social mobilization issues and challenges in mass drug administration with anti-filarial drugs in Tamil Nadu, South India.
Topics: Albendazole; Animals; Community Health Services; Community Health Workers; Community Participation; | 2013 |
Effect of Diethylcarbamazine (DEC) on prostaglandin levels in Wuchereria bancrofti infected microfilaraemics.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Diethylcarbamazine; Dinoprostone; Elephantiasis, Filarial; Fi | 2013 |
Knowledge and practice related to compliance with mass drug administration during the Egyptian national filariasis elimination program.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albendazole; Animals; Diethylcarbamazine; Egypt; Elephan | 2013 |
Rural-urban population movement, community context and impact on DEC fortified salt program to eliminate lymphatic filariasis.
Topics: Animals; Diethylcarbamazine; Elephantiasis, Filarial; Female; Filaricides; Health Knowledge, Attitud | 2011 |
Coverage and awareness of and compliance with mass drug administration for elimination of lymphatic filariasis in Burdwan District, West Bengal, India.
Topics: Adolescent; Age Distribution; Awareness; Child; Child, Preschool; Cross-Sectional Studies; Diethylca | 2013 |
Semiparametric regression analysis of clustered interval-censored failure time data with informative cluster size.
Topics: Adolescent; Adult; Aged; Albendazole; Biometry; Cluster Analysis; Computer Simulation; Diethylcarbam | 2013 |
A longitudinal analysis of the effect of mass drug administration on acute inflammatory episodes and disease progression in lymphedema patients in Leogane, Haiti.
Topics: Adolescent; Adult; Aged; Albendazole; Anthelmintics; Child; Diethylcarbamazine; Elephantiasis, Filar | 2014 |
Persistence of lymphatic filarial infection in the paediatric population of rural community, after six rounds of annual mass drug administrations.
Topics: Albendazole; Animals; Antigens, Helminth; Child; Child, Preschool; Diethylcarbamazine; Drug Administ | 2014 |
Liquid chromatography-mass spectrometry analysis of diethylcarbamazine in human plasma for clinical pharmacokinetic studies.
Topics: Albendazole; Chromatography, Liquid; Diethylcarbamazine; Elephantiasis, Filarial; Humans; Ivermectin | 2014 |
Awareness and coverage of mass drug administration for elimination of lymphatic filariasis: a community based cross sectional study in Nepal.
Topics: Adult; Community Health Workers; Cross-Sectional Studies; Diethylcarbamazine; Elephantiasis, Filaria | 2015 |
Measuring impact on filarial infection status in a community study: role of coverage of mass drug administration (MDA).
Topics: Albendazole; Diethylcarbamazine; Drug Therapy; Drug Utilization; Elephantiasis, Filarial; Filaricide | 2014 |
Diethylcarbamazine inhibits NF-κB activation in acute lung injury induced by carrageenan in mice.
Topics: Animals; Anti-Inflammatory Agents; Carrageenan; Curcumin; Diethylcarbamazine; Disease Models, Animal | 2014 |
Decline in lymphatic filariasis transmission with annual mass drug administration using DEC with and without albendazole over a 10year period in India.
Topics: Albendazole; Animals; Culex; Diethylcarbamazine; Disease Eradication; Drug Administration Schedule; | 2015 |
A comprehensive assessment of lymphatic filariasis in Sri Lanka six years after cessation of mass drug administration.
Topics: Adolescent; Adult; Albendazole; Animals; Anthelmintics; Antibodies, Helminth; Antigens, Helminth; Ch | 2014 |
Are we nearly there yet? Coverage and compliance of mass drug administration for lymphatic filariasis elimination.
Topics: Diethylcarbamazine; Disease Eradication; Elephantiasis, Filarial; Filaricides; Health Plan Implement | 2015 |
Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis.
Topics: Adult; Albendazole; Animals; Anthelmintics; Auranofin; Brugia malayi; Cattle; Cell Line; Diethylcarb | 2015 |
Impact on prevalence of intestinal helminth infection in school children administered with seven annual rounds of diethyl carbamazine (DEC) with albendazole.
Topics: Albendazole; Animals; Child; Diethylcarbamazine; Drug Administration Schedule; Elephantiasis, Filari | 2015 |
Residual microfilaraemia in rural pockets of South India after five rounds of DEC plus albendazole administration as part of the LF elimination campaign.
Topics: Adolescent; Adult; Albendazole; Animals; Anthelmintics; Child; Child, Preschool; Diethylcarbamazine; | 2015 |
Evaluation of mass drug administration in the program to control imported lymphatic filariasis in Thailand.
Topics: Adult; Animals; Communicable Disease Control; Cross-Sectional Studies; Diethylcarbamazine; Elephanti | 2015 |
Post-Mass Drug Administration Transmission Assessment Survey for Elimination of Lymphatic Filariasis in La Ciénaga, Dominican Republic.
Topics: Albendazole; Child; Child, Preschool; Chromatography, Affinity; Diethylcarbamazine; Disease Eradicat | 2015 |
Impact of insecticide treated mosquito nets and low dose monthly diethylcarbamazine on lymphatic filariasis infection between 1999 and 2004 in two endemic communities of north-eastern Tanzania.
Topics: Child; Child, Preschool; Cross-Sectional Studies; Diethylcarbamazine; Elephantiasis, Filarial; Femal | 2012 |
Circulating filarial antigen detection in brugian filariasis.
Topics: Adult; Animals; Antigens, Helminth; Asymptomatic Diseases; Diethylcarbamazine; Elephantiasis, Filari | 2016 |
Can community-based integrated vector control hasten the process of LF elimination?
Topics: Albendazole; Animals; Brugia malayi; Community Participation; Culicidae; Diethylcarbamazine; Disease | 2016 |
Antifilarial activity of diterpenoids from Taxodium distichum.
Topics: Animals; Brugia malayi; Diethylcarbamazine; Disease Models, Animal; Diterpenes; Elephantiasis, Filar | 2016 |
On the Thermal Stability of the Diethylcarbamazine-Fortified Table Salt Used in the Control of Lymphatic Filariasis.
Topics: Animals; Cooking; Diethylcarbamazine; Drug Stability; Elephantiasis, Filarial; Filaricides; Hot Temp | 2016 |
Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators.
Topics: Albendazole; Animals; Computer Simulation; Culex; Diethylcarbamazine; Drug Administration Schedule; | 2016 |
Controlling Neglected Tropical Diseases (NTDs) in Haiti: Implementation Strategies and Evidence of Their Success.
Topics: Albendazole; Animals; Anthelmintics; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Haiti | 2016 |
The Impact of Lymphatic Filariasis Mass Drug Administration Scaling Down on Soil-Transmitted Helminth Control in School-Age Children. Present Situation and Expected Impact from 2016 to 2020.
Topics: Africa; Albendazole; Animals; Anthelmintics; Antinematodal Agents; Asia; Child; Diethylcarbamazine; | 2016 |
Global elimination of lymphatic filariasis.
Topics: Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans | 2017 |
Effectiveness of a triple-drug regimen for global elimination of lymphatic filariasis: a modelling study.
Topics: Albendazole; Animals; Anthelmintics; Antiparasitic Agents; Diethylcarbamazine; Drug Administration S | 2017 |
Effectiveness of a triple-drug regimen for global elimination of lymphatic filariasis: a modelling study.
Topics: Albendazole; Animals; Anthelmintics; Antiparasitic Agents; Diethylcarbamazine; Drug Administration S | 2017 |
Effectiveness of a triple-drug regimen for global elimination of lymphatic filariasis: a modelling study.
Topics: Albendazole; Animals; Anthelmintics; Antiparasitic Agents; Diethylcarbamazine; Drug Administration S | 2017 |
Effectiveness of a triple-drug regimen for global elimination of lymphatic filariasis: a modelling study.
Topics: Albendazole; Animals; Anthelmintics; Antiparasitic Agents; Diethylcarbamazine; Drug Administration S | 2017 |
Effectiveness of a triple-drug regimen for global elimination of lymphatic filariasis: a modelling study.
Topics: Albendazole; Animals; Anthelmintics; Antiparasitic Agents; Diethylcarbamazine; Drug Administration S | 2017 |
Effectiveness of a triple-drug regimen for global elimination of lymphatic filariasis: a modelling study.
Topics: Albendazole; Animals; Anthelmintics; Antiparasitic Agents; Diethylcarbamazine; Drug Administration S | 2017 |
Effectiveness of a triple-drug regimen for global elimination of lymphatic filariasis: a modelling study.
Topics: Albendazole; Animals; Anthelmintics; Antiparasitic Agents; Diethylcarbamazine; Drug Administration S | 2017 |
Effectiveness of a triple-drug regimen for global elimination of lymphatic filariasis: a modelling study.
Topics: Albendazole; Animals; Anthelmintics; Antiparasitic Agents; Diethylcarbamazine; Drug Administration S | 2017 |
Effectiveness of a triple-drug regimen for global elimination of lymphatic filariasis: a modelling study.
Topics: Albendazole; Animals; Anthelmintics; Antiparasitic Agents; Diethylcarbamazine; Drug Administration S | 2017 |
Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
Topics: Africa; Albendazole; Anthelmintics; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Fi | 2017 |
Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
Topics: Africa; Albendazole; Anthelmintics; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Fi | 2017 |
Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
Topics: Africa; Albendazole; Anthelmintics; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Fi | 2017 |
Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
Topics: Africa; Albendazole; Anthelmintics; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Fi | 2017 |
Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
Topics: Africa; Albendazole; Anthelmintics; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Fi | 2017 |
Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
Topics: Africa; Albendazole; Anthelmintics; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Fi | 2017 |
Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
Topics: Africa; Albendazole; Anthelmintics; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Fi | 2017 |
Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
Topics: Africa; Albendazole; Anthelmintics; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Fi | 2017 |
Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
Topics: Africa; Albendazole; Anthelmintics; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Fi | 2017 |
Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
Topics: Africa; Albendazole; Anthelmintics; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Fi | 2017 |
Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
Topics: Africa; Albendazole; Anthelmintics; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Fi | 2017 |
Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
Topics: Africa; Albendazole; Anthelmintics; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Fi | 2017 |
Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
Topics: Africa; Albendazole; Anthelmintics; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Fi | 2017 |
Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
Topics: Africa; Albendazole; Anthelmintics; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Fi | 2017 |
Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
Topics: Africa; Albendazole; Anthelmintics; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Fi | 2017 |
Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
Topics: Africa; Albendazole; Anthelmintics; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Fi | 2017 |
An elephantine problem.
Topics: Adult; Animals; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans; Male; Skin Disease | 2017 |
Impact of two rounds of mass treatment with diethylcarbamazine plus albendazole on Wuchereria bancrofti infection and the sensitivity of immunochromatographic test in Malindi, Kenya.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albendazole; Animals; Anti-Infective Agents; Antigens, B | 2008 |
Effect of repeated mass chemotherapy for filariasis control on soil-transmitted helminth infections in Sri Lanka.
Topics: Albendazole; Animals; Anthelmintics; Child; Communicable Disease Control; Diethylcarbamazine; Drug T | 2008 |
Pharmacovigilance through consumer feedback (reporting) in the mass treatment of lymphatic filariasis using diethylcarbamazine and albendazole in two districts of Sri Lanka.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Albendazole; An | 2008 |
[ Bancroftian lymphatic filariasis: toward its elimination from the Pacific?].
Topics: Aedes; Albendazole; Animals; Antigens, Helminth; Diethylcarbamazine; Elephantiasis, Filarial; Filari | 2008 |
Clinical and pathological aspects of filarial lymphedema and its management.
Topics: Adult; Child; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans | 2008 |
Lymphatic filariasis elimination programme in India: progress and challenges.
Topics: Albendazole; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans; India; National Healt | 2009 |
The impact of repeated rounds of mass drug administration with diethylcarbamazine plus albendazole on bancroftian filariasis in Papua New Guinea.
Topics: Adult; Aging; Albendazole; Animals; Anopheles; Anthelmintics; Antigens, Helminth; Child; Culicidae; | 2008 |
Treatment-seeking behavior and treatment practices of lymphatic filariasis patients with lymphoedema in the Colombo district, Sri Lanka.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Child; Cross-Sectional Studies; Diethylca | 2008 |
Clinicians' attitude on mass drug administration under the program to eliminate lymphatic filariasis: a qualitative study from Orissa, India.
Topics: Communicable Disease Control; Community Health Centers; Diethylcarbamazine; Elephantiasis, Filarial; | 2009 |
Strengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: an evaluation study.
Topics: Adult; Child; Community Health Services; Community Health Workers; Community Participation; Cross-Se | 2008 |
Antifilarial drugs, in the doses employed in mass drug administrations by the Global Programme to Eliminate Lymphatic Filariasis, reverse lymphatic pathology in children with Brugia malayi infection.
Topics: Adolescent; Albendazole; Animals; Brugia malayi; Child; Child, Preschool; Diethylcarbamazine; Drug C | 2009 |
Prolonged persistence of residual Wuchereria bancrofti infection after cessation of diethylcarbamazine-fortified salt programme.
Topics: Adolescent; Adult; Animals; Antigens, Helminth; Carrier State; Child; Child, Preschool; Diethylcarba | 2009 |
The effect of HIV on filarial-specific antibody response before and after treatment with diethylcarbamazine in Wuchereria bancrofti infected individuals.
Topics: Adult; Animals; Antibodies, Helminth; Antibody Specificity; CD4 Lymphocyte Count; Diethylcarbamazine | 2009 |
Intrascrotal nodules in adult men as a marker for filarial granuloma in a bancroftian filariasis-endemic area.
Topics: Adolescent; Adult; Brazil; Diethylcarbamazine; Elephantiasis, Filarial; Endemic Diseases; Filaricide | 2009 |
Imported bancroftian filariasis: diethylcarbamazine response and benzimidazole susceptibility of Wuchereria bancrofti in dynamic cross-border migrant population targeted by the National Program to Eliminate Lymphatic Filariasis in South Thailand.
Topics: Adult; Amino Acid Sequence; Animals; Base Sequence; Benzimidazoles; Diethylcarbamazine; Elephantiasi | 2010 |
Interruption of annual single dose DEC regimen administration: impact on Wuchereria bancrofti microfilaraemia, vector infection and infectivity rates.
Topics: Adolescent; Adult; Animals; Child; Child, Preschool; Culex; Diethylcarbamazine; Drug Administration | 2009 |
Lymphatic filariasis in Andhra Pradesh Paper Mill Colony, Rajahmundry, India after nine rounds of MDA programme.
Topics: Administration, Oral; Animals; Blood; Culex; Diethylcarbamazine; Drug Therapy; Elephantiasis, Filari | 2010 |
Coverage survey for assessing mass drug administration against lymphatic filariasis in Gulbarga district, Karnataka, India.
Topics: Administration, Oral; Adolescent; Adult; Aged; Albendazole; Animals; Child; Child, Preschool; Diethy | 2010 |
Geographic and ecologic heterogeneity in elimination thresholds for the major vector-borne helminthic disease, lymphatic filariasis.
Topics: Albendazole; Animals; Anthelmintics; Bayes Theorem; Computer Simulation; Diethylcarbamazine; Elephan | 2010 |
Role of community empowerment in the elimination of lymphatic filariasis in south India.
Topics: Albendazole; Anthelmintics; Community Health Services; Community Participation; Diethylcarbamazine; | 2010 |
Increasing compliance with mass drug administration programs for lymphatic filariasis in India through education and lymphedema management programs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albendazole; Analysis of Variance; Animals; Child; Child | 2010 |
Improving community participation to eliminate lymphatic filariasis in American Samoa.
Topics: Albendazole; American Samoa; Animals; Anthelmintics; Community Participation; Diethylcarbamazine; Dr | 2011 |
Zoonotic Brugia pahangi filariasis in a suburbia of Kuala Lumpur City, Malaysia.
Topics: Adult; Aged; Albendazole; Animals; Cats; Culicidae; Diethylcarbamazine; Elephantiasis, Filarial; Fem | 2011 |
A rare case of reversible acquired AA-type renal amyloidosis in a chronic filariasis patient receiving antifilarial therapy.
Topics: Adult; Amyloidosis; Angiotensin-Converting Enzyme Inhibitors; Animals; Anthelmintics; Antigens, Helm | 2011 |
Influence of anti-filarial chemotherapy strategies on the genetic structure of Wuchereria bancrofti populations.
Topics: Albendazole; Animals; Diethylcarbamazine; Drug Administration Schedule; Drug Therapy, Combination; E | 2011 |
Effect of annual mass administration of diethylcarbamazine and albendazole on bancroftian filariasis in five villages in south India.
Topics: Albendazole; Animals; Antigens, Helminth; Culex; Diethylcarbamazine; Drug Administration Schedule; E | 2011 |
Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Anthelmintics; beta-Cyclodextrins; Brugia; Chemistry, Ph | 2011 |
Lymphatic filariasis in Australia: an update on presentation, diagnosis and treatment.
Topics: Adult; Australia; Diethylcarbamazine; Doxycycline; Drug Therapy, Combination; Elephantiasis, Filaria | 2011 |
Acquired alpha 1-antitrypsin deficiency in tropical pulmonary eosinophilia.
Topics: Adult; Aged; Alleles; alpha 1-Antitrypsin; alpha 1-Antitrypsin Deficiency; Animals; Case-Control Stu | 2011 |
An uncommon infectious cause of pleural effusion.
Topics: Adult; Animals; Axilla; Biopsy, Fine-Needle; Diethylcarbamazine; Elephantiasis, Filarial; Female; Fi | 2011 |
Costs of integrated mass drug administration for neglected tropical diseases in Haiti.
Topics: Albendazole; Anthelmintics; Costs and Cost Analysis; Diethylcarbamazine; Drug Therapy; Elephantiasis | 2011 |
Adverse reactions following mass drug administration with diethylcarbamazine in lymphatic filariasis endemic areas in the Northeast of Brazil.
Topics: Adolescent; Adult; Animals; Brazil; Cross-Sectional Studies; Diethylcarbamazine; Elephantiasis, Fila | 2012 |
New goals set for filariasis elimination in India.
Topics: Albendazole; Anthelmintics; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; | 2002 |
Compliance with the mass chemotherapy program for lymphatic filariasis.
Topics: Adult; Aged; Chi-Square Distribution; Diethylcarbamazine; Elephantiasis, Filarial; Female; Filaricid | 2001 |
Lymphatic filariasis in kenya since 1910, and the prospects for its elimination: a review.
Topics: Clinical Trials as Topic; Diethylcarbamazine; Elephantiasis, Filarial; Endemic Diseases; Epidemiolog | 2001 |
Targeting of children in filariasis mass drug administration.
Topics: Adolescent; Adult; Albendazole; Anthelmintics; Child; Child, Preschool; Diethylcarbamazine; Elephant | 2002 |
Major progress toward eliminating lymphatic filariasis.
Topics: Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Humans; Ivermec | 2002 |
[Technical measures of filariasis elimination in Tengzhou City].
Topics: Animals; China; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans; Microfilariae; Pre | 2002 |
A brief introduction to the research achievement on the strategy and technical measures for interrupting the transmission of lymphatic filariasis in China.
Topics: China; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans; Mosquito Control; Populatio | 2001 |
Progress towards, and challenges for, the elimination of filariasis from Pacific-island communities.
Topics: Albendazole; Animals; Culicidae; Diethylcarbamazine; Disease Vectors; Elephantiasis, Filarial; Endem | 2002 |
Operational issues in the control of the vectors of Brugia.
Topics: Animals; Brugia; Brugia malayi; Culicidae; Diethylcarbamazine; Disease Vectors; Elephantiasis, Filar | 2002 |
Cost-effectiveness of the use of vector control and mass drug administration, separately or in combination, against lymphatic filariasis.
Topics: Animals; Cost-Benefit Analysis; Culex; Diethylcarbamazine; Disease Vectors; Drug Therapy, Combinatio | 2002 |
Use of floating layers of polystyrene beads to control populations of the filaria vector Culex quinquefasciatus.
Topics: Animals; Culex; Diethylcarbamazine; Disease Vectors; Elephantiasis, Filarial; Endemic Diseases; Fila | 2002 |
Modelling the epidemiology, transmission and control of lymphatic filariasis.
Topics: Animals; Computer Simulation; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial | 2002 |
Factors responsible for coverage and compliance in mass drug administration during the programme to eliminate lymphatic filariasis in the East Godavari District, South India.
Topics: Attitude of Health Personnel; Attitude to Health; Community Health Services; Diethylcarbamazine; Ele | 2003 |
Ensuring supplies of quality diethylcarbamazine citrate (DEC).
Topics: Chromatography, High Pressure Liquid; Diethylcarbamazine; Drug Industry; Drug Stability; Elephantias | 2003 |
Strategic options for global lymphatic filariasis elimination.
Topics: Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans | 2003 |
Lymphatic filariasis.
Topics: Albendazole; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Endemic Disease | 2003 |
Frequency, severity, and costs of adverse reactions following mass treatment for lymphatic filariasis using diethylcarbamazine and albendazole in Leogane, Haiti, 2000.
Topics: Adolescent; Adult; Age Factors; Albendazole; Anthelmintics; Diethylcarbamazine; Elephantiasis, Filar | 2003 |
Acute scrotum secondary to filarial infection: a case report.
Topics: Acute Disease; Adult; Animals; Diagnosis, Differential; Diethylcarbamazine; Elephantiasis, Filarial; | 2002 |
Dance of live adult filarial worms is a reliable sign of scrotal filarial infection.
Topics: Adult; Animals; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Genital Diseases, Male; Hu | 2003 |
FLUORIDE IN FILARIAL ELEPHANTIASIS.
Topics: Animals; Diethylcarbamazine; Drug Therapy; Elephantiasis, Filarial; Filariasis; Fluorides; Humans; I | 1964 |
Report on active surveillance for adverse events following the use of drug co-administrations in the global programme to eliminate lymphatic filariasis.
Topics: Adverse Drug Reaction Reporting Systems; Albendazole; Animals; Diethylcarbamazine; Drug Therapy, Com | 2003 |
Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study.
Topics: Albendazole; Animals; Computer Simulation; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; | 2003 |
Pacific nations lead the way in fighting lymphatic filariasis. Region aims to eliminate.
Topics: Albendazole; Anthelmintics; Diethylcarbamazine; Elephantiasis, Filarial; Fiji; Filaricides; Humans; | 2003 |
Impact of two annual single-dose mass drug administrations with diethylcarbamazine alone or in combination with albendazole on Wuchereria bancrofti microfilaraemia and antigenaemia in south India.
Topics: Adolescent; Adult; Albendazole; Animals; Anthelmintics; Antigens, Helminth; Child; Child, Preschool; | 2004 |
Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India.
Topics: Adolescent; Albendazole; Antiprotozoal Agents; Child; Child, Preschool; Diethylcarbamazine; Drug The | 2004 |
Contrasting Wuchereria bancrofti microfilaria rates in two Mangyan-populated Philippine villages.
Topics: Albendazole; Animals; Antiprotozoal Agents; Child; Child, Preschool; Diethylcarbamazine; Elephantias | 2004 |
Effectiveness of two annual, single-dose mass drug administrations of diethylcarbamazine alone or in combination with albendazole on soil-transmitted helminthiasis in filariasis elimination programme.
Topics: Albendazole; Anthelmintics; Child; Cross-Sectional Studies; Diethylcarbamazine; Drug Therapy, Combin | 2004 |
Community-wide reduction in prevalence and intensity of intestinal helminths as a collateral benefit of lymphatic filariasis elimination programs.
Topics: Adolescent; Adult; Age Distribution; Albendazole; Animals; Anthelmintics; Child; Child, Preschool; D | 2004 |
Histopathologic improvement with lymphedema management, Léogâne, Haiti.
Topics: Adolescent; Adult; Dermis; Diethylcarbamazine; Elephantiasis, Filarial; Epidermis; Female; Filaricid | 2004 |
Physicians' management of filarial lymphoedema and hydrocele in Pondicherry, India.
Topics: Acute Disease; Chronic Disease; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans; Hy | 2005 |
Some morphological aspects of Wuchereria bancrofti uterus after treatment with diethylcarbamazine.
Topics: Animals; Diethylcarbamazine; Elephantiasis, Filarial; Female; Filaricides; Humans; Male; Microfilari | 2005 |
Elimination of lymphatic filariasis in India.
Topics: Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans; India; Public Health | 2005 |
Report on the mid-term assessment of microfilaraemia reduction in sentinel sites of 13 countries of the Global Programme to Eliminate Lymphatic Filariasis.
Topics: Albendazole; Developing Countries; Diethylcarbamazine; Disease Outbreaks; Drug Therapy, Combination; | 2004 |
Evaluation of a single oral dose of diethylcarbamazine 300 mg as provocative test and simultaneous treatment in Myanmar migrant workers with Wuchereria bancrofti infection in Thailand.
Topics: Adolescent; Adult; Animals; Antigens, Helminth; Diethylcarbamazine; Elephantiasis, Filarial; Enzyme- | 2004 |
Pattern of community compliance with spaced, single-dose, mass administrations of diethylcarbamazine or ivermectin, for the elimination of lymphatic filariasis from rural areas of southern India.
Topics: Animals; Chi-Square Distribution; Cohort Studies; Diethylcarbamazine; Drug Administration Schedule; | 2005 |
Ultrasonographic examination of Haitian children with lymphatic filariasis: a longitudinal assessment in the context of antifilarial drug treatment.
Topics: Adolescent; Albendazole; Child; Child, Preschool; Diethylcarbamazine; Elephantiasis, Filarial; Femal | 2005 |
A rapid method to assess the coverage of the mass drug administration of diethylcarbamazine in the program to eliminate lymphatic filariasis in India.
Topics: Cluster Analysis; Cost-Benefit Analysis; Diethylcarbamazine; Drug Utilization Review; Elephantiasis, | 2005 |
Border and imported bancroftian filariases: baseline seroprevalence in sentinel populations exposed to infections with Wuchereria bancrofti and concomitant HIV at the start of diethylcarbamazine mass treatment in Thailand.
Topics: Adolescent; Adult; Age Distribution; Aged; Animals; Antigens, Helminth; Child; Diethylcarbamazine; E | 2005 |
Preventing confusion about side effects in a campaign to eliminate lymphatic filariasis.
Topics: Aged; Aged, 80 and over; Animals; Diethylcarbamazine; Elephantiasis, Filarial; Endemic Diseases; Fil | 2005 |
Is anthelmintic resistance a threat to the program to eliminate lymphatic filariasis?
Topics: Albendazole; Animals; Anthelmintics; Diethylcarbamazine; Drug Resistance; Drug Therapy, Combination; | 2005 |
Evaluation of the program to eliminate lymphatic filariasis in Vanuatu following two years of mass drug administration implementation: results and methodologic approach.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Antigens, Helminth; Bedding and Linens; Child; Child, | 2005 |
The Leogane, Haiti demonstration project: decreased microfilaremia and program costs after three years of mass drug administration.
Topics: Albendazole; Animals; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filari | 2005 |
Adverse reactions following mass drug administration during the Programme to Eliminate Lymphatic Filariasis in Orissa State, India.
Topics: Adolescent; Adult; Albendazole; Animals; Child; Child, Preschool; Communicable Disease Control; Diet | 2006 |
Bancroftian filariasis: effect of repeated treatment with diethylcarbamazine and albendazole on microfilaraemia, antigenaemia and antifilarial antibodies.
Topics: Adolescent; Adult; Albendazole; Animals; Anthelmintics; Antibodies, Helminth; Antigens, Helminth; Di | 2006 |
Evidence for the use of albendazole for the elimination of lymphatic filariasis.
Topics: Adolescent; Adult; Albendazole; Child; Clinical Trials as Topic; Diethylcarbamazine; Drug Therapy, C | 2006 |
Lymphatic filariasis: possible pathophysiological nexus with oxidative stress.
Topics: Adult; Antigens, Helminth; Chronic Disease; Diethylcarbamazine; Elephantiasis, Filarial; Female; Fil | 2006 |
Elimination of transmission of lymphatic filariasis in Egypt.
Topics: Albendazole; Animals; Culex; Diethylcarbamazine; Disease Vectors; Egypt; Elephantiasis, Filarial; Fi | 2006 |
A campaign of "communication for behavioural impact" to improve mass drug administrations against lymphatic filariasis: structure, implementation and impact on people's knowledge and treatment coverage.
Topics: Attitude to Health; Communication; Diethylcarbamazine; Elephantiasis, Filarial; Endemic Diseases; Fi | 2006 |
Community-based study to assess the efficacy of DEC plus ALB against DEC alone on bancroftian filarial infection in endemic areas in Tamil Nadu, south India.
Topics: Adolescent; Adult; Albendazole; Animals; Anthelmintics; Antigens, Helminth; Child; Child, Preschool; | 2006 |
Elimination of lymphatic filariasis.
Topics: Albendazole; Diethylcarbamazine; Egypt; Elephantiasis, Filarial; Filaricides; Humans; Models, Theore | 2006 |
Changes in Wuchereria bancrofti infection in a highly endemic community following 10 rounds of mass administration of diethylcarbamazine.
Topics: Adult; Aged; Animals; Antigens, Helminth; Child; Child, Preschool; Cross-Sectional Studies; Diethylc | 2007 |
Use of an inclusive-partnership strategy in urban areas of Orissa, India, to increase compliance in a mass drug administration for the control of lymphatic filariasis.
Topics: Adolescent; Adult; Attitude to Health; Child; Child, Preschool; Community Participation; Diethylcarb | 2006 |
School-based health education campaign--a potential tool for social mobilization to promote the use of DEC-fortified salt towards elimination of lymphatic filariasis.
Topics: Diethylcarbamazine; Elephantiasis, Filarial; Endemic Diseases; Female; Filaricides; Health Education | 2007 |
Using knowledge, attitudes and practice (KAP) surveys on lymphatic filariasis to prepare a health promotion campaign for mass drug administration in Alor District, Indonesia.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Albendazole; Anthelmintics; Communicat | 2006 |
Wuchereria bancrofti: effect of single and multiple larval inoculations on infection dynamics and development of clinical manifestations in non-human primate Presbytis entellus.
Topics: Animals; Cercopithecidae; Culex; Diethylcarbamazine; Disease Models, Animal; Elephantiasis, Filarial | 2007 |
Albendazole for mass drug administration to eliminate lymphatic filariasis.
Topics: Albendazole; Anthelmintics; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; | 2006 |
Vector control complements mass drug administration against bancroftian filariasis in Tirukoilur, India.
Topics: Adolescent; Adult; Albendazole; Animals; Antiparasitic Agents; Culex; Diethylcarbamazine; Elephantia | 2007 |
Serum immune complexes as diagnostic and therapeutic markers in lymphatic filariasis.
Topics: Animals; Antigen-Antibody Complex; Antigens, Helminth; Biomarkers; Carrier State; Diethylcarbamazine | 2007 |
Impact of the 2004 mass drug administration for the control of lymphatic filariasis, in urban and rural areas of the Western province of Sri Lanka.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albendazole; Animals; Anthelmintics; Child; Child, Presc | 2007 |
Endpoints for lymphatic filariasis programs.
Topics: Albendazole; Animals; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filari | 2007 |
Clinicians' practices related to management of filarial adenolymphangitis and lymphoedema in Orissa, India.
Topics: Acute Disease; Data Collection; Diethylcarbamazine; Elephantiasis, Filarial; Female; Filaricides; He | 2007 |
Probability risk transmission matrix as a decision tool for assessing methods of transmission interruption of Wuchereria bancrofti infection.
Topics: Animals; Child, Preschool; Culex; Decision Support Techniques; Diethylcarbamazine; Elephantiasis, Fi | 2008 |
Lymphatic filariasis in the coastal areas of Digha, West Bengal, India.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Child; Culex; Diethylcarbamazine; Elephantiasis | 2007 |
Unfulfilled potential: using diethylcarbamazine-fortified salt to eliminate lymphatic filariasis.
Topics: Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Guyana; Humans; Iodine; Public Health Prac | 2007 |
Mass drug administration against lymphatic filariasis: experiences from Kozhikode district of Kerala State.
Topics: Adult; Animals; Child; Culex; Diethylcarbamazine; Drug Administration Schedule; Elephantiasis, Filar | 2006 |
National mass drug administration costs for lymphatic filariasis elimination.
Topics: Albendazole; Anthelmintics; Burkina Faso; Costs and Cost Analysis; Diethylcarbamazine; Dominican Rep | 2007 |
Effect of mass drug administration programme on microfilaria carriers in East Godavari district of Andhra Pradesh.
Topics: Animals; Carrier State; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans; India; Mas | 2007 |
The effect of compliance on the impact of mass drug administration for elimination of lymphatic filariasis in Egypt.
Topics: Adolescent; Adult; Albendazole; Animals; Antigens, Helminth; Child; Cross-Sectional Studies; Diethyl | 2007 |
Kinetics of microfilaraemia & antigenaemia status by Og(4)C(3) ELISA in bancroftian filariasis.
Topics: Adolescent; Adult; Animals; Antigens, Helminth; Carrier State; Child; Diethylcarbamazine; Elephantia | 2007 |
Study on the factors affecting the MDA programme in Kerala state.
Topics: Diethylcarbamazine; Elephantiasis, Filarial; Endemic Diseases; Filaricides; Humans; India; Knowledge | 2007 |
Impact of seven rounds of mass administration of diethylcarbamazine and ivermectin on prevalence of chronic lymphatic filariasis in south India.
Topics: Adult; Antiparasitic Agents; Community Health Services; Cross-Sectional Studies; Diethylcarbamazine; | 2008 |
Huge filarial elephantiasis vulvae in a Nigerian woman with subfertility.
Topics: Adult; Diethylcarbamazine; Elephantiasis, Filarial; Female; Humans; Infertility, Female; Vulvar Dise | 2008 |
Lymphatic filariasis.
Topics: Adult; Antiparasitic Agents; Child; Diethylcarbamazine; Elephantiasis, Filarial; Female; Humans; Ive | 2008 |
Knowledge on lymphatic filariasis and mass drug administration (MDA) programme in filaria endemic districts of Andhra Pradesh, India.
Topics: Animals; Diethylcarbamazine; Drug Administration Schedule; Elephantiasis, Filarial; Endemic Diseases | 2008 |
A great success in lymphatic filariasis control in China. National Technical Steering Group for Filariasis Control and Research, MOPH.
Topics: Animals; Brugia malayi; China; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans; Pre | 1995 |
[Lymphatic filariasis: towards a better use of diethylcarbamazine].
Topics: Africa; Diethylcarbamazine; Drug Administration Schedule; Elephantiasis, Filarial; Humans | 1995 |
Determination of the earliest appearance and peak count of microfilariae of Wuchereria bancrofti and Brugia malayi after taking a single dose of diethylcarbamazine at noon.
Topics: Animals; Brugia malayi; Carrier State; Diethylcarbamazine; Elephantiasis, Filarial; Filariasis; Huma | 1994 |
Elevated cellular immune responses and interferon-gamma release after long-term diethylcarbamazine treatment of patients with human lymphatic filariasis.
Topics: Adolescent; Adult; Animals; Antigens, Helminth; Brugia malayi; Diethylcarbamazine; Drug Administrati | 1995 |
Introduction of an integrated community-based bancroftian filariasis control program into the Mt Bosavi region of the Southern Highlands of Papua New Guinea.
Topics: Adolescent; Adult; Aged; Altitude; Animals; Bedding and Linens; Child; Community Participation; Diet | 1994 |
Response of chyluria and circulating microfilaria to treatment with diethylcarbamazine citrate--a case report.
Topics: Adult; Animals; Chyle; Diethylcarbamazine; Elephantiasis, Filarial; Female; Humans; Microfilariae; U | 1993 |
Bancroftian lymphadenopathy: absence of eosinophils in tissues despite peripheral blood hypereosinophilia.
Topics: Adolescent; Animals; Child; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; | 1994 |
Interleukin-6 and tumor necrosis factor in the pathogenesis of adverse reactions after treatment of lymphatic filariasis and onchocerciasis.
Topics: Adult; Animals; Diethylcarbamazine; Elephantiasis, Filarial; Humans; Interleukin-6; Male; Onchocerca | 1994 |
Kinetics of serum and cellular interleukin-5 in posttreatment eosinophilia of patients with lymphatic filariasis.
Topics: Adolescent; Adult; Diethylcarbamazine; Elephantiasis, Filarial; Eosinophilia; Eosinophils; Humans; I | 1993 |
Follow-up investigations on clinical manifestations after filariasis eradication by diethylcarbamazine medicated common salt on Kinmen (Quemoy) Islands, Republic of China.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Animals; Carrier State; Chronic Disease; Data Collect | 1995 |
Diethylcarbamazine-induced reversal of early lymphatic dysfunction in a patient with bancroftian filariasis: assessment with use of lymphoscintigraphy.
Topics: Adult; Animals; Antibodies, Helminth; Diethylcarbamazine; Elephantiasis, Filarial; Humans; Magnetic | 1996 |
Selective usage of defined TCRBV genes in response to filarial antigens.
Topics: Adolescent; Adult; Animals; Antigens, Helminth; Brugia malayi; Clone Cells; Diethylcarbamazine; Elep | 1997 |
Renal disease in lymphatic filariasis: evidence for tubular and glomerular disorders at various stages of the infection.
Topics: Acetylglucosaminidase; Adolescent; Adult; Aged; Alpha-Globulins; Animals; Antibodies, Helminth; Brug | 1997 |
A review of the present status of lymphatic filariasis in Vietnam.
Topics: Animals; Brugia malayi; Cats; Culicidae; Data Collection; Diethylcarbamazine; Disease Reservoirs; El | 1998 |
Long-term effect of diethylcarbamazine citrate on microfilaraemia status in treated individuals.
Topics: Adolescent; Adult; Child; Child, Preschool; Diethylcarbamazine; Elephantiasis, Filarial; Female; Fil | 1998 |
Bancroftian filariasis in Egypt: visualization of adult worms and subclinical lymphatic pathology by scrotal ultrasound.
Topics: Adult; Animals; Diethylcarbamazine; Elephantiasis, Filarial; Humans; Lymphatic System; Male; Middle | 1998 |
Filarial antibody responses in Wuchereria bancrofti transmission area are related to parasitological but not clinical status.
Topics: Adult; Aged; Animals; Antibodies, Helminth; Diethylcarbamazine; Elephantiasis, Filarial; Female; Fil | 1999 |
Efficacy of five annual single doses of diethylcarbamazine for treatment of lymphatic filariasis in Fiji.
Topics: Animals; Brugia malayi; Data Interpretation, Statistical; Diethylcarbamazine; Drug Administration Sc | 1998 |
Antibody response to a filarial antigen fraction in individuals exposed to Wuchereria bancrofti infection in India.
Topics: Adolescent; Adult; Aged; Aging; Animals; Antibodies, Helminth; Antigens, Helminth; Child; Child, Pre | 1999 |
A longitudinal study of Bancroftian filariasis in the Nile Delta of Egypt: baseline data and one-year follow-up.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Animals; Antibodies, Helminth; Antigens, He | 1999 |
Proposed panel of diagnostic criteria, including the use of ultrasound, to refine the concept of 'endemic normals' in lymphatic filariasis.
Topics: Adult; Animals; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans; Male; Middle Aged; | 1999 |
Perturbations in eosinophil homeostasis following treatment of lymphatic filariasis.
Topics: Adult; Animals; Case-Control Studies; Cell Degranulation; Chemokine CCL5; Chemokines; Cytokines; Die | 2000 |
Estimation of different degrees of provocation by DEC (diethyl carbamazine citrate) medication in bancroftian filariasis in Vellore, Tamilnadu.
Topics: Adolescent; Adult; Animals; Child; Child, Preschool; Diethylcarbamazine; Elephantiasis, Filarial; Fe | 1999 |
A 60 year old woman with axillary mass. Diagnosis: axillary lymphadenitis: filarial.
Topics: Animals; Diagnosis, Differential; Diethylcarbamazine; Elephantiasis, Filarial; Female; Filaricides; | 2000 |
Cost of mass annual single dose diethylcarbamazine distribution for the large scale control of lymphatic filariasis.
Topics: Adolescent; Adult; Child; Child, Preschool; Cost Savings; Diethylcarbamazine; Drug Costs; Elephantia | 2000 |
A programme to eliminate lymphatic filariasis in Tamil Nadu state, India: compliance with annual single-dose DEC mass treatment and some related operational aspects.
Topics: Animals; Diethylcarbamazine; Elephantiasis, Filarial; Female; Filaricides; Humans; India; Male; Pati | 2000 |
Elimination of bancroftian filariasis (Wuchereria bancrofti) in Santa Catarina state, Brazil.
Topics: Animals; Brazil; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans; Mass Screening; P | 2000 |
The impact of 34 years of massive DEC chemotherapy on Wuchereria bancrofti infection and transmission: the Maupiti cohort.
Topics: Aedes; Animals; Antigens, Helminth; Cohort Studies; Diethylcarbamazine; Elephantiasis, Filarial; Fil | 2001 |
Filariasis control: ethics, economics, and good science.
Topics: Carrier State; Control Groups; Developing Countries; Diethylcarbamazine; Elephantiasis, Filarial; Fi | 2001 |
Lymphatic filariasis in children: adenopathy and its evolution in two young girls.
Topics: Animals; Brazil; Child; Diethylcarbamazine; Elephantiasis, Filarial; Female; Filaricides; Humans; Ly | 2001 |
A high performance liquid chromatographic method for the estimation of diethylcarbamazine content in medicated salt samples.
Topics: Animals; Chromatography, High Pressure Liquid; Diethylcarbamazine; Elephantiasis, Filarial; Filarici | 2001 |
Effectiveness of community and health services-organized drug delivery strategies for elimination of lymphatic filariasis in rural areas of Tamil Nadu, India.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Community Health Services; Community Health Worker | 2001 |
Microfilaria in thyroid aspirate.
Topics: Adult; Animals; Biopsy, Needle; Diethylcarbamazine; Elephantiasis, Filarial; Female; Filaricides; Hu | 2002 |
Genetic variability of the human filarial parasite, Wuchereria bancrofti in South India.
Topics: Animals; Diethylcarbamazine; Drug Resistance, Microbial; Elephantiasis, Filarial; Filaricides; Genet | 2002 |
Filarial lymphoedema and alpha-1-adrenergic receptor blockade.
Topics: Adrenergic alpha-Antagonists; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial | 2002 |
Mass drug administration to treat lymphatic filariasis.
Topics: Albendazole; Anthelmintics; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; | 2002 |
Efficacy of bi-annual administration of DEC in the control of bancroftian filariasis.
Topics: Animals; Body Weight; Culex; Diethylcarbamazine; Drug Administration Schedule; Drug Evaluation; Elep | 1992 |
A cloned antigen for serological diagnosis of Wuchereria bancrofti microfilaremia with daytime blood samples.
Topics: Amino Acid Sequence; Animals; Antibodies, Helminth; Antibody Specificity; Antigens, Helminth; Base S | 1992 |
Long-term efficacy of single-dose mass treatment with diethylcarbamazine citrate against diurnally subperiodic Wuchereria bancrofti: eight years' experience in Samoa.
Topics: Adolescent; Adult; Age Factors; Animals; Child; Child, Preschool; Diethylcarbamazine; Elephantiasis, | 1992 |
In vitro and in vivo effect of diethylcarbamazine on the activity of acetylcholinesterase from Wuchereria bancrofti infected human serum.
Topics: Acetylcholinesterase; Administration, Oral; Animals; Antigen-Antibody Complex; Carrier State; Chemic | 1992 |
Mass treatment of filariasis using DEC-medicated salt.
Topics: Animals; Brugia; China; Diethylcarbamazine; Elephantiasis, Filarial; Filariasis; Humans; Microfilari | 1992 |
Wuchereria bancrofti microfilarial density of autochthonous cases and natural Culex infectivity rates in northeast Brazil.
Topics: Animals; Brazil; Culex; Diethylcarbamazine; Elephantiasis, Filarial; Female; Humans; Microfilariae; | 1992 |
Renal abnormalities in microfilaremic patients with Bancroftian filariasis.
Topics: Adolescent; Adult; Animals; Blood Urea Nitrogen; Creatinine; Diethylcarbamazine; Elephantiasis, Fila | 1992 |
Serum interleukin-6 levels and adverse reactions to diethylcarbamazine in lymphatic filariasis.
Topics: Adolescent; Adult; Animals; Brugia; Diethylcarbamazine; Elephantiasis, Filarial; Humans; Interleukin | 1992 |
Efficacy of diethylcarbamazine and pirimiphos-methyl residual spraying in controlling brugian filariasis.
Topics: Adolescent; Adult; Animals; Brugia; Child; Child, Preschool; Culicidae; Diethylcarbamazine; Elephant | 1991 |
Bancroftian filariasis: long-term effects of treatment with diethylcarbamazine in a Haitian population.
Topics: Animals; Diethylcarbamazine; Elephantiasis, Filarial; Follow-Up Studies; Haiti; Humans; Treatment Ou | 1991 |
Effect of diethylcarbamazine on the alveolitis of tropical eosinophilia.
Topics: Acute Disease; Adolescent; Adult; Animals; Bronchoalveolar Lavage Fluid; Chronic Disease; Diethylcar | 1991 |
Efficacy of ivermectin for control of microfilaremia recurring after treatment with diethylcarbamazine. II. Immunologic changes following treatment.
Topics: Adolescent; Adult; Animals; Antibodies, Helminth; Antigens, Helminth; Diethylcarbamazine; Elephantia | 1991 |
Monitoring of filarial antigens in jirds and patients after treatment.
Topics: Animals; Antibodies, Monoclonal; Antigens, Helminth; Brugia; Diethylcarbamazine; Elephantiasis, Fila | 1991 |
Changes in circulating parasite antigen levels after treatment of bancroftian filariasis with diethylcarbamazine and ivermectin.
Topics: Animals; Antigens, Helminth; Diethylcarbamazine; Elephantiasis, Filarial; Humans; Ivermectin; Microf | 1991 |
Control of filariasis.
Topics: Animals; China; Cluster Analysis; Diethylcarbamazine; Elephantiasis, Filarial; Humans; Microfilariae | 1991 |
Influence of diethylcarbamazine on the patent period of infection in periodic Brugia malayi.
Topics: Adolescent; Adult; Animals; Brugia; Carrier State; Child; Cohort Studies; Diethylcarbamazine; Elepha | 1991 |
Filariasis eradication on Kinmen Proper, Kinmen (Quemoy) Islands, Republic of China.
Topics: Adolescent; Animals; Culicidae; Diethylcarbamazine; Elephantiasis, Filarial; Female; Fenitrothion; F | 1990 |
Evidence of nonsusceptibility to diethylcarbamazine in Wuchereria bancrofti.
Topics: Animals; Diethylcarbamazine; Elephantiasis, Filarial; Female; Humans; Male; Microfilariae; Wuchereri | 1991 |
Serological evaluation of the macrofilaricidal effects of diethylcarbamazine treatment in bancroftian filariasis.
Topics: Adolescent; Adult; Age Factors; Animals; Antigens, Helminth; Blotting, Western; Child; Diethylcarbam | 1991 |
Control and surveillance of filariasis in Shandong.
Topics: Animals; China; Diethylcarbamazine; Elephantiasis, Filarial; Humans; Mass Screening; Wuchereria banc | 1991 |
A single diethylcarbamazine dose for treatment of Wuchereria bancrofti carriers in French Polynesia: efficacy and side effects.
Topics: Adolescent; Adult; Animals; Diethylcarbamazine; Elephantiasis, Filarial; Humans; Male; Microfilariae | 1990 |
Bancroftian filariasis and ivermectin.
Topics: Animals; Diethylcarbamazine; Elephantiasis, Filarial; Filariasis; Humans; Ivermectin; Male; Wucherer | 1990 |
Eradication of bancroftian filariasis by diethylcarbamazine-medicated common salt on Little Kinmen (Liehyu district), Kinmen (Quemoy) Islands, Republic of China.
Topics: Adolescent; Adult; Aged; Animals; Carrier State; Child; Child, Preschool; Culex; Diethylcarbamazine; | 1990 |
Effect of a single dose (3 mg/kg) of diethylcarbamazine on Wuchereria bancrofti var pacifica microfilaraemia.
Topics: Adolescent; Adult; Animals; Diethylcarbamazine; Elephantiasis, Filarial; Filariasis; Humans; Male; M | 1990 |
Susceptibility of Mastomys natalensis to Brugia malayi following pretreatment with antifilarials.
Topics: Animals; Brugia; Diethylcarbamazine; Disease Susceptibility; Elephantiasis, Filarial; Female; Filari | 1990 |
Estimation of fecundic life span of Wuchereria bancrofti from longitudinal study of human infection in an endemic area of Pondicherry (south India).
Topics: Adolescent; Adult; Animals; Child; Child, Preschool; Cohort Studies; Diethylcarbamazine; Elephantias | 1990 |
Diethylcarbamazine in the control of bancroftian filariasis in the highly endemic Ok Tedi area of Papua New Guinea: phase 1.
Topics: Adult; Animals; Communicable Disease Control; Diethylcarbamazine; Elephantiasis, Filarial; Female; H | 1990 |
Parasite antigenemia in untreated and treated lymphatic filarial infections.
Topics: Animals; Antibodies, Monoclonal; Antigens, Helminth; Brugia; Diethylcarbamazine; Elephantiasis, Fila | 1990 |
Possible direct effect of diethylcarbamazine on the infective larvae of Brugia pahangi.
Topics: Animals; Brugia; Diethylcarbamazine; Elephantiasis, Filarial; Gerbillinae; Larva | 1990 |
Antifilarial activity of intravenous suramin and oral diethylcarbamazine citrate on subperiodic Brugia malayi in the leaf-monkey, Presbytis cristata.
Topics: Administration, Oral; Animals; Brugia; Cercopithecidae; Diethylcarbamazine; Disease Models, Animal; | 1990 |
Observations on the clinical manifestations and treatment of an experimental infection with Brugia malayi in man.
Topics: Animals; Brugia; Culicidae; Diethylcarbamazine; Elephantiasis, Filarial; Eosinophils; Filariasis; Hu | 1989 |
Ivermectin and prothrombin time.
Topics: Administration, Oral; Adult; Animals; Diethylcarbamazine; Elephantiasis, Filarial; Filariasis; Human | 1989 |
Antibodies to phosphocholine-bearing antigens in lymphatic filariasis and changes following treatment with diethylcarbamazine.
Topics: Adolescent; Adult; Aged; Animals; Antibodies; Antigens; Blood; Choline; Diethylcarbamazine; Elephant | 1989 |
Effectiveness of spaced doses of diethylcarbamazine citrate for the control of bancroftian filariasis.
Topics: Adolescent; Adult; Animals; Carrier State; Child; Diethylcarbamazine; Drug Administration Schedule; | 1989 |
Control of bancroftian filariasis by diethylcarbamazine medicated common salt in Karaikal, Pondicherry, India.
Topics: Adolescent; Adult; Animals; Child; Child, Preschool; Culex; Diethylcarbamazine; Drug Carriers; Eleph | 1989 |
Filariasis control in rural areas through detection and treatment with diethylcarbamazine.
Topics: Animals; Diethylcarbamazine; Elephantiasis, Filarial; Filariasis; Humans; India; Microfilariae; Rura | 1989 |
Feasibility of controlling lymphatic filarial diseases through primary health care system.
Topics: Community Health Workers; Diethylcarbamazine; Elephantiasis, Filarial; Feasibility Studies; Filarias | 1989 |
Combined low dosage and short term standard dose treatment with diethylcarbamazine to control Timorian filariasis.
Topics: Adolescent; Adult; Aged; Brugia; Child; Child, Preschool; Diethylcarbamazine; Drug Administration Sc | 1985 |
Increase in natural killer cell activity during diethylcarbamazine treatment of patients with filariasis.
Topics: Adult; Animals; Diethylcarbamazine; Elephantiasis, Filarial; Female; Filariasis; Humans; Killer Cell | 1987 |
Microfilaraemia, filarial antibody, antigen and immune complex levels in human filariasis before, during and after DEC therapy. A two-year follow-up.
Topics: Animals; Antibodies, Helminth; Antigen-Antibody Complex; Antigens, Helminth; Diethylcarbamazine; Ele | 1988 |
Persistence of microfilaremia in bancroftian filariasis after diethylcarbamazine citrate therapy.
Topics: Animals; Diethylcarbamazine; Elephantiasis, Filarial; Filariasis; Humans; Microfilariae; Time Factor | 1988 |
A quantitative analysis of the diagnostic value of diethylcarbamazine provocation in endemic Wuchereria bancrofti infection.
Topics: Animals; Child; Diethylcarbamazine; Elephantiasis, Filarial; Female; Filariasis; Humans; Male; Micro | 1988 |
Use of mebendazole in combination with DEC in bancroftian filariasis.
Topics: Adolescent; Adult; Animals; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; | 1988 |
The effect of diethylcarbamazine treatment of Bancroftian filariasis on the immunological reactivity of microfilaraemic individuals.
Topics: Adolescent; Adult; Aged; Animals; Antibodies, Helminth; Antigens, Helminth; Brugia; Child; Diethylca | 1988 |
Diethylcarbamazine prophylaxis against bancroftian filariasis given by a member of the local community in Kenya.
Topics: Adolescent; Adult; Animals; Child; Child, Preschool; Diethylcarbamazine; Elephantiasis, Filarial; Fi | 1988 |
Persistence of parasite antigenemia following diethylcarbamazine therapy of bancroftian filariasis.
Topics: Animals; Antibodies, Helminth; Antigens, Helminth; Diethylcarbamazine; Elephantiasis, Filarial; Fila | 1988 |
The effect of diethylcarbamazine citrate on incidence and recovery rates of Brugia malayi microfilaremia in Sabah, Malaysia.
Topics: Adolescent; Adult; Animals; Child; Child, Preschool; Cohort Studies; Diethylcarbamazine; Elephantias | 1988 |
[Upper extremity lymphedema in bancroftial filariasis].
Topics: Adult; Animals; Arm; Diethylcarbamazine; Elephantiasis, Filarial; Female; Filariasis; Humans; Physic | 1988 |
Acute tropical pulmonary eosinophilia. Characterization of the lower respiratory tract inflammation and its response to therapy.
Topics: Adult; Bronchi; Brugia; Cell Count; Diethylcarbamazine; Elephantiasis, Filarial; Eosinophils; Female | 1987 |
Control of filariasis in India.
Topics: Animals; Diethylcarbamazine; Elephantiasis, Filarial; Filariasis; Humans; India; Insect Vectors; Mos | 1986 |
Control of bancroftian filariasis in rural areas through selected treatment with diethylcarbamazine.
Topics: Animals; Carrier State; Costs and Cost Analysis; Diethylcarbamazine; Elephantiasis, Filarial; Filari | 1986 |
Factor influencing acceptance and non-acceptance to DEC in a bancroftian endemic area.
Topics: Animals; Diethylcarbamazine; Elephantiasis, Filarial; Filariasis; Humans; Patient Compliance; Wucher | 1986 |
Bancroftian filariasis in coastal north Trinidad: the effects of mass chemotherapy using spaced doses of diethylcarbamazine citrate on human microfilaraemias and vector infection rates.
Topics: Animals; Culex; Diethylcarbamazine; Elephantiasis, Filarial; Filariasis; Humans; Insect Control; Ins | 1987 |
[Effectiveness of mass chemotherapy campaigns with diethylcarbamazine on blood microfilaria of Wuchereria bancrofti in Mayotte].
Topics: Animals; Diethylcarbamazine; Elephantiasis, Filarial; Filariasis; Humans; Microfilariae; Pacific Isl | 1987 |
Prophylactic effect of diethylcarbamazine on Wuchereria bancrofti filariasis.
Topics: Animals; Diethylcarbamazine; Drug Administration Schedule; Elephantiasis, Filarial; Female; Filarias | 1987 |
Prophylactic effect of diethylcarbamazine on W. bancrofti filariasis.
Topics: Adolescent; Adult; Animals; Child; Child, Preschool; Diethylcarbamazine; Elephantiasis, Filarial; Fe | 1987 |
Control of bancroftian filariasis in a rural area through selected treatment with diethylcarbamazine.
Topics: Animals; Carrier State; Diethylcarbamazine; Elephantiasis, Filarial; Filariasis; Humans; India; Pilo | 1987 |
Basic studies on the laboratory assessment of macrofilaricides using Brugia malayi in the jird, Meriones unguiculatus. 2. Establishment and evaluation of a new method of macrofilaricide assessment.
Topics: Animals; Anthelmintics; Arsenicals; Brugia; Diethylcarbamazine; Drug Evaluation, Preclinical; Elepha | 1988 |
[Studies on criteria of transmission-interruption of filariasis due to Brugia malayi].
Topics: Animals; Anopheles; Brugia; Diethylcarbamazine; Elephantiasis, Filarial; Filariasis; Humans; Insect | 1987 |
New approaches to the control of lymphatic filariasis using diethylcarbamazine.
Topics: Developing Countries; Diethylcarbamazine; Elephantiasis, Filarial; Filariasis; Humans | 1987 |
Brugian filariasis: 10-year follow-up study on the effectiveness of selective chemotherapy with diethylcarbamazine on Che Ju island, Republic of Korea.
Topics: Adolescent; Adult; Aged; Brugia; Child; Child, Preschool; Diethylcarbamazine; Elephantiasis, Filaria | 1987 |
Detection of circulating parasite antigen in bancroftian filariasis by counterimmunoelectrophoresis.
Topics: Antibodies; Antigens, Helminth; Brugia; Counterimmunoelectrophoresis; Diethylcarbamazine; Dirofilari | 1986 |
[Wuchereria bancrofti: value of the diethylcarbamazine provocation test for the diurnal detection of microfilaria carriers].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Circadian Rhythm; Diethylcarbamazine; Elephantiasi | 1986 |
Diethylcarbamazine-mediated clearance of Brugia pahangi microfilariae in immunodeficient nude mice.
Topics: Animals; Brugia; Diethylcarbamazine; Elephantiasis, Filarial; Female; Fluorescent Antibody Technique | 1985 |
Treatment of elephantiasis in a community with timorian filariasis.
Topics: Adolescent; Adult; Aged; Brugia; Child; Diethylcarbamazine; Elephantiasis, Filarial; Female; Humans; | 1985 |
Brugia malayi: clearance of microfilaremia induced by diethylcarbamazine independently of antibody.
Topics: Animals; Antibodies; Brugia; Diethylcarbamazine; Elephantiasis, Filarial; Liver; Lymphedema; Mice; N | 1985 |
Adverse reactions to a single dose of diethylcarbamazine in patients with Brugia malayi infection in Riau Province, West Indonesia.
Topics: Adolescent; Adult; Blood Pressure; Brugia; Child; Diethylcarbamazine; Elephantiasis, Filarial; Femal | 1985 |